IMS HEOR Bibliographies

Search criteria
Country: Germany

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Authors: Avraham Karasik (1), Stefanie Lanzinger (2,3), Elise Chia-Hui Tan (4), Daisuke Yabe (5,6,7 8), Dae Jung Kim (9), Wayne H-H Sheu (10), Cheli Melzer-Cohen (1), Reinhard W. Holl (2), Kyoung-Hwa Ha (9), Kamlesh Khunti (11), Francesco Zaccardi (11), Anuradhaa Subramanian (12), Krishnarajah Nirantharakumar (12,13,14), Thomas NystrÃ¶m (15), Leo Niskanen (16), Majken Linnemann Jensen (17), Fabian Hoti (18), Riho Klement (19), Anouk DÃ©ruaz-Luyet (20), Moe H.Kyaw (21), Lisette Koeneman (22), Dorte Vistisen (23, 24) Bendix Carstensen (23), Sigrun Halvorsen (25), Gisle Langslet (26), Soulmaz Fazeli Farsani (20), Elisabetta Patorno (27), JÃºlio NÃºÃ±ez (28), EMPRISE Europe and Asia Study Group
Affiliations: "1 Maccabi Institute for Research and Innovation Center, Tel Aviv University, Tel Aviv, Israel 2 Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany 3 German Centre for Diabetes Research (DZD), MÃ¼nchen-Neuherberg, Germany 4 Department of Health Service Administration, China Medical University, Taichung, Taiwan 5 Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan 6 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 7 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 8 Preemptive Food Research Center, Gifu University Institute for Advanced Study, Gifu, Japan 9 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 10 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 11 Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK 12 Institute of Applied Health Research, University of Birmingham, Birmingham, UK 13 Midlands Health Data Research UK, Birmingham, UK 14 DEMAND Hub, University of Birmingham, Birmingham, UK 15 Department of Clinical Science and Education, SÃ¶dersjukhuset, Karolinska Institutet, Sweden 16 PÃ¤ijÃ¤t-HÃ¤me Joint Authority for Health and Wellbeing, PÃ¤ijÃ¤t-HÃ¤me Central Hospital, Lahti Finland and University of Eastern Finland, Kuopio, Finland 17 IQVIA Solutions Denmark A/S, Copenhagen, Denmark 18 IQVIA, Espoo, Finland 19 IQVIA, Tartu, Estonia 20 Boehringer Ingelheim International GmbH, Ingelheim, Germany 21 Boehringer Ingelheim International GmbH, US 22 Lilly Deutschland GmbH, Bad Homburg, Germany 23 Steno Diabetes Center Copenhagen, Herlev, Denmark 24 Department of Public Health, University of Copenhagen, Copenhagen, Denmark 25 Department of Cardiology, Oslo University Hospital UllevÃ¥l, and University of Oslo, Oslo, Norway 26 Lipid Clinic, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway 27 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA 28 Department of Cardiology, Hospital ClÃnico Universitario de Valencia, INCLIVA, Universidad de Valencia, CIBER Cardiovascular, Valencia, Spain"
Publications: "Diabetes & Metabolism. 2023 Jan; 101418; ISSN 1262-3636 Virtual Conference: American Diabetes Association, 25-29 June 2021 and EASD 27 September -01 October"
Document Types: , Article
Countries: , Denmark, Finland, Germany, Norway, Spain, Sweden, UK
Abstract: https://doi.org/10.1016/j.diabet.2022.101418 (https://www.sciencedirect.com/science/article/pii/S1262363622000994)
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study	2023	English	, Clinical setting: hospital, Clinical setting: Primary care


Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review
Authors: Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4)
Affiliations: 1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: Pharmaceutical Medicine
Document Types: , Article
Countries: , France, Germany, Japan, UK, USA
Abstract: https://link.springer.com/article/10.1007/s40290-022-00457-5
Condition	Year	Language	Analysis type
, Miscellaneous	2023	English	, Literature Review


The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis
Authors: Helmut Butzkueven, Jan Hillert, Merja Soilu-HÃ¤nninen, Tjalf Ziemssen, Jens Kuhle, Stig Wergeland, Melinda Magyari, Joseph R. Berger, Nicholas Moore, Aida Aydemir, Irene Bezemer & Meritxell SabidÃ³
Affiliations: "a Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia; b The Alfred Hospital, Melbourne, VIC, Australia; c Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; d Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland; e Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany; f Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland; g Department of Neurology, University Hospital and University of Basel, Basel, Switzerland; h Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway; i Department of Clinical Medicine, University of Bergen, Bergen, Norway; j Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; k Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; l Bordeaux PharmacoEpi (BPE), Universitï¿½e de Bordeaux, Bordeaux, France; m EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA; n Global Epidemiology, IQVIA, Amsterdam, The Netherlands; o Merck Healthcare KGaA, Darmstadt, Germany"
Publications:
Document Types: , Article
Countries: , Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2256220
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Neurological disorders	2023	English	, clinical setting: Secondary care, Epidemiological study, Population Based Study


The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets
Authors: Helmut Butzkueven 1 2, Nicholas Moore 3, Aida Aydemir 4, Jaak SÃµnajalg 5, Irene Bezemer 6, Pasi Korhonen 7, Meritxell SabidÃ³ 8, CLARION Study Group
Affiliations: 1Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia. 2The Alfred Hospital, Melbourne, Australia. 3Bordeaux PharmacoEpi (BPE), UniversitÃ© de Bordeaux, Bordeaux, France. 4Global Biostatistics, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA (an affiliate of Merck KGaA). 5Global Database Studies, IQVIA, Tartu, Estonia. 6Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, The Netherlands. 7IQVIA (former EPID Research), Espoo, Finland. 8Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany.
Publications: Current Medical Research and Opinion, DOI: 10.1080/03007995.2022.2059977
Document Types: , Article
Countries: , Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey
Abstract: https://pubmed.ncbi.nlm.nih.gov/35357268/
Condition	Year	Language	Analysis type
, Drug safety, Neurological disorders	2022	English	, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Retrospective database analysis


Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany
Authors: Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2
Affiliations: 1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of TÃ¼bingen, TÃ¼bingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA
Publications: Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000
Document Types: , Article
Countries: , Germany
Abstract: https://pubmed.ncbi.nlm.nih.gov/33761803/
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2021	English	, Clinical setting: Primary care, Cost effectiveness


Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults â€“ A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study)
Authors: Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas
Affiliations: University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States
Publications:
Document Types: , Article
Countries: , Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446
Condition	Year	Language	Analysis type
, Infectious disease	2021	English	, Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study


Predictors of sick leave days in patients affected by major depressive disorder receiving antidepressant treatment in general practice setting in Germany
Authors: Kasper S, Bonelli A, Cattaneo A, Comandini A, Di Dato G, Heiman F, Pegoraro V, Palao D, Roca M, Volz HP
Affiliations: Kasper S: Center for Brain Research, Medical University of Vienna, Austria; Pegoraro V, Heiman F: IQVIA Solutions Italy S.r.l., RWS
Publications: Int J Psychiatry Clin Pract. 2021 Sep 20:1-10. doi: 10.1080/13651501.2021.1972120. Epub ahead of print. PMID: 34543170.
Document Types: , Article
Countries: , Germany
Abstract: https://www.tandfonline.com/doi/full/10.1080/13651501.2021.1972120
Condition	Year	Language	Analysis type
, Mental health	2021	English	, Clinical setting: Primary care, Epidemiological study, Retrospective database analysis


Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiology and Drug Safety.
Authors: Alison Bourke 1, William G Dixon 2, Andrew Roddam 3, Kueiyu Joshua Lin 4, Gillian C Hall 5, Jeffrey R Curtis 6, Sabine N van der Veer 7, Montse Soriano-GabarrÃ³ 8, Juliane K Mills 9, Jacqueline M Major 10, Thomas Verstraeten 11, Matthew J Francis 12, Dorothee B Bartels 13
Affiliations: 1Real World Solutions, IQVIA, London, UK. 2Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK. 3Data & Computational Sciences, GSK, London, UK. 4Brigham and Women's & Department of Medicine, Boston, Massachusetts, USA. 5Gillian Hall Epidemiology Ltd, London, UK. 6Division of Clinical Immunology & Rheumatology, The University of Birmingham, Birmingham, Alabama, USA. 7Centre for Health Informatics, Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. 8Bayer AG, Berlin, Germany. 9PRA Health Sciences, Raleigh, North Carolina, USA. 10Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. 11P95 Pharmacovigilance and Epidemiology, Leuven, Belgium. 12The Procter & Gamble Company, Cincinnati, Ohio, USA. 13UCB Pharma, Anderlecht, Belgium.
Publications: Pharmacoepidemiol Drug Saf . 2020 Dec;29(12):1540-1549. doi: 10.1002/pds.5169. Epub 2020 Nov 13.
Document Types: , Article
Countries: , Belgium, Germany, UK, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/33146896/
Condition	Year	Language	Analysis type
, Database Validity and methodology, Health status & patient reported outcomes, Patient Registries & Real-World Study Methods	2021	English	, Patient questionnaire, Review


Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
Authors: A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. NystrÃ¶m7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. NÃºÃ±ez11, EMPRISE EU and East Asia Study Group;
Affiliations: Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, SÃ¶dersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, PÃ¤ijÃ¤t-HÃ¤me Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital ClÃnico Universitario de Valencia, Valencia, Spain
Publications: https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021
Document Types: , Abstract
Countries: , Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan
Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2021	English	, Database Study, Methodology, Population Based Study


Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk ofcardiovascular and renal disease among type 2 diabetes patients in routinecare in europe and israel: EMPRISE study results
Authors: T Nystroem1;AKarasik2; J Nunez3; S Lanzinger4; C Melzer-Cohen2; R W Holl4;P Casajust5; E Toresson Grip6; M Carrasco7; J Foersch8; K Karlsdotter9;M Tuovinen10; R Klement11;MHKyaw12; L Niskanen
Affiliations: Karolinska Institutet,Department of Clinical Science and Education, SÃ¶dersjukhuset, Solna, Sweden;2Tel Aviv University, Maccabi Research and Innovation Center, Tel Aviv, Israel;3University of Valencia, Department of Cardiology, Hospital ClÃnico Universitariode Valencia, INCLIVA, CIBER Cardiovascular, Valencia, Spain;4University of Ulm,Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany;5Trial FormSupport, Real-World Evidence, Barcelona, Spain;6Swedish Institute for HealthEconomics Quantify Research, Stockholm, Sweden;7Boehringer Ingelheim EspaÃ±aS.A., Barcelona, Spain;8Boehringer Ingelheim Pharma GmbH & Co. Kg, HP CountryMedical Affairs, Ingelheim Am Rhein, Germany;9Boehringer Ingelheim AB, Stock-holm, Sweden;10Boehringer Ingelheim KY, Secondment Boehringer Ingelheim UKHEOR Team, Helsinki, Finland;11IQVIA, Global Database Studies, Tartu, Estonia;12Boehringer Ingelheim Pharmaceutical Inc., Connecticut, United States of America;13University of Eastern Finland, Kuopio, Finland;
Publications: European Journal of Heart Failure (2021)23(Suppl. S2) 2â€“322doi:10.1002/ejhf.2297
Document Types: , Abstract, Article
Countries: , Finland, Germany, Israel, Spain, Sweden
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2297
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes	2021	English	, Database Study, Meta analysis, Methodology, Population Based Study


Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Authors: Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1
Affiliations: 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom
Publications: First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
Document Types: , Abstract, Article
Countries: , France, Germany, UK
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775
Condition	Year	Language	Analysis type
, Database Validity and methodology, Drug safety, Health policy	2020	English	, Retrospective database analysis


The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: GÃ³mez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, PÃ©rez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2020	English	, Burden of illness, Observational study, Retrospective Field Study


The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results
Authors: Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8
Affiliations: 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la SantÃ©, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands
Publications: European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, UK
Condition	Year	Language	Analysis type
, Clinical practice, Public Health	2020	English	, Population Based Study, Public Health, Retrospective database analysis


Predictors of ironâ€‘deficiency anemia in primary care older adults: a realâ€‘world European multiâ€‘country longitudinal study
Authors: Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations: Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico â€œA. Gemelliâ€, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6
Condition	Year	Language	Analysis type
, Hematology	2020	English	, Epidemiological study, Retrospective database analysis


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations: 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publications: Postgraduate Medicine
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Compliance


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4
Affiliations: 1 Eli Lilly and Company, Indianapolis, US 2 Eli Lilly and Company, HaaPACS GmbH, Schriesheim, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Real World Solutions, Barcelona, Spain
Publications: Postgraduate Medicine
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063p207
Condition	Year	Language	Analysis type
, Diabetes	2020	English	, Compliance


Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach
Authors: Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M.
Affiliations: IQVIA HEOR Zaventem
Publications: ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2020	English	, Clinical setting: Primary care, Cost effectiveness


Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Authors: Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations: 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publications: ISPOR 2020 Conference
Document Types: , Abstract
Countries: , Australia, Canada, France, Germany, Italy, Japan, Spain, UK
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019
Condition	Year	Language	Analysis type
	2020	English


Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Authors: Alejandra Martinez De Pinillos, Isabel Ricote Lobera, Cristina Martinez, Caroline Anger, Filippo Guglielmetti, Roberto Jorge Bitton
Affiliations: IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publications: Journal of Clinical Oncology 2019 37:15_suppl, e20631-e20631
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Retrospective database analysis


GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data.
Authors: Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K
Affiliations: IQVIA, Eli Lilly
Publications: Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
Document Types: , Article
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Retrospective database analysis


Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Authors: Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations: Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publications: Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Types: , Article
Countries: , Belgium, France, Germany, Spain, UK
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3
Condition	Year	Language	Analysis type
, Drug safety, Drug Utlization Study	2019	English	, Population Based Study, Retrospective database analysis


European Multi-Country Drug Utilization Study of Dulaglutide
Authors: Ayad K. Ali1, Karen E. Wells2, Mathieu Rosé3, Massoud Toussi3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France
Publications: ICPE, Philadelphia, USA, 24-28 August 2019
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden, UK
Condition	Year	Language	Analysis type
, Diabetes, Drug safety	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life
Authors: Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7
Affiliations: 1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. George’s University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charité Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Survey research


Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries
Authors: Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2
Affiliations: 1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy
Publications: Annals of Hematology (2019) 98:1573–1582
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Hematology	2019	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on DarzalexÂ® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu RosÃ©, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: Presented at ISPEâ€™s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24â€“28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition	Year	Language	Analysis type
, Hematology, Oncology	2019	English	, Public Health, Survey research


An assessment of physician reasons for prescribing insulin lispro 200 units/ml in a prefilled pen in Germany
Authors: Jieling Chen1, Magaly Perez-Nieves1, Carolina Piras De Oliveira1, Erik Spaepen2, Beatrice Osumili3, Jiat Ling Poon1, Nanette Schloot2, Nuria Lara4, Laura Garcia Alvarez4, Montserrat Roset4 & Dirk Lennartz5
Affiliations: 1Lilly and Company, Indianapolis, USA; 2Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany; 3Eli Lilly and Company, Surrey, United Kingdom; 4IQVIA, Real-World Evidence Solutions, Barcelona, Spain; 5IQVIA, Real-World Evidence Solutions, Munich, Germany.
Publications: Endocrine Abstracts (2019) 63 P207 \| DOI: 10.1530/endoabs.63.P207
Document Types: , Article
Countries: , Germany
Abstract: https://www.endocrine-abstracts.org/ea/0063/ea0063P207
Condition	Year	Language	Analysis type
, Diabetes	2019	English	, Compliance, Survey research


No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS
Authors: R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. SabidÃ³ 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. MehtÃ¤lÃ¤ 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group
Affiliations: 1StatFinn-EPID Research, Espoo, Finland
Publications: EAN, Oslo, Norway, June 29-2 July, 2019
Document Types: , Oral presentation
Countries: , Finland, Germany, Norway, Sweden, Switzerland, UK
Abstract: https://www.ean.org/fileadmin/_files/AbstractBook/EAN_Journal_2019_Book.pdf
Condition	Year	Language	Analysis type
, Neurological disorders	2019	English	, Epidemiological study, Population Based Study, Retrospective database analysis


An Assessment of Physician Reasons for Prescribing Insulin Lispro 200 units/ml in a Prefilled Pen in Germany
Authors: Chen J1, Perez-Nieves M1, Piras De Oliveira C1, Spaepen E2, Osumili B3, Ling Poon J1, Schloot N2, Lara N4, Garcia Alvarez L4, Roset M4, Lennartz D5
Affiliations: 1 Lilly and Company, Indianapolis, US 2 Eli Lilly and Company Deutschland GmbH, Bad Homburg, Germany 3 Eli Lilly and Company, Surrey, UK 4 IQVIA, Barcelona, Spain 5 IQVIA, Munich, Germany
Publications: ECE, Lyon, France, 18-21 May 2019
Document Types: , Poster
Countries: , Germany
Abstract: htpps://doi.org/10.1530/endoabs.63.P207
Condition	Year	Language	Analysis type
, Endocrinology	2019	English	, Survey research


The clinical and economic impact of adding an adherence module to the IQVIAcore diabetes model
Authors: Ramos M1, Monteiro S2, Altrabsheh E2, Lamotte M1
Affiliations: 1 IQVIA, Zaventem, Belgium 2 IQVIA, London, UK
Publications: ISPOR, Copenhagen, Denmark, 4-6 November 2019
Document Types: , Poster
Countries: , Germany
Abstract: https://doi.org/10.1016/j.jval.2019.09.943
Condition	Year	Language	Analysis type
, Diabetes, Health economics	2019	English	, Cost effectiveness, Survey research


Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Authors: Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 HÃ´pital EuropÃ©en Georges-Pompidou UniversitÃ© Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publications: EUROGIN, Monaco, France, 4-7 December 2019
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Spain, UK, USA
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf
Condition	Year	Language	Analysis type
, Clinical practice, Infectious disease, Methodology	2019	English	, Epidemiological study, Observational study, Population Based Study


Impact of Stable Angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey
Authors: Manolis AJ, Ambrosio G, Collins P, Dechend F, Lopez-Sendon J, Pegoraro V, Camm AJ
Affiliations: Manolis AJ: Department of Cardiology, Asklepeion General Hospital, Athens, Greece. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy.
Publications: Eur J Intern Med. 2019 Dec;70:60-67. doi: 10.1016/j.ejim.2019.09.013
Document Types: , Article
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.sciencedirect.com/science/article/pii/S0953620519303267?via%3Dihub
Condition	Year	Language	Analysis type
, Cardiovascular disease	2019	English	, Quality of life, Survey research


Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy
Authors: Malfertheiner P1, Ripellino C2, Cataldo N3
Affiliations: 1 Klinik fÃ¼r Gastroenterologie, Hepatologie und Infektiologie, Otto-von-Guericke UniversitÃ¤t, Magdeburg, Germany 2 2HEOR Consultant Freelance, Milan, Italy 3 IQVIA, RWI, Milan, Italy
Publications: Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):581-586
Document Types: , Article
Countries: , Germany, Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29457309
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2018	English	, Database Study, Epidemiological study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Basic characteristics and representativeness of the German Disease Analyzer Database
Authors: Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K.
Affiliations: Institute of Biometrics, Epidemiology, German Diabetes Center, DÃ¼sseldorf, Real World Insights, IQVIA, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther. 2018 Aug 31. doi: 10.5414/CP203320â€©.
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Basic+characteristics+and+representativeness+of+the+German+Disease+Analyzer+Database%E2%80%A9.
Condition	Year	Language	Analysis type
, Database Validity and methodology	2018	English	, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective cohort analysis


Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications:
Document Types:
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition	Year	Language	Analysis type
	2018	English


Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD
Authors: Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R
Affiliations: Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel
Publications: ISPOR Europe 2018
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy
Condition	Year	Language	Analysis type
, Nutritional Disorders, Oncology	2018	English	, Clinical setting: Home care, Epidemiological study


Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries
Authors: Hoyer L, Schmidt N
Affiliations: IQVIA Frankfurt Germany
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Authors: Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations: 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publications: ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Oral presentation
Countries: , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963
Condition	Year	Language	Analysis type
, Cardiovascular disease, Health economics	2018	English	, Burden of illness, Cost of illness


EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Authors: Bodaghi Charles, Benque Emma, Troubat Arnaud
Affiliations: IQVIA France - RWI
Publications: ISPOR 2018
Document Types: , Poster
Countries: , France, Germany, Spain, UK
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Clinical setting: Home care, Pricing & Reimbursement


PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4)
Authors: Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2
Affiliations: 1IQVIA Milan Italy , 2IQVIA London UK
Publications: CTOS 2018 Rome
Document Types: , Poster
Countries: , France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Oncology	2018	English


Drug treatment in melanoma: a real-world analysis across Europe and Japan
Authors: Martinez de Pinillos, Anger C, Nasuti P
Affiliations: IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition	Year	Language	Analysis type
, Oncology	2018	English


Treatment algorithm for multiple myeloma: real-world insights across five European countries
Authors: Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2
Affiliations: 1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
Authors: Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2
Affiliations: 1 IQVIA London UK , 2IQVIA Madrid Spain
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Authors: Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations: 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Authors: Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations: IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Depression is Associated with Chronic Disorders in Children and Adolescents
Authors: Kostev K, Dombrowski S, Konrad M
Affiliations: IQVIA, Frankfurt am Main, Germany, FOM University of Applied Sciences, Frankfurt am Main, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes, Mental health, Pediatrics	2018	English	, Database Study, Epidemiological study, Retrospective database analysis


The Prevalence of Multimorbidity and Polypharmacy in Elderly Patients Followed in General Practices in Germany
Authors: Kostev K, Kap EJ, Jacob L
Affiliations: IQVIA, Frankfurt am Main, Germany, University of Paris 5, Paris, France
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Patient Registries & Real-World Study Methods	2018	English	, Epidemiological study, Retrospective database analysis


The Prescription Patterns of Selective Serotonin (Norepinephrine) Reuptake Inhibitors in Germany
Authors: Kap EJ1, Konrad M2, Bohlken J3, Kostev K1
Affiliations: 1IQVIA, Frankfurt am Main, Germany, 2FOM University of Applied Sciences, Frankfurt am Main, Germany, 3Praxis fÃ¼r Neurologie und Psychiatrie, Berlin, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2018	English	, Database Study, Epidemiological study


Persistence with Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in Germany
Authors: Kostev K, Kap EJ
Affiliations: IQVIA, Frankfurt am Main, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Mental health	2018	English	, Database Study, Epidemiological study


Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG
Authors: Fischer T, Bonduelle D, Antoni B
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Health policy	2018	German	, Market impact


Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considered by Federal Joint Committee for Determining the Appropriate Comparator?
Authors: Scheler E, Stratil AS, Roxlau T, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Guidelines, Health policy	2018	German	, Review


Success Factors for Â§137h SGB V Assessment of Medical Devices in Germany
Authors: Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2018	English	, Review


The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to Â§35A SGB V in Germany Oncological and Metabolic Diseases
Authors: Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement	2018	English	, Cost analysis, Pricing & Reimbursement


DERMATOLOGY AS AN EXAMPLE Originator and Generic Market Access Pretection Strategies in Germany Using Dermatology as an Example
Authors: Greiner RA, Antoni B, Batscheider A, Bonduelle D Roxlau T, Stratil AS
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology, Health economics	2018	English	, Market impact


Duration of Inability to Work in Depression Patients Treated in General or Psychiatric Practices in Germany
Authors: Kostev K, Dombrowski S, Konrad M, Bohlken J
Affiliations: IQVIA, Frankfurt am Main, Germany FOM University of Applied Sciences, Frankfurt am Main, Germany Praxis fÃ¼r Neurologie und Psychiatrie, Berlin, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Mental health	2018	English	, Real World Data, Retrospective cohort analysis


Persistence and Compliance Amongst Sacubitril/Valsartan Patients in Germany, a Retrospective Cohort Study a Longitudinal Pharmacy Database
Authors: WIRTA SB WACHTER R, BALAS B, KLEBS S, FONSECA AF, PROENCA CC, DWORAK M, SCHLIENGER R, ENGELHARD J, MAIER T, KOSTEV K
Affiliations: Wirta SB, Wachter R, Balas B, Klebs S, Fonseca AF, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Kostev K
Publications:
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English	, Retrospective cohort analysis


Concomitant use of Heart Failure Medication AMongst Patients with Sacubitril/Valsartan Therapy in Germany, A Retrospective Cohort Study Using a Longitudinal Pharmacy Database
Authors: Wachter R, Fonsenca AF, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Kostev K
Affiliations:
Publications:
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	German	, Retrospective cohort analysis


Real-World Titration and Treatment Patterns of Sacubitril/Valsartan in Germany, Retrospective Cohort Study Using a Longitudinal Pharmacy Database
Authors: Wachter R, Klebs S, Balas B, Proenca CC, Dworak M, Schlienger R, Engelhard J, Maier T, Wirta SB, Klostev K
Affiliations:
Publications:
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English	, Retrospective cohort analysis


Changes in Patient Characteristics, Glucose Lowering Treatment, Glycemic Control and Complications in Type 2 Diabetes in General Practices (Disease Analyzer, Germany: 2008-2016)
Authors: Rathmann W, Scheerer M, Rohwedder K, Busch S, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2018	English


Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Monitoring in Patients Affected by Hypertension - A Retrospective Study with 176.565 Patients in Germany
Authors: Jacob L, Seitz F, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English	, Retrospective cohort analysis


Persistence with Antihypertensive Drugs in Hypertension Patients with Depression in Germany
Authors: Jacob L, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English


PREVALENCE AND TREATMENT OF SEXUALLY TRANSMITTED DISEASES IN GYNECOLOGICAL PRACTICES IN GERMANY- A RETROSPECTIVE STUDY WITH MORE THAN 1,000,000 PATIENTS
Authors: Prevalence and Treatment of Sexuality Transmitted Diseases in Gynecological Practices in Germany - A Retrospective Study with more than 1,000,000 Patients
Affiliations:
Publications: INT J CLIN PHARMACOL THER. 2018 FEB 2.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Infectious disease	2018	German	, Retrospective cohort analysis


Seasonal Variation of Epistaxis in Germany
Authors: Seidel DU, Sesterhenn AM, Kostev K
Affiliations:
Publications: J CRANIOFAC SURG. 2018 FEB 12.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
	2018	English


Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices
Authors: Muigai J, Jacob L, Klostev K, Kalder M
Affiliations:
Publications: ONCOTARGET. 2018 JAN 3;9(9):8725-8730
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2018	English


Diagnoses of Dizziness- and Vertigo-Related in ENT Practices in Germany
Authors: Seidel DU, Park JJH, Sesterhenn AM, Kostev K
Affiliations:
Publications:
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Diagnosis and Treating Dementia in German Primary and Specialized Care Between 2011 and 2015
Authors: Michalowsky B, Kostev K, Iliffe S, Hoffmann W, Bohlken J
Affiliations:
Publications: INT J CLIN PHARMACOL THER. 2018 APR 27.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Association of Laryngeal Cancer with Vocal Cord Leukoplakia and related Risk Factors in 1,184 Patients Diagnosed in Otorhinolaryngology Practices in Germany
Authors: Kostev K, Jacob L, Kalder M, Sesterhenn AM, MDD, Seidel DU
Affiliations:
Publications: MOL CLIN ONCOLOGY 2018; 8: 689-693, 2018
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


The Impact of Non-Persistence in the Direct and Indirect Costs in Patients Treated with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Germany
Authors: Ziegelbauer K, Kostev K, HÃ¼binger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S
Affiliations:
Publications: RHEUMATOLOGY (OXFORD). 2018 APR 12
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


Prevalence and Treatment of Sexually Transmitted Infections in Men Followed by Urologists in Germany- A Cross Sectional Study with 347,090 Men
Authors: Jacob L, Duse DA, Kostev K
Affiliations:
Publications:
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Infectious disease	2018	English


Prevalence and Prescribed Drugs for Treatment of Vulvovaginal Candidiasis in Gynecological Practices in Germany: A Retrospective Study of 954,186 Patients
Authors: Jacob K, John M, Kalder M, Kostev K
Affiliations:
Publications:
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Womens Health	2018	English	, Retrospective cohort analysis


Time Between Suspected and Confirmed Diagnosis of Crohn's Disease and Ulcerative Colitis in Patients Followed in Gastroenterological Practices in Germany
Authors: Jacob K, Konrad M, Kostev K
Affiliations:
Publications: INT J COLORECTAL DIS. 2018 MAY
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2018	English


Diagnoses of Suspected Cancer in Otolaryngology Practices in Germany
Authors: Kostev K, Lasrich M, SchÃ¼ller L, Diogo I, Sesterhenn A, Jacob L
Affiliations:
Publications: MOL CLIN ONCOLOGY
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


Association Between Sleep Disorders and the Presence of Breast Cancer Metastases in Gynecological Practices in Germany: A Case-Control Study of 11,412 Women
Authors: Jacob L, Schloten PC, Kostev K, Kalder M
Affiliations:
Publications: BREAST CANCER RES TREAT. 2018 MAY 29.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2018	English


The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany
Authors: Bohlken J, Jacob L, Van Den Bussche H, Kostev K
Affiliations:
Publications: J ALZHEIMERS DIS. 2018 JUN 6.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Relevance of Coded Prodromal MCI in the Future Routine Treatment of Patients with Dementia in Germany
Authors: Bohlekn J, Kostev K
Affiliations:
Publications: J ALZHEIMERS DIS.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany
Authors: Kostev K, Hadji P, Jacob L
Affiliations:
Publications: J ALZHEIMERS DIS.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2018	English


Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients with Nonvalvular Atrial Fibrillation Treated in Routine German Practice
Authors: Oleman CI, Peacock WF, Antz M
Affiliations:
Publications: HEART LUNG CIRC. 2018 MAR;27(3):390-393
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2018	English


The Impact of Risk Minimization Measures on Compliance and Prescribing Practices of Flupirtine in Germany.
Authors: Kaplan S, Ehlken B, Hamann X
Affiliations: Teva Pharmaceutical Industries Ltd , Petach Tikva , Israel. IQVIA (formerly IMS Health) , Munich , Germany. Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany
Publications: Curr Med Res Opin
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Drug Utlization Study, Medication compliance	2018	English	, Retrospective cohort analysis


Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe
Authors: Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA
Affiliations: Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA
Publications: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , Denmark, Finland, Germany, Norway, Sweden, UK
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods	2018	English	, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review


Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study
Authors: Ali AK, Toussi M, Phillips S, Roste M
Affiliations: Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA
Publications: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden
Condition	Year	Language	Analysis type
, Diabetes, Drug Utlization Study, Drug Utlization Study	2018	English	, Database Study, Epidemiological study


TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES
Authors: Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M
Affiliations: Eli Lilly, IQVIA
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383
Condition	Year	Language	Analysis type
, Diabetes	2018	English	, Retrospective database analysis


Estimating glomerular filtration rate in primary care electronic medical record databases in Europe
Authors: Jouaville SL1, Bizouard G1, Boutmy E1, Keja J2
Affiliations: 1QuintilesIMS, Boulogne Billancourt, France, 2QuintilesIMS, Rotterdam, Netherlands
Publications: 22nd ISPOR Annual International Meeting, Boston, 2017
Document Types: , Abstract
Countries: , Germany, UK
Condition	Year	Language	Analysis type
, Diabetes, Methodology, Nephrology	2017	English	, Clinical setting: Primary care, Retrospective database analysis


Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6.
Affiliations: Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom.
Publications: Breast. 2017 Apr;32:247-255.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648
Condition	Year	Language	Analysis type
, Oncology	2017	English	, clinical setting: Secondary care, Retrospective database analysis


Regional Differences in Insulin Therapy Regimens in 5 European Countries
Authors: Rathmann W, Czech M, Franek E, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 May;55(5):403-408.
Document Types: , Article
Countries: , France, Germany, Hungary, Poland, UK
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe.
Authors: Katz P1, Pegoraro V2, Liedgens H1.
Affiliations: 1 Grunenthal GmbH , Aachen , Germany. 2 QuintilesIMS, Milan, Italy.
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28537441
Condition	Year	Language	Analysis type
, Pain	2017	English	, Database Study, Epidemiological study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmartÂ® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis
Authors: Marieke Krol1, Gert de Voer2, Ulrike Osowski3
Affiliations: 1QuintilesIMS, Capelle aan den Ijssel, the Netherlands; 2Merck B.V., Schiphol-Rijk, the Netherlands; 3Merck KGaA, Darmstadt, Germany
Publications: Patient Preference and Adherence 2017:11 1189â€“1196
Document Types: , Article
Countries: , Germany, Netherlands
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2017	English	, Retrospective cohort analysis, Retrospective database analysis


Perception of symptoms and quality of life â€“comparison of patientsâ€™ and physiciansâ€™ views in the COPD MIRROR study
Authors: Celli B1, Blasi F2, Gaga M3, Singh D4, Vogelmeier C5, Pegoraro V6, Caputo N7, Agusti A8.
Affiliations: 1 Pulmonary and Critical Care Medicine Division, Brigham and Womenâ€™s Hospital, Harvard Medical School, Boston, MA, USA 2 Department of Pathophysiology and Transplantation, UniversitÃ degli Studi di Milano, Milan, Italy, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS CÃ Granda Ospedale Maggiore Policlinico, Milan, Italy 3 7th Respiratory Medicine Department and Asthma Centre, Athens Chest Hospital, Athens, Greece 4 Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester, Manchester, UK 5 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-UniversitÃ¤t Marburg, Marburg, Germany, German Center for Lung Research (DZL), Giessen, Germany 6 Real World Insight, QuintilesIMS, Milan, Italy 7 Primary Market Research, QuintilesIMS, Milan, Italy 8 Respiratory Institute, Hospital Clinic, IDIBAPS, CibeRes, University of Barcelona, Barcelona, Spain
Publications: International Journal of COPD
Document Types: , Article
Countries: , Germany, Italy, Spain
Abstract: https://www.dovepress.com/perception-of-symptoms-and-quality-of-life-comparison-of-patients-and--peer-reviewed-article-COPD
Condition	Year	Language	Analysis type
, Respiratory disease	2017	English	, Survey research


Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings
Authors: De Bortoli N1, Ripellino C2, Cataldo N3, Marchi S1
Affiliations: 1 Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 2 Department of Real World Evidence, HEOR Consultant Freelance, Milan, Italy 3 Department of Real World Evidence, QuintilesIMS, Milan, Italy
Publications: Expert Opinion on Drug Safety. doi: 10.1080/14740338.2017.1376647. [Epub ahead of print]
Document Types: , Article
Countries: , Germany, Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28871813
Condition	Year	Language	Analysis type
, Drug safety, Gastrointestinal disorders, Rare Diseases	2017	English	, Clinical setting: Primary care, Database Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Angiotensin II receptor blockers and intestinal malabsorption: an observational cohort study in Germany and Italy
Authors: Malfertheiner P1, Heiman F2, Ripellino C3, Cataldo N2
Affiliations: 1 Otto-von-Guericke UniversitÃ¤t, Klinik fÃ¼r Gastroenterologie, Hepatologie und Infektiologie 2 QuintilesIMS, Milan, Italy 3 HEOR Consultant, Freelance, Milan, Italy
Publications: ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Types: , Poster
Countries: , Germany, Italy
Condition	Year	Language	Analysis type
, Drug safety, Gastrointestinal disorders, Rare disease	2017	English	, Database Study, Epidemiological study, Longitudinal study, Observational study, Population Based Study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis


Prevalence of use of cardiovascular drugs in dementia patients treated in general practices in Germany
Authors: Jacob L, Bohlken J, Kostev K
Affiliations:
Publications: J Alzheimers Dis. 2017;56(4):1519-1524.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Neurological disorders	2017	English	, Epidemiological study


Prevalence and predictors of prescription of antibiotics in pregnant women treated by gynecologists in Germany
Authors: Jacob L, Kalder M, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Aug;55(8):643-649.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Womens Health	2017	English	, Epidemiological study


Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
Authors: Jacob L, Kostev K, Hadji P
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 May;55(5):394-39
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Epidemiological study


Impact of attention deficit hyperactivity disorder therapy on fracture risk in children treated in German pediatric practices
Authors: Jacob L, Kostev K
Affiliations:
Publications: Osteoporos Int. 2017 Apr;28(4):1265-1269
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Pediatrics	2017	English


Risk of dementia in German patients treated with antidepressants in general or psychiatric practicesâ€©.
Authors: Jacob L, Bohlken J, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Apr;55(4):322-328.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2017	English


Treatment Persistence of Basal Insulins in Poland and Germany
Authors: Rathmann W, Czech M, Franek E, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Feb;55(2):119-125.
Document Types: , Article
Countries: , Germany, Poland
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Prescription patterns and drugs costs in German patients with dementia in nursing homes and home care settings
Authors: Jacob L, Bohlken J, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Jan;55(1):9-15
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English


Prescription patterns and costs of migraine treatments in German general and neurological practices
Authors: Jacob L, Kostev K
Affiliations:
Publications: Pain Pract. 2017 Jul;17(6):747-752.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English


Prescription patterns and costs of migraine treatments in German general and neurological practices
Authors: Jacob L, Kostev K
Affiliations:
Publications: Pain Pract. 2017 Jul;17(6):747-752.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English


Depression risk in patients with late-onset rheumatoid arthritis in Germany
Authors: Drosselmeyer J, Jacob L, Rapp M, Kostev K
Affiliations:
Publications: Qual Life Res. 2017 Feb;26(2):437-443
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Musculoskeletal disease	2017	English


Psoriasis risk in patients with type 2 diabetes in German primary care practices
Authors: Jacob L, Kostev K
Affiliations:
Publications: Prim Care Diabetes. 2017 Feb;11(1):52-56
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology, Diabetes	2017	English


Treatment outcomes and tolerability following initiation of GLP-1 Receptor Agonists among Type 2 diabetes patients in Primary Care Practices in Germany
Authors: Qiao Q, Johnsson K, Grandy S, Kostev K
Affiliations:
Publications: J Diabetes Sci Technol. 2017 Mar;11(2):272-277.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Prescription patterns and the cost of antihyperglycemic drugs in patients with type 2 diabetes mellitus in Germany
Authors: Jacob L, von Vultee C, Kostev K
Affiliations:
Publications: J Diabetes Sci Technol. 2017 Jan;11(1):123-127.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Impact of disease management program on HbA1c values in diabetes type 2 patients in Germany
Authors: Kostev K , Rockel T, Jacob J
Affiliations:
Publications: J Diabetes Sci Technol. 2017 Jan;11(1):117-122.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Persistence with antihypertensive drugs in patients with hypertension and dementia in Germany
Authors: Jacob L, Adam-Schnepf L, Kostev K
Affiliations:
Publications: J Alzheimers Dis. 2017
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Neurological disorders	2017	English


Adherence to antiepileptic drugs in children and adolescents: a retrospective study in primary care settings in Germany
Authors: Jacob L, Hamer H, Kostev K
Affiliations: Faculty of Medicine, University of Paris 5, Paris, France. Electronic address: louis.jacob.contacts@gmail.com. Department of Neurology, Epilepsy Center, University of Erlangen, Germany. Electronic address: Hajo.Hamer@uk-erlangen.de. Epidemiology, QuintilesIMS, Frankfurt, Germany. Electronic address: kkostev@de.imshealth.com.
Publications: Epilepsy Behav. 2017 Epilepsy Behav. 2017 Oct;75:36-41
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28821006
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English	, Retrospective cohort analysis


Risk factors for epistaxis in patients followed in general practices in Germany
Authors: Seidel DU, Jacob L, Kostev K, Sesterhenn AM
Affiliations: Department of Otorhinolaryngology, Head and Neck Surgery, Solingen Municipal Hospital, Solingen, Germany. Faculty of Medicine, University of Paris 5, Paris, France. Epidemiology, QuintilesIMS, Frankfurt, Germany
Publications: Rhinology [Epub ahead of print] Rhinology. 2017 Dec 1;55(4):312-318
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28821888
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English	, Retrospective cohort analysis


Persistence with oral antihyperglycemic drugs in type 2 diabetes mellitus patients with dementia in Germany
Authors: Jacob L, Adam-Schnepf L, Kostev K
Affiliations: Faculty of Medicine, University of Paris 5, Paris, France. Department of Neurology, Epilepsy Center, University of Erlangen, Germany. Epidemiology QuintilesIMS, Frankfurt, Germany. Electronic address: kkostev@de.imshealth.com.
Publications: J Diabetes Sci Technol. 2017 Jun 1:1932296817719090
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28648971
Condition	Year	Language	Analysis type
, Diabetes, Neurological disorders	2017	English	, Retrospective database analysis


Persistence with antiepileptic drugs in epilepsy patients treated in neurological practices in Germany
Authors: Jacob L, Hamer H, Kostev K
Affiliations:
Publications: Epilepsy Behav. 2017 Jun 22;73:204-207. doi: 10.1016/j.yebeh.2017.06.008. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English


Compliance with vaccination against hepatitis A virus in Germany: a retrospective analysis
Authors: Jacob L, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Jul 24. doi: 10.5414/CP202990. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Pediatrics	2017	English	, Retrospective cohort analysis


Prescription patterns and disease control in type 2 diabetes mellitus patients in nursing home and home care settings: a retrospective analysis in Germany
Authors: Kostev K, Rockel T, Jacob L
Affiliations: QuintilesIMS, Frankfurt, Germany. Faculty of Medicine, University of Paris 5, Paris, France.
Publications: J Diabetes Sci Technol. 2017 J Diabetes Sci Technol. 2018 Jan;12(1):136-139
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28539088
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Retrospective cohort analysis


Benzodiazepine prescribing in the elderly in Germany and Korea: A comparison of two observational studiesâ€©.
Authors: Woodcock BG, Kostev K, Shin JY
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 May 10. doi: 10.5414/CP203042. [Epub ahead of print]
Document Types: , Article
Countries: , Germany, Korea
Condition	Year	Language	Analysis type
, Mental health	2017	English	, Observational study


Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany â€“ a retrospective analysis of real-world data
Authors: Dombrowski S, Kostev K, Jacob L
Affiliations:
Publications: Osteoporos Int. 2017 Apr 29. doi: 10.1007/s00198-017-4051-y. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Real World Data, Retrospective cohort analysis


Seasonality of insulin use in German outpatients with diabetes: a retrospective analysis
Authors: Kostev K, GlÃ¤ser S, Jacob L
Affiliations:
Publications: J Diabetes Sci Technol. 2017 Apr 1:1932296817703994. doi: 10.1177/1932296817703994. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Retrospective cohort analysis


Patterns of benzodiazepine prescribing by neuropsychiatrists and general practitioners for elderly patients in Germany in 2014
Authors: Mell T, Jacob L, Fuhr I, Dick S, Rapp MA, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 Apr 13. doi: 10.5414/CP202904. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2017	English


Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.
Authors: Bohlken J, Jacob L, Kostev K
Affiliations:
Publications: J Alzheimers Dis. 2017 Mar 29. doi: 10.3233/JAD-170091. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English	, Retrospective cohort analysis


Prevalence of depression, anxiety, adjustment disorders, and somatoform disorders in patients with age-related macular degeneration in Germany
Authors: Jacob L, Spiess A, Kostev K
Affiliations:
Publications: Ger Med Sci. 2017 Feb 9;15:Doc04. doi: 10.3205/000245.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Ophthalmology	2017	English	, Epidemiological study


Compliance with vaccination against tick-borne encephalitis virus in Germany
Authors: Jacob L, Kostev K
Affiliations:
Publications: Clin Microbiol Infect. 2017 Jan 28. pii: S1198-743X(17)30045-9. doi: 10.1016/j.cmi.2017.01.012. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2017	English


Characteristics of Patients with Heart Failure Prescribed Sacubitril/Valsartan in the Primary Care Setting in Germany
Authors: Klebs S, Balas B, Grunow SS, Schindler M,Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Wirta SB
Affiliations:
Publications: ESC Meeting 2017
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English


Characteristics of Patients with Heart Failure Prescribed Sacubitril/Valsartan in the Primary Care and Cardiology Settings in Germany
Authors: Wirta SB, Klebs S, Grunow SS, Schindler M,Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B
Affiliations:
Publications: ESC Meeting 2017
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English


EXTRAPOLATION OF ADULT DATA FOR PEDIATRIC DRUG BENEFIT ASSESSMENT IN THE AMNOG DOSSIER IN THE LIGHT OF THE NEW AMVSG
Authors: Stoecker P, Hofmann-Xu L, Bonduelle D
Affiliations: QuintilesIMS Health Germany, Munich, Germany
Publications: ISPOR Glasgow 2017
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Methodology, Pediatrics	2017	English	, Retrospective database analysis


DIFFERENCES AND DECISION DRIVERS IN THE HTA-OUTCOME CATEGORY LOWER BENEFIT BETWEEN IQWIG AND G-BA ASSESSMENT IN THE GERMAN AMNOG PROCESS
Authors: von Hein, Mirko; Peters, Ann-Sophie; Jakovac, Mihael
Affiliations: QuintilesIMS
Publications: ISPOR 20th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics	2017	English	, Public Health


IMPLICATIONS OF THE GERMAN HTA-PROCESS ON MARKET-UPTAKE OF ORAL TREATMENTS FOR TYPE-2-DIABETES (T2DM) SINCE 2007
Authors: Dr. Roger-Axel Greiner; Tina Fischer; Benno Antoni; Dr. Ariane Batscheider
Affiliations:
Publications: ISPOR 20th Annual European Congress
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Market impact, Retrospective database analysis


CLOSING THE EVIDENCE GAP FOR ORPHAN DRUGS: DO GERMAN REGULATORY REQUIREMENTS GIVE INCENTIVES FOR HIGH LEVEL EVIDENCE GENERATION?
Authors: Ana Babac, Roger-Axel Greiner, Doreen Bonduelle
Affiliations: "QuintilesIMS, IMS Health GmbH & Co. OHG, Landshuter Allee 10, 80637 MÃ¼nchen "
Publications: ISPOR 20th Annual European Congress, Glasgow
Document Types: , Poster
Countries: , Germany
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PHS
Condition	Year	Language	Analysis type
, Rare Diseases	2017	English	, Pricing & Reimbursement, Retrospective database analysis


Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis.
Authors: Alten R1, NeregÃ¥rd P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7
Affiliations: 1 Shlosspark-Klinik Teaching Hospital of the CharitÃ©, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden
Publications: ISPOR 20th Annual European Congress
Document Types:
Countries: , Germany, Nordic, Sweden
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology	2017	English	, Retrospective database analysis


Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Authors: Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations: 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of TÃ¼bingen, TÃ¼bingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publications: JHEOR 2017;5(1):89-108
Document Types: , Article
Countries: , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease, Respiratory disease	2017	English	, Epidemiological study, Public Health


Patient adherence to subcutaneous IFN beta-1a injections using the RebismartÂ® injection device:a retrospective real-world among Dutch and German patients with multiple sclerosis.
Authors: Krol M1, deVoer G2, Osowski U3
Affiliations: 1 QuintilesIMS, The Netherlands 2 Merck B.V., Schiphol-Rijk, the Netherlands 3 Merck KGaA, Darmstadt, Germany
Publications:
Document Types: , Article
Countries: , Germany, Netherlands
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513881/
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English	, clinical setting: Secondary care, Compliance, Retrospective database analysis


Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany
Authors: Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5
Affiliations: 1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Abstract: https://academic.oup.com/annonc/article/28/suppl_2/mdx091.052/3799717/132PReal-world-treatment-patterns-and-outcomes-for
Condition	Year	Language	Analysis type
, Clinical practice, Health status & patient reported outcomes, Oncology	2017	English	, clinical setting: Secondary care, Patient questionnaire, Quality of life


Comparison of incremental cost-utility ratios and sales of direct oral anticoagulants across EU-5 countries.
Authors: Viayna E, Planellas L
Affiliations: Quintiles IMS
Publications: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/Event/index/2017Glasgow
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English	, Cost utility, Literature Review


ModelizaciÃ³n del comportamiento de fÃ¡rmacos biosimilares en 5 paÃses de europa [Modeling of the behavior of biosimilar drugs in 5 European countries].
Authors: Manganelli AG1, Solozabal M2, Planellas L2, Rebollo P2, Puig-Junoy J1
Affiliations: 1 CRES - Universitat Pompeu Fabra, Barcelona, Spain 2 QuintilesIMS, RWI, Barcelona, Spain
Publications: XXXVII Jornadas de EconomÃa de la Salud, 2017, 6 - 8 de septiembre, Barcelona, EspaÃ±a
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.aes.es/jornadas/es/#comunicaciones
Condition	Year	Language	Analysis type
, Clinical practice, Drug Utlization Study	2017	Spanish	, Clinical setting: hospital


Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story
Authors: Mpima S1, Moehler T2, Kanter S3, Mitrofan L4
Affiliations: 1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA
Publications: ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016.
Authors: Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3
Affiliations: 1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom
Publications: ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016.
Authors: Hoyer L, Schmidt N
Affiliations: QuintilesIMS Global Oncology, Central, East & South Europe
Publications: ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries.
Authors: Divino V., DeKoven M., Khan FA., Boye KS., Sapin H., Norrbacka K.
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: Diabetes Ther.
Document Types: , Article
Countries: , Belgium, France, Germany, Netherlands, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28070733
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Retrospective database analysis


Cinacalcet Persistence and Adherence in France, Germany, and Italy
Authors: Dionne M. Hines1, Catherine B. McGuiness1, Rolin L. Wade1, Bruno Fouqueray2, Paul Dluzniewski2
Affiliations: 1QuintilesIMS, 2Amgen
Publications: 54th ERA-EDTA Congress
Document Types: , Poster
Countries: , France, Germany, Italy
Condition	Year	Language	Analysis type
, Endocrinology, Nephrology	2017	English	, Retrospective database analysis


Real World analysis for immune related side effects in 3000 patients
Authors: Mitrofan L 1, Moehler T 2, Ruiz M 3
Affiliations: 1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain
Publications: ESMO - ImmunoOncology
Document Types: , Poster
Countries: , Europe, France, Germany, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English


SCHÃ‰MAS THÃ‰RAPEUTIQUES ET POSOLOGIQUES CHEZ DES PATIENTS AVEC UN DIABÃˆTE DE TYPE 2 (DT2) INITIANT UN TRAITEMENT PAR AGONISTE DU RÃ‰CEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (AR GLP-1) EN EUROPE
Authors: Norrbacka K, Divino V, Dekoven M, Boye KS
Affiliations: Eli Lilly, IQVIA
Publications: SocietÃ© Francophone du Diabete 2017
Document Types: , Poster
Countries: , Belgium, Canada, France, Germany, Italy, Netherlands
Abstract: https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/evenements/17sfd_final_v12.pdf
Condition	Year	Language	Analysis type
, Diabetes	2017	English	, Retrospective database analysis


Conflicts at work are associated with a higher risk of cardiovascular disease.
Authors: Jacob L, Kostev K.
Affiliations: Faculty of Medicine, University of Paris 5, Paris, France. Epidemiology, IMS Health, Frankfurt, Germany.
Publications: Ger Med Sci. 2017 Apr 26;15:Doc08
Document Types: , Abstract
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28496397
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English	, Retrospective database analysis


Diagnostic and Prescription Behavior of General Practitioners and Specialist Physicians in Patients with Dementia in 2005 and 2015 in Germany
Authors: Bohlken J, Kostev K
Affiliations: Neuro-psychiatrische Praxis, Berlin, Demenz-Referat im Berufsverband Deutscher NervenÃ¤rzte (BVDN). QuintilesIMS, Arbeitsgruppe Epidemiologie, Frankfurt/M.
Publications: Psychiatr Prax. 2018 Apr;45(3):154-159
Document Types: , Abstract
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28499316
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English	, Retrospective database analysis


Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
Authors: Kostev K, Parhofen K, Dippel FW
Affiliations: Department of Epidemiology, IMS Health, Frankfurt am Main. Medical Clinic II-Grosshadern, Munich. Department of Evidence-Based Medicine, Sanofi-Aventis, Berlin, Germany.
Publications: Cardiovasc Endocrinol. 2017 Jun;6(2):81-85.
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28540139
Condition	Year	Language	Analysis type
, Cardiovascular disease	2017	English	, Epidemiological study


High Prevalence of Antipsychotic Medication Use in Dementia Patients in German Neuropsychiatric Practices
Authors: Bohlken J, Booker A, Kostev K
Affiliations: Berufsverband Deutscher NervenÃ¤rzte, Praxis Bohlken, Berlin. Epidemiologie, IMS Health, Frankfurt am Main.
Publications: Fortschr Neurol Psychiatr. 2017 Jun;85(6):345-351
Document Types: , Abstract
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28645127
Condition	Year	Language	Analysis type
, Neurological disorders	2017	English	, Retrospective database analysis


Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: Reply to Dr. Driessen and colleagues [letter].
Authors: Kostev K, Dombrwoski S
Affiliations: Epidemiology, QuintilesIMS, DarmstÃ¤dter LandstraÃŸe 108, 60598, Frankfurt am Main, Germany. kkostev@de.imshealth.com. Epidemiology, QuintilesIMS, DarmstÃ¤dter LandstraÃŸe 108, 60598, Frankfurt am Main, Germany.
Publications: Osteoporos Int. 2017 Jul 13. doi: 10.1007/s00198-017-4139-4. [Epub ahead of print]
Document Types: , Abstract, Letter
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28707089
Condition	Year	Language	Analysis type
, Diabetes	2017	English


Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis
Authors: Jacob L, Rapp MA, Kostev K
Affiliations: Faculty of Medicine, University of Paris 5, Paris, France. Department of Social and Preventive Medicine, University of Potsdam, Germany. Epidemiology, Real World Evidence Solutions, IMS Health, DarmstÃ¤dter LandstraÃŸe 108, 60598 Frankfurt am Main, Germany.
Publications: Ther Adv Psychopharmacol. 2017 Jul;7(6-7):191-200
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28740636
Condition	Year	Language	Analysis type
, Mental health	2017	English	, Retrospective database analysis


Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings
Authors: Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H
Affiliations: Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, DÃ¼sseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La DÃ©fense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France.
Publications: Rheumatology (Oxford). 2017 May 1;56(5):818-828
Document Types: , Article
Countries: , France, Germany, Italy, Spain, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Rheumatology	2017	English	, Retrospective Field Study


TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES
Authors: Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2
Affiliations: 1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain
Publications: ISPOR 21st, May 2016 Washington, USA
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care.
Authors: Levi M1-2, Rosselli M3, Simonetti M1, Brignoli O4, Cancian M4, Masotti A5, Pegoraro V6, Cataldo N6, Heiman F6, Chelo M1, Cricelli I1, Cricelli C4, Lapi F1.
Affiliations: 1 Health Search Italian College of General Practitioners and Primary Care, Florence 2 Department of Health Sciences, University of Florence, Florence, Italy 3 Institute for Liver and Digestive Health, Royal Free Hospital, University College of London, London, UK 4 Italian College of General Practitioners and Primary Care, Florence 5 Department of Transfusion Medicine, Local Health Authority nÂ°5, Pordenone 6 IMS Health Information Solutions Medical Research srl, Milan, Italy
Publications: Eur J Haematol. 2016 May 7. doi: 10.1111/ejh.12776
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Epidemiology+of+iron+deficiency+anaemia+in+four+European+countries%3A+a+population-based+study+in+primary+care.
Condition	Year	Language	Analysis type
, Nutritional Disorders	2016	English	, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis


Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Authors: Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publications: Clinical Epidemiology
Document Types: , Article
Countries: , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Literature Review


Unspecified intestinal malabsorption associated with angiotensin receptor blocker therapy: results from a nationwide, population-based study in Italy and Germany.
Authors: Ripellino C1, Cataldo N1, Scarpignato C.
Affiliations: 1 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publications: ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Types: , Poster
Countries: , Germany, Italy
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2016	English	, Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis


Characteristics, resources utilization and safety profile of patients with acute pain: a European real world evidence study.
Authors: Katz P1, Pegoraro V2, Heiman F, Liedgens H1.
Affiliations: 1 Grunenthal GmbH, Aachen, Germany 2 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publications: ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Types: , Poster
Countries: , Belgium, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Infectious disease, Neurological disorders, Pain	2016	Italian	, Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis


Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Authors: Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publications: 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK
Condition	Year	Language	Analysis type
, Cardiovascular disease	2016	English


BIOSIMILARS AND REFERENCE PRICE GROUPS IN GERMANY
Authors: Eheberg D1, Pointner J1, Antoni B1, Gossmann JA1, Batscheider A1
Affiliations: 1IMS Health, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics	2016	English	, Pricing & Reimbursement


COSTS EVOLUTION OF CANCER THERAPIES IN EUROPE FROM 2004 TO 2014
Authors: Tetafort A, Aubert JM, Perrot D, Brigot G, Kolahi C, Ansolabehere X
Affiliations: IMS Health France
Publications: 19th ISPOR Congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN82.pdf
Condition	Year	Language	Analysis type
, Oncology, Pricing and reimbursement	2016	English	, Clinical setting: hospital, Cost analysis, Pricing & Reimbursement, Retrospective database analysis


USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA
Authors: Jubert H, Kolahi C, Karusisi N, Mitrofan L
Affiliations: IMS Health France
Publications: 19th ISPOR congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition	Year	Language	Analysis type
, Health economics, Oncology	2016	English	, Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis


COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS Study
Authors: Hoti F, Mushnikov V, MehtÃ¤lÃ¤ J, et al.
Affiliations:
Publications: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland
Document Types: , Abstract
Countries: , Germany, Nordic, Sweden, USA
Condition	Year	Language	Analysis type
, Respiratory disease	2016	English	, Real World Evidence


Patterns of Roflumilast Use for the Treatment of COPD Across Three Distinct Populations: Findings from the Roflumilast PASS Study
Authors: Knox C, Mountford W, Kaufman E, et al.
Affiliations:
Publications: 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management; 2016; Dublin, Ireland
Document Types: , Abstract
Countries: , Germany, Sweden, USA
Condition	Year	Language	Analysis type
, Respiratory disease	2016	English	, Epidemiological study, Real World Evidence


Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Authors: Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lÃ¨s-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de InvestigaciÃ³n Sanitaria Princesa (IIS-IP) and Centro de InvestigaciÃ³n BiomÃ©dica en Red de Enfermedades HepÃ¡ticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publications: Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2016	English	, Burden of illness, Patient questionnaire, Survey research


Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Authors: Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lÃ¨s-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de InvestigaciÃ³n Sanitaria Princesa (IIS-IP) and Centro de InvestigaciÃ³n BiomÃ©dica and Red de Enfermedades HepÃ¡ticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publications: Dig Liver Dis. 2016 Jun;48(6):592-600
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2016	English	, Burden of illness, Patient questionnaire


Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Authors: Lyu R1, Govoni M2, Ding Q1, Black CM3, Kachroo S4, Fan T1, Ogbonnaya A5, Donga P5, Hill J5, Makin C5.
Affiliations: 1Merck Co., Inc, Whitehouse Station, NJ, USA. 2MSD Italy, Rome, Italy. 3Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. 4Merck Co., Inc, 126 E. Lincoln Avenue, Mail code: RY32-211, Rahway, NJ, 07065, USA. sumesh.kachroo@merck.com. 5IMS Health, Alexandria, VA, USA.
Publications: Rheumatol Int. 2016 Jan;36(1):143-53.
Document Types: , Article
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26314368
Condition	Year	Language	Analysis type
, Rheumatology	2016	English	, Retrospective database analysis


Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7.
Affiliations: 1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com.
Publications: Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Quantification of patient preference analysis_Wearing the federal joint committee lens to assess evidence
Authors: Gaba D1, Eheberg D, Bonduelle D
Affiliations: 1 Quintiles IMS, Gurgaon, India 2 QuintilesIMS, Munich, Germany
Publications:
Document Types: , Poster
Countries: , Germany, India
Condition	Year	Language	Analysis type
, Health status & patient reported outcomes, Pricing and reimbursement	2016	English	, Pricing & Reimbursement


Best supportive care or therapy according to physicians choice as appropriate comparator for german HTA dossiers-an underestimated chance or risk for the benefit assessment
Authors: Bonduelle D1, Eheberg D1, Jakovac M1, Dannemann S1
Affiliations: 1 QuintilesIMS, Munich, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2016	English	, Pricing & Reimbursement


Market uptake of direct oral anticoagulants (DOACS) in germany
Authors: Batscheider A1, Greese B1, Dannemann S1, Gaba D2, Paulus G1, StÃ¶cker P1, Greiner R1
Affiliations: 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Gurgaon, India
Publications:
Document Types: , Poster
Countries: , Germany, India
Condition	Year	Language	Analysis type
, Cardiovascular disease	2016	English	, Market impact


Biosimilars and reference price groups in germany
Authors: Eheberg D1, Antoni B1, Gossmann J1
Affiliations: 1 QuintilesIMS, Munich, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
	2016	English	, Cost analysis


Real world data: use of novel treatments and biomarkers in malignant melanoma in European countries
Authors: von Bredow D1, Kolb N1, Schmidt N2, Eheberg D1
Affiliations: 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Frankfurt, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Real World Data


A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
Authors: Gizzo S1, Garcia-Velasco JA2, Heiman F3, Ripellino C3, BÃ¼hler K4
Affiliations: 1 Department of Woman and Child Health, University of Padua, Padua, Italy 2 Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain 3 IMS Health Information Solutions Italy Srl, Milan, Italy 4 Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: Int J Womens Health
Document Types: , Manuscript in preparation
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
Condition	Year	Language	Analysis type
, Health economics, Pregnancy	2016	English	, Cost effectiveness


Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.
Authors: Nyberg F1,2, Horne L3, Morlock R4, Nuevo J5, Storgard C4, Aiyer L4, Hines DM6, Ansolabehere X7, Chevalier P8
Affiliations: 1 AstraZeneca, MÃ¶lndal, Sweden 2 University of Gothenburg, Gothenburg, Sweden 3 AstraZeneca, Wilmington, USA 4 Ardea Biosciences, San Diego, USA 5 AstraZeneca, Madrid, Spain 6 IMS Health, Alexandria, USA 7 IMS Health, Paris, France 8 IMS Health, Vilvoorde, Belgium
Publications: Advances in Therapy, 2016, 33(7): 1180â€“1198
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition	Year	Language	Analysis type
	2016	English


Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Authors: Morlock R1, Chevalier P2, Horne L3, Nuevo J4, Storgard C1, Aiyer L1, Hines DM5, Ansolabehere X6, Nyberg F7,8
Affiliations: 1 Ardea Biosciences, San Diego, CA, USA 2 IMS Health HEOR, Zaventem, Belgium 3 AstraZeneca, Wilmington, DE, USA 4 AstraZeneca, Madrid, Spain 5 IMS Health HEOR, Fairfax, VA, USA, 6 IMS Health HEOR, Paris, France, 7 AstraZeneca, MÃ¶lndal, Sweden 8 University of Gothenburg, Gothenburg, Sweden
Publications: Rheumatol Ther., 2016, 3(1): 53-75
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition	Year	Language	Analysis type
, Rheumatology	2016	English


Gender- and age-related treatment compliance in patients with osteoporosis in Germany
Authors: Hadji P, Jacob L. Kostev K
Affiliations:
Publications: Patient Prefer Adherence. 2016 Nov 23;10:2379-2385
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2016	English


Prevalence of medically treated children with ADHD and type 1 diabetes in Germany â€“ Analysis of two representative databases
Authors: Kapellen TM, Reimann R, Kiess W, Kostev K
Affiliations:
Publications: J Pediatr Endocrinol Metab. 2016 Nov 1;29(11):1293-1297
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes, Neurological disorders, Pediatrics	2016	English	, Epidemiological study


Comorbid disorders associated with asthma in children in Germany- national analysis of pediatric primary care data
Authors: Jacob L., Keil T. & Kostev K
Affiliations:
Publications: Pediatr Allergy Immunol. 2016 Dec;27(8):861-866.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Pediatrics, Respiratory disease	2016	English


Depression risk in patients with coronary heart disease in Germany
Authors: Konrad M, Jacob L, Rapp M, Kostev K
Affiliations:
Publications: World J Cardiol. 2016 Sep 26;8(9):547-552.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Mental health	2016	English


Caesarean section and its impact on fertility and time to a subsequent pregnancy in Germany: a database analysis in gynecological practices.
Authors: Jacob L, Weber K, Sechet I, Macharey G, Kostev K, Ziller V.
Affiliations:
Publications: Arch Gynecol Obstet. 2016 Nov;294(5):1005-1010.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Surgery, Womens Health	2016	English	, Database Study


The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany
Authors: Jacob L, Hadji P, Kostev K
Affiliations:
Publications: Climacteric. 2016 Oct;19(5):478-81
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Womens Health	2016	English


Impact of caesarean section on mode of delivery, pregnancy-induced and pregnancy-associated disorders, and complications in the subsequent pregnancy in Germany
Authors: Jacob L, Taskan S, Macharey G, Ziller V, Kostev K
Affiliations:
Publications: Ger Med Sci. 2016 Jun 14;14:Doc06. doi: 10.3205/000233. eCollection 2016.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Surgery, Womens Health	2016	English


Persistence with antipsychotics in dementia patients in Germany
Authors: Booker A, Jacob L, Bohlken J, Rapp MA, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2016 Nov;54(11):835-840.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2016	English


Prevalence with and type of antidepressant therapy used by German general practitioners to treat female patients with osteoporosis
Authors: Drosselmeyer J, Rapp M, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2016 Oct;54(10):743-9
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Musculoskeletal disease, Womens Health	2016	English	, Epidemiological study


Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis.
Authors: Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F.
Affiliations:
Publications: Rheumatol Ther. 2016 Jun;3(1):53-75.
Document Types: , Article
Countries: , France, Germany, UK, USA
Condition	Year	Language	Analysis type
, Health economics, Health policy, Metabolic Disorders , Public Health	2016	English	, Retrospective cohort analysis


Depression risk in female patients with osteoporosis in primary care practices in Germany
Authors: Drosselmeyer J, Hadji P, Rapp M, Kostev K
Affiliations:
Publications: Osteoporos Int. 2016 Sep;27(9):2739-44
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Musculoskeletal disease	2016	English


Non-adherence to antiepileptic drugs in Germany: a retrospective, population based study
Authors: Gollwitzer S, Kostev K, Hagge M, Lang J, Graf W, Hamer HH
Affiliations:
Publications: Neurology. 2016 Aug 2;87(5):466-72
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2016	English


Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany
Authors: Jacob L, Hadji P, Kostev K
Affiliations:
Publications: J Geriatr Oncol. 2016 Apr 16. pii: S1879-4068(16)30019-4
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2016	English


Clinical and Patient-Related Variables Associated with Initiating GLP-1 Receptor Agonist Therapy in Type 2 Diabetes Patients in Primary Care in Germany
Authors: Qiao Q, Grandy S, Hiller J, Kostev K
Affiliations:
Publications: PLoS One. 2016 Mar 28;11(3):e0152281
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2016	English


Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Type 2 Diabetes Patients in Germany
Authors: Qiao Q, Grandy S, Ouwens M, Kostev K
Affiliations:
Publications: Diabetes Metab Syndr Obes. 2016 Jun 28;9:201-5
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes, Metabolic Disorders	2016	English


Prevalence of chronic diseases among older patients in German general practices
Authors: Jacob L, Breuer J, Kostev K
Affiliations:
Publications: Ger Med Sci. 2016 Mar 3;14:Doc03. doi: 10.3205/000230
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Miscellaneous	2016	English	, Epidemiological study


Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis
Authors: Gossen N, Jacob L, Kostev K
Affiliations:
Publications: Rheumatol Int. 2016 Aug;36(8):1113-8
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Rheumatology	2016	English	, Retrospective database analysis


Treatment of depression in patients with cardiovascular diseases by German psychiatrists.
Authors: Konrad M, Jacob L, Rapp M, Kostev K
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2016 Aug;54(8):557-63
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Mental health	2016	English


Gender-based differences in the antidepressant treatment of patients with depression in German psychiatric practices
Authors: Jacob L, Kostev K
Affiliations:
Publications: Ger Med Sci. 2016 Feb 15;14:Doc02. doi: 10.3205/000229
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2016	English


Microvascular Outcomes in Patients with Type 2 Diabetes Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Study Using German Electronic Medical Records.
Authors: Kolaczynski WM, Hankins M, Ong SH, Richter H, Clemens A, Toussi M.
Affiliations:
Publications: Diabetes Ther. 2016 Sep;7(3):483-96. doi: 10.1007/s13300-016-0177-8.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Diabetes, Metabolic Disorders	2016	English	, Retrospective database analysis


Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Authors: Lyu R, Govoni M, Ding Q, Black CM, Kachroo S, Fan T, Ogbonnaya A, Donga P, Hill J, Makin C.
Affiliations:
Publications: Rheumatol Int. 2016 Jan;36(1):143-53. doi: 10.1007/s00296-015-3348-4.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Rheumatology	2016	English


Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Brain metastasis in NSCLC in the era of precision Medicine.
Authors: Mpima S, Anger C, Mitrofan L
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Observational study


17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5).
Authors: Bermudez F, Karanais Y, Mistry H, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data.
Authors: Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I
Affiliations: GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Longitudinal study


Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK.
Authors: Mpima S, Casey V, Nasuti P
Affiliations: QuintilesIMS, London, United Kingdom
Publications: IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Observational study


Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma.
Authors: Jubert H, Karusisi N, Kolahi C, Mitrofan L
Affiliations: QuintilesIMS, La Defense, France
Publications: IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English


Treatment and dosing patterns among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Europe.
Authors: Kirsi Norrbacka; Victoria Divino; Mitch DeKoven; Kristina Secnik Boye
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: European Association for the Study of Diabetes 52nd annual meeting
Document Types: , Poster
Countries: , Belgium, France, Germany, Netherlands, Sweden
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/treatment-and-dosing-patterns-among-patients-with-type-2-diabetes-initiating-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-in-europe-5ef3fe71-7e5d-4bdd-8b32-b4187d2a9aac
Condition	Year	Language	Analysis type
, Diabetes	2016	English	, Retrospective database analysis


RISK FACTORS FOR DEMENTIA DIAGNOSIS IN GERMAN PRIMARY CARE PRACTICES
Authors: Wendschlag A1, Jacob L2, Kostev K3, Bohlken J4, Rapp MA5
Affiliations: 1IMS Health, Frankfurt / Main, Germany, 2Ecole Normale Superieure of Lyon, Lyon, France, 3IMS Health, Frankfurt am Main, Germany, 4Praxis Bohlken, Berlin, Germany, 5University of Potsdam, Potsdam, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2015	English	, Retrospective database analysis


Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies.
Authors: McDonell AL1, Kiiskinen U2, Zammit DC3, Kotchie RW1, Thuresson PO3, Nicolay C4, Haslam T1, Bruinsma M5, Janszen-Van Oosterhout AJ6, Otto T4
Affiliations: 1IMS Health, London, UK; 2Eli Lilly and Company, Helsinki, Finland; 3IMS Health, Basel, Switzerland; 4Eli Lilly and Company, Bad Homburg, Germany; 5IMS Health, Rotterdam, the Netherlands; 6Eli Lilly Nederland, Houten, the Netherlands
Publications: ClinicoEconomics and Outcomes Research, 2015; 7:95-103
Document Types: , Article
Countries: , Germany, Netherlands, UK
Abstract: http://www.dovepress.com/estimating-the-real-world-daily-usage-and-cost-for-exenatide-twice-dai-peer-reviewed-article-CEOR
Condition	Year	Language	Analysis type
, Diabetes	2015	English	, Retrospective database analysis


Incidence of Microvascular Outcomes among Type 2 Diabetes Patients Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Cohort Study Using German Electronic Medical Records
Authors: Hankins M1, Ong SH, Richter H, Kolaczynski WM, Clemens A, Vora J, Machnicki G, Toussi M
Affiliations: 1 IMS Health, London, UK 2 Novartis 3 IMS Health, Paris, France
Publications: American Diabetes Associationâ€™s 75th Scientific Sessions, June 5-9, 2015, Boston, Massachusetts
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2015	English	, Retrospective cohort analysis


DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases
Authors: Charbonnel B1, Gomes MB2, Khunti K3, Nicolucci A4, Pocock S5, Shestakova MV6, Shimomura I6, Fenici P7, GarcÃa-Ãlvarez L8, Hammar N9, Hashigami K10, Hiller J8, Medina J11, Surmont FA12, Ji L13
Affiliations: 1University of Nantes, Nantes, France; 2Rio de Janeiro State University, Rio de Janeiro, Brazil; 3University of Leicester, Leicester, UK; 4Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy; 5London School of Hygiene and Tropical Medicine, London, UK; 6Endocrinology Research Center, Moscow, Russian Federation; 7Osaka University, Osaka, Japan; 8AstraZeneca, Cambridge, UK; 9IMS Health, London, UK; 10AstraZeneca, MÃ¶lndal, Sweden; 11AstraZeneca, Tokyo, Japan; 12AstraZeneca, Madrid, Spain; 13AstraZeneca, Shanghai, China; 14Diabetes Center, Peking University Peopleâ€™s Hospital, Beijing, China
Publications: EASD - 51st Annual Meeting of the European Association for the Study of Diabetes, 14â€“18 September 2015, Stockholm, Sweden
Document Types: , Poster
Countries: , Canada, France, Germany, UK
Abstract: http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3
Condition	Year	Language	Analysis type
, Diabetes	2015	English	, Real World Data, Retrospective database analysis


High prevalence of co-morbidities and complex polypharmacy with drug-drug interaction (DDI) potential in patients with chronic Hepatitis C (CHC). Consistent findings from large primary care databases in the United Kingdom, Germany, and France
Authors: Fiona Marra1, 10, Werner Leber3, Stephen T. Barclay2, Stefan Christensen 5, Denis Ouzan7, Valerie Oules8, Peter McMahon4, Karel Kostev6, Xavier Ansolabehere9
Affiliations: 1. NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. 2. Walton Liver Clinic, Glasgow, United Kingdom. 3. Centre for Primary Care and Public Health, London, United Kingdom. 4. IMS Health UK, London, United Kingdom. 5. Center for Interdisciplinary Medicine (CIM) Infectious Diseases, MÃ¼nster, Germany. 6. IMS Health Germany, Frankfurt, Germany. 7. Institut Arnault Tzanck, Saint-Laurent-du-Var, France. 8. HÃ´pital Saint Joseph, Marseille, France. 9. IMS Health France, Paris, France. 10. University of Liverpool, Glasgow, United Kingdom.
Publications: AASLD - Congress of American Association for the Study of Liver Diseases
Document Types: , Abstract, Poster
Countries: , France, Germany, UK
Condition	Year	Language	Analysis type
, Infectious disease	2015	English	, Database Study, Real World Data


Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Authors: Katsarava Z1,2, Ehlken B3, Limmroth V4, Taipale K5, Patel SN5, Niemczyk G5, Rehberg-Weber K5, WernsdÃ¶rfer C5; C.A.R.E. Study Group
Affiliations: 1 Department of Neurology, Evangelic Hospital Unna, Unna, Germany 2 Department of Neurology, University Hospital Essen, Essen, Germany 3 IMS HEALTH, Munich, Germany 4 Department of Neurology, Cologne City Hospitals, University of Cologne, Cologne, Germany 5 Biogen GmbH, Ismaning, Germany
Publications: BMC Neurol. 2015 Sep 22;15(1):170.
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/26395989
Condition	Year	Language	Analysis type
, Medication compliance, Neurological disorders	2015	German	, Cost analysis, Observational study, Prospective study


Costs Associated with Routine Management of Febrile Neutropenia/Leukopenia in Three Tumour Types in German Hospitals - A Cost Study Update
Authors: Ihbe-Heffinger A1, Shlaen M5, Jacobs V3, Von Schilling C4, Paessens B1, Berger K6, Kiechle M3, Bernard R1, Peschel C2
Affiliations: 1 Hospital Pharmacy Unit, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 2 Third Medical Dept., Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 3 Dept. of Gynecology, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Third Medical Dept., Klinikum Freising, Freising, Germany 5 IMS Health GmbH, Munich, Germany 6 Medizinische Klinik III, HÃ¤matologie, Onkologie, Klinikum der UniversitÃ¤t, Munich, Germany
Publications: MASCC/ISOO Annual Meeting on Supportive Care in Cancer, 2015, February 15th, Copenhagen, Denmark
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2015	English


Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany - results of a database analysis from May 2010 to April 2012.
Authors: Ehlken B1, Anastassopoulou A2, Hain J2, SchrÃ¶der C1,3, Wahle K4.
Affiliations: 1 IMS Health, MÃ¼nchen, Germany 2 GlaxoSmithKline GmbH & Co. KG, MÃ¼nchen, Germany 3 Novo Nordisk Pharma GmbH, Mainz, Germany 4 Department of General Medicine, MÃ¼nster, Germany
Publications: BMC Public Health
Document Types: , Online article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475612/pdf/12889_2015_Article_1885.pdf
Condition	Year	Language	Analysis type
, Infectious disease	2015	English	, Cost analysis, Cost of illness, Economic evaluation


Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis.
Authors: McDonell A,Wahn U,Demuth D,Richards C,Hawes C,Andreasen J N,Allen-Ramey F
Affiliations: 1Real-World Evidence Solutions and Health Economics & Outcomes Research, IMS Health, 210 Pentonville Road, London N1 9JY, UK. 2Department for Pediatric Pneumology and Immunology, CharitÃ© Medical University, Berlin, Germany. 3Worked at IMS Health at time of study, Real-World Evidence Solutions and Health Economics & Outcomes Research, London, UK. 4Global Market Access, ALK-AbellÃ³ A/S, HÃ¸rsholm, Denmark. 5Global Health Outcomes, Merck & Co., West Point, PA 19486, USA.
Publications: Allergy, Asthma & Clinical Immunology (2015) 11:19
Document Types: , Manuscript in preparation
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Infectious disease, Respiratory disease	2015	English	, Retrospective database analysis


Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland and Spain.
Authors: De Francesco M, Ronco C, Wacinski PJ, Wessely R, HernÃ¡ndez P, Lamotte M.
Affiliations:
Publications:
Document Types:
Countries: , Germany, Italy, Poland, Spain
Abstract: http://dx.doi.org/10.3111/13696998.2015.1105809
Condition	Year	Language	Analysis type
	2015	English


An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Authors: Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2.
Affiliations: 1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy.
Publications: Drugs Context. 28;4:212285.
Document Types: , Article
Countries: , France, Germany, Italy
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf
Condition	Year	Language	Analysis type
, Health economics, Oncology	2015	English	, Survey research


Incidence of Microvascular Outcomes among Type 2 Diabetes Patients Treated with Vildagliptin vs. Sulfonylurea: A Retrospective Cohort Study Using German Electronic Medical Records
Authors: Matthew Hankins, Siew Hwa Ong, Hartmut Richter, Wlodzimierz M. Kolaczynski, Andreas Clemens, Gerardo Machnicki, Jiten Vora, Massoud Toussi
Affiliations:
Publications: 75th Scientific Sessions of the American Diabetes Association, American Diabetes Associationâ€™s 75th Scientific Sessions, June 5-9, 2015, Boston, Massachusetts
Document Types: , Conference
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2015	English	, Retrospective cohort analysis


PREVALENCE OF DEPRESSION AND ANXIETY AND THEIR RISK FACTORS IN WOMEN WITH BREAST CANCER IN GERMAN PRIMARY CARE
Authors: Engelhard J1, Bleicher L2, Kostev K1
Affiliations: 1IMS Health, Frankfurt am Main, Germany, 2University Clinic of Marburg, Marburg, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2015	English


THERAPY OF DEPRESSION IN CANCER AND NON-CANCER PATIENTS IN GERMAN NEUROPSYCHIATRIC PRACTICES
Authors: Ziegelbauer K, Engelhard J, Kostev K
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2015	English


CANCER IS ASSOCIATED WITH INTRAOPERATIVE AND POSTPROCEDURAL COMPLICATIONS AND DISORDERS
Authors: Engelhard J1, Jockwig A2, Kostev K1
Affiliations: 1IMS Health, Frankfurt am Main, Germany, 2Fresenius University of Applied Sciences, Idstein, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
	2015	English


DOES CONDITIONAL MARKETING AUTHORISATION INFLUENCE MARKET ACCESS IN FRANCE, ENGLAND, AND GERMANY?
Authors: Kaaniche A1, Troubat A1, Sherwood A2
Affiliations: 1IMS, PARIS, France, 2IMS Health, La DÃ©fense, France
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Abstract, Poster
Countries: , France, Germany, UK
Condition	Year	Language	Analysis type
, Health policy, Pricing and reimbursement	2015	English	, Market impact


A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN
Authors: Phan T1, Boutmy E2, Coulombel N2
Affiliations: 1Novo Nordisk Health Care AG, ZÃ¼rich, Switzerland, 2IMS Health, Boulogne-Billancourt, France
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ispor.org/research_pdfs/51/pdffiles/PDB13.pdf
Condition	Year	Language	Analysis type
, Diabetes	2015	English	, Retrospective database analysis


REDUCTION IN C-REACTIVE PROTEIN WITH BIOLOGIC DRUGS IN RHEUMATOID ARTHRITIS AND SPONDYLITIS PATIENTS IN GERMAN RHEUMATOLOGIST PRACTICES
Authors: Gossen N, Kostev K
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Drug safety, Rheumatology	2015	English


Drug utilization pattern of Lisdexamfetamine Dimesylate (LDX) in Europe
Authors: Cook M1, Varughese S1, Maxwell T1, Thun B2, Ehlken B2, Bredow D2Keja J2
Affiliations: 1 Shire, Wayne, PA, USA; 2 IMS HEALTH GmbH & Co. OHG, Real-World Evidence Solutions, Germany
Publications: ISPOR 18th Annual European Congress, 7-11 November 2015, Milan, Italy
Document Types: , Poster
Countries: , Germany, USA
Condition	Year	Language	Analysis type
, Mental health	2015	English	, Database Study


From centralized marketing authorization to national reimbursement - a challenging journey for new medical products with placebo controlled trials
Authors: Eheberg D1, Paulus G1, Dannemann S1, Batscheider A1
Affiliations: 1 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: ISPOR 18th Annual European Congress, 7-11 November 2015, Milan, Italy
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2015	English	, Pricing & Reimbursement


Filling GAP between risk-benefit assessment for pharmaceutical products and consumer goods
Authors: Hofmann-Xu L1, Bonduelle D1, PlantÃ¶r S1
Affiliations: 1 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: 18th International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Milan 2015
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/
Condition	Year	Language	Analysis type
, Methodology	2015	English	, Real World Evidence


Cardiovascular outcomes of antidiabetics therapy-results of a literature search
Authors: Greiner R1, Eheberg D1, Paulus G1 , Batscheider A1
Affiliations: 1 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: 18th ISPOR European Meeting, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2015	English	, Literature Review


Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
Authors: Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14.
Affiliations: 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario MarquÃ©s de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro MÃ©dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, MÃ©xico City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland.
Publications: Ann Rheum Dis. 2015 Jun;74(6):979-84
Document Types: , Article
Countries: , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Rheumatology	2015	English	, Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles


Use of a German longitudinal prescription database (LRx) in pharmacoepidemiology.
Authors: pharmacoepidemiology. Richter H1, Dombrowski S1, Hamer H2, Hadji P3, Kostev K4.
Affiliations: 1IMS Health, Real World Evidence Solutions, Frankfurt, Germany. 2Department of Neurology, Epilepsy Center, University of Erlangen, Germany. 3Department of Women's Health, North West Hospital, Frankfurt, Germany. 4Fresenius University of Applied Sciences, Idstein, Germany.
Publications: Ger Med Sci. 2015; 13: Doc14.
Document Types: , Review
Countries: , Germany
Condition	Year	Language	Analysis type
, Database Validity and methodology	2015	English	, Retrospective database analysis


Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed?
Authors: Charnock J, Bruce A, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581
Condition	Year	Language	Analysis type
, Oncology	2015	English


Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5).
Authors: Bruce A, Anger C, Gajeperia C
Affiliations: IMS Health, London, United Kingdom
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK).
Authors: Bruce A, Hurlock J
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Stratification of high risk HER2-/HR+ patients following AI therapy.
Authors: Mitrofan L, Gajperia C, Charnock J, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Patterns of systemic lupus erythematosus expression in Europe
Authors: Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12
Affiliations: 1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitiÃ© SalpetriÃ¨re Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La DÃ©fense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France
Publications: Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629
Document Types: , Article, Manuscript in preparation
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders	2014	English	, Epidemiological study, Observational study, Prospective study


Trends In Prescribing Of Specific Immunotherapy For Grass Pollen Allergy In Germany: 2005-2012
Authors: Wahn U1, McDonell A2, Richards C2, Allen-Ramey F3, Andreasen J4, Hawes C2, Demuth D2
Affiliations: 1Dept. of Ped. Pneumology and Immunology, Charite, Berlin, Germany, 2IMS Health, London, UK, 3Merck, West Point, Pennsylvania, 4ALK, Horsholm, Denmark
Publications: American Academy of Allergy Asthma & Immunology, San Diego, CA, USA
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2014	English	, Retrospective database analysis


Macro- and microvascular outcomes in patients with type 2 diabetes treated with rapid-acting insulin analogues or human regular insulin: a retrospective database analysis.
Authors: Rathmann W1, Schloot NC2, Kostev K3, Reaney M4, Zagar AJ5, Haupt A2
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 Lilly Deutschland GmbH, Bad Homburg, Germany 3 IMS Health, Frankfurt, Germany 4 Lilly Research Centre, Windlesham, Surrey, UK 5 Eli Lilly and Company, Indianapolis, US
Publications: Exp Clin Endocrinol Diabetes., 2014 Feb;122(2):92-9
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24558019
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Retrospective database analysis


Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis.
Authors: Ziller M1, Ziller V1, Haas G2, Rex J2, Kostev K1 2
Affiliations: 1 Phillips-University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany
Publications: Arch Gynecol Obstet., 2014, Feb;289(2):413-9
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Risk+of+venous+thrombosis+in+users+of+hormonal+contraceptives+in+German+gynaecological+practices+-+a+patient+database+analysis
Condition	Year	Language	Analysis type
, Womens Health	2014	English	, Retrospective database analysis


Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: A retrospective database analysis in Germany and UK.
Authors: Kostev K1, Jockwig A2, Hallwachs A3, Rathmann W4
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 Praxis for Internal Medicine and Nephrology, Munich, Germany 4 Institute of Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany
Publications: Prim Care Diabetes., 2014, Feb 13. pii: S1751-9918(14)00012-6. doi: 10.1016/j.pcd.2014.01.011. [Epub ahead of print]
Document Types: , Article
Countries: , Germany, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Prevalence+and+Risk+Factors+of+Neuropathy+in+Newly+Diagnosed+Type+2+Diabetes+in+Primary+Care+Practices%3A+A+Retrospective+Database+Analysis+in+Germany+and+UK
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Retrospective database analysis


Physicians influence on breast cancer patient compliance.
Authors: Kostev K1, Waehlert L2, Jockwig A2, Jockwig B2, Hadji P3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany
Publications: GMS Ger Med Sci., 2014, 12:Doc03 doi: 10.3205/000188, http://www.egms.de/static/en/journals/gms/2014-12/000188.shtml
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895867/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Compliance


Gender differences in persistency to bisphosphonates in patients with metastatic breast and prostate cancer.
Authors: Hadji P1, Kyvernitakis J1, Albert U, Jockwig J2, Kostev K3
Affiliations: 1 Phillips-University of Marburg, Marburg, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 IMS Health, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther., 2014, Apr 2. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gender+differences+in+persistency+to+bisphosphonates+in+patients+with+metastatic+breast+and+prostate+cancer
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Use of antidiabetic agents in the treatment of gestational dia-betes mellitus in Germany: developments between 2008 and 2012.
Authors: Heilmaier C1, Thielscher C1, Ziller M2, Altmann V3, Kostev K3
Affiliations: 1 FOM University, Essen, Germany 2 Phillips-University of Marburg, Marburg, Germany 3 IMS Health, Frankfurt, Germany
Publications: Journal of Obstetrics and Gynaecology Research, 2014, Jun; 40(6): 1592-7
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Retrospective database analysis


Impact of comorbidities on the treatment of atopic dermatitis in clinical practice.
Authors: Werner-Busse A1, Kostev K2, Heine G1, Worm M1
Affiliations: 1 Charite University Berlin Germany 2 IMS Health, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther,2014 Sept;52(9):726-31
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology	2014	English	, Retrospective database analysis


Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients.
Authors: Kostev K1, Rockel T1, Rosenbauer J2, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany
Publications: Prim Care Diabetes., 2014
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Burden of illness


(Supply profile of patients with occupational therapy regulations in their own practices) Versorgungsprofil der Patienten mit Ergotherapie-Verordnungen in niedergelassenen Praxen.
Authors: Kostev K1, Drosselmeyer2, Jockwig A2, Hog D2, Heilmaier C3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 FOM University, Essen, Germany
Publications: Monitor Versorgungsforschung, 2014, Maerz. (02):
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2014	German	, Economic evaluation


Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review
Authors: Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6
Affiliations: 1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, MÃ¼nchen, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA
Publications: Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22â€“24 September, 2014 (Poster)
Document Types: , Abstract
Countries: , Germany, Netherlands, Spain, UK, USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Literature Review


Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
Authors: JÃ¼rgensen J1 + 2, Ikenberg R3,Greiner R-A3,HÃ¶sel V4
Affiliations: 1 Charite UniversitÃ¤tsmedizin, Berlin, Germany 2 Hochschule fÃ¼r Ã–konomie und Management, Berlin, Germany 3 IMS Health, Munich, Germany 4 StatsciConsult, Munich, Germany
Publications: European Journal of Health Economics
Document Types: , Article
Countries: , Germany
Abstract: http://link.springer.com/article/10.1007%2Fs10198-014-0579-3
Condition	Year	Language	Analysis type
, Nephrology	2014	English	, Cost effectiveness


Drug utilisation pattern of lisdexamfetamine dimesylate in Germany
Authors: Cook M1, Varughese S1, Maxwell T1, von Bredow D2, Keja J2, Rex J2
Affiliations: 1 Shire, Wayne, PA, USA 2 IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2014	English	, Database Study


Description of Cardiovascular Event Rates in Patients Initiating Chronic Opioid Therapy for Noncancer Pain in Observational Cohort Studies in the US, UK, and Germany
Authors: LoCasale R1, Kern DM2, Chevalier P3, Zhou S2, Chavoshi S1, Sostek M
Affiliations: 1 AstraZeneca, Wilmington Delaware, USA 2 HealthCore Inc., Wilmington Delaware, USA 3 IMS Health, Vilvoorde, Belgium
Publications: Adv Ther. 2014 Jul;31(7):708-23
Document Types: , Manuscript in preparation
Countries: , Germany, UK, USA
Condition	Year	Language	Analysis type
, Cardiovascular disease, Pain	2014	English	, Epidemiological study, Retrospective database analysis


Using an innovative approach to build a prospective Diabetes Cohort Registry Of Patients with type 2 Diabetes in Germany: Diareg (PRM 61)
Authors: Garcia Alvarez L1, Rathmann W2, Bode-Greuel K3, Engelhard J3, Busch S4, SchrÃ¶der-Bernhardi D3, Hiller J1
Affiliations: 1IMS Health, London, UK, 2German Diabetes Center, Duesseldorf, Germany, 3IMS Health, Frankfurt am Main, Germany, 4AstraZeneca, Hamburg Area, Germany
Publications: ISPOR 17th Annual European Conference, Amsterdam 8 - 12 November 2014
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes, Methodology	2014	English	, Methodology


Epidemiology and unmet medical need in diabetes mellitus type 2 in Germany â€“ results of a literature search
Authors: Greiner R, Paulus G, Driedger J, SchrÃ¶der C, Timtschenko V, Batscheider A, Eheberg D, Vosgerau S
Affiliations: IMS Health, Munich, Germany,
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Epidemiological study


Quality of life â€“ a rarely acknowledged key category within the AMNOG process in Germany
Authors: Eheberg D1, Shlaen R2, Batscheider A2, Gohlke A2
Affiliations: 1IMS Health, Munich, Germany, 2IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2014	English	, Quality of life


Understanding the role of subgroup analysis and tests for homogeneity or interaction in the AMNOG dossier
Authors: Hofmann-Xu L1, Bonduelle D2, Eheberg D3
Affiliations: IMS Health Germany, Munich, Germany, 2IMS HEALTH GmbH & Co. OHG, Munich, Germany, 3IMS HEALTH, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2014	English	, Methodology


First experiences with the new testing examination and treatment methods in Germany: Is this a new AMNOG clone?
Authors: Bonduelle D1, Eheberg D2, Plantoer S1
Affiliations: 1IMS Health GmbH & Co. OHG, Munich, Germany, 2IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2014	English	, Market impact


Prevalence of chronic diseases among older patients (>65 years) in German general practitioner practices
Authors: Kostev K1, Rex J, Engelhard J, Altmann V, Jockwig A
Affiliations: 1 IMS Health, Frankfurt, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Miscellaneous	2014	English	, Population Based Study


Oncology products in the AMNOG process â€“ learnings for a successful dossier submission
Authors: Dehnen J1, Goldhagen K2
Affiliations: 1 IMS Health, Cambridge, UK 2 IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Willingness to pay


Pediatric trends in prescribing of specific immunotherapy for grass pollen allergy in Germany: 2005-2012
Authors: Wahn UH1, Norgaard Andreasen J2, McDonell A3, Richards C3, Allen-Ramey F4, Demuth D3
Affiliations: 1 Allergy and Immunology, Berlin, Germany, 2 ALK-AbellÃ³, Horsholm, Denmark, 3 IMS Health, London, UK, 4 Merck, West Point, US
Publications: European Academy of Allergy and Clinical Immunology Congress 7-11 June 2014, Copenhagen, Denmark
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2014	English	, Retrospective database analysis


Trends in first prescriptions of specific immunotherapy for grass pollen allergy in Germany: 2005-2012
Authors: Norgaard Andreasen J1, Wahn U2, McDonell A3, Richards C3, Allen-Ramey F4, Demuth D3
Affiliations: 1 ALK-AbellÃ³, Horsholm, Denmark, 2 Pediatric Allergy and Immunology, Berlin, Germany, 3 IMS Health, London, UK, 4 Merck, West Point, US
Publications: European Academy of Allergy and Clinical Immunology Congress 7-11 June 2014, Copenhagen, Denmark
Document Types: , Poster
Countries: , Germany
Abstract: http://www.professionalabstracts.com/eaaci2014/planner/index.php?go=abstract&action=abstract_iplanner&print=0&lprID=1690&highlight=wahn&PSID=DWJLDURMOSTVZOWHRYYC
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2014	English	, Retrospective database analysis


First experiences with the new testing examination and treatment methods in Germany: Is this a new AMNOG clone?
Authors: Bonduelle D1, Eheberg D1, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2014	English	, Pricing & Reimbursement


Quality of life-a rarely acknowledged key category within the AMNOG process in Germany
Authors: Eheberg D., Shlaen R., Batscheider A., Gohlke A.
Affiliations: IMS Health, Munich, Germany
Publications: VALUE IN HEALTH 17 (2014) A323â€“A686
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2014	English	, Quality of life


Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Authors: Lebioda A1, Gasche D2, Dippel F-W3, Theobald K4, PlantÃ¶r S1
Affiliations: 1 IMS Health,Munich, Germany 2 IMS Health, Barcelona, Spain 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Publications: Health Economics Review, 2014, 4(31)
Document Types: , Article
Countries: , Germany
Abstract: doi:10.1186/s13561-014-0031-5
Condition	Year	Language	Analysis type
, Health economics	2014	English	, Methodology


Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany.
Authors: D. Wu1, G. Mansoor2, C. Kempf3, M.-S. Schwalm4 andJ. Chin4
Affiliations: 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, USA 2Clinical Research, Merck & Co., Inc., Whitehouse Station, NJ, USA 3Cegedim Strategic Data, Paris, France 4Cegedim Strategic Data, Jersey City, NJ, USA
Publications: Int J Clin Pract. 2014 Jun;68(6):714-24
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24499317
Condition	Year	Language	Analysis type
, Cardiovascular disease, Nephrology	2014	English	, Retrospective database analysis


Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries.
Authors: CottÃ© FE1, Benhaddi H2, Duprat-Lomon I2, Doble A3, Marchant N4, Letierce A5, Huguet M5.
Affiliations: Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. Electronic address: francois-emery.cotte@bms.com. 2Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. 3Foxymed, Paris, France. 4Pfizer, Walton Oaks, United Kingdom. 5Cegedim Strategic Data, Boulogne-Billancourt, France
Publications: Clin Ther. 2014 Sep 1;36(9):1160-8. doi: 10.1016/j.clinthera.2014.07.016. Epub 2014 Aug 21.
Document Types: , Article
Countries: , France, Germany, Italy, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25151574
Condition	Year	Language	Analysis type
, Cardiovascular disease	2014	English	, Retrospective database analysis


Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios.
Authors: Hoogendoorn M1, Feenstra TL2, Asukai Y3, Borg S4, Hansen RN5, Jansson SA6, Samyshkin Y3, Wacker M7, Briggs AH8, Lloyd A3, Sullivan SD5, Rutten-van MÃ¶lken1 MP.
Affiliations: 1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands. 2Department for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology, University Medical Centre Groningen, The Netherlands.3IMS Health, Health Economics and Outcomes Research, Real-World Evidence Solutions, London, UK 4The Swedish Institute for Health Economics, Lund, Sweden 5Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA 6The OLIN Studies, LuleÃ¥, Sweden 7Helmholtz Zentrum MÃ¼nchen, Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich, Neuherberg, Germany. 8Institute of Health & Wellbeing, University of Glasgow, UK.
Publications: Value Health. 2014 Jul;17(5):525-36.
Document Types: , Article
Countries: , Germany, Netherlands, Sweden, UK, USA
Condition	Year	Language	Analysis type
, Respiratory disease	2014	English	, Cost effectiveness


Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis.
Authors: Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7
Affiliations: 1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del RocÃo, US, CSIC), Seville, Spain.
Publications: Lung Cancer. 2014 Aug;85(2):230-8
Document Types: , Article
Countries: , China, Germany, Hong Kong, Spain, Taiwan, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Meta analysis


Renal function, attributes and coagulation treatment in atrial fibrillation (R-FACT Study): retrospective, observational, longitudinal cohort study of renal function and antithrombotic treatment patterns in atrial fibrillation patients with documented eGFR in real-world clinical practices in Germany.
Authors: Wu D1, Mansoor G, Kempf C2, Schwalm MS2, Chin J.
Affiliations: 1Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, USA. 2 Cegedim strategic Data
Publications: Int J Clin Pract. 2014 Jun;68(6):714-24.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease, Nephrology	2014	English	, Retrospective database analysis


Description of GCSF usage in oncology in 5 European countries.
Authors: Anger C1, Schmidt N2, Ricarte C3
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://meetinglibrary.asco.org/record/97923/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Observational study


Association of diabetes and cancer diagnoses in primary care practices in Germany.
Authors: Schmidt N, Kostev K, Ziller V, Kowall B, Rathmann W
Affiliations: 1 IMS Health GmBH & Co. OHG, Frankfurt/Main, 2 Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Poster
Countries: , Germany
Abstract: http://meetinglibrary.asco.org/record/96337/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English


Importance of durational hormone therapy in breast cancer patients in Germany: Retrospective database analysis.
Authors: Schmidt N, Haas G, Kostev K, Peyman H
Affiliations: 1IMS Health GmBH & Co. OHG, Frankfurt/Main, 2Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Poster
Countries: , Germany
Abstract: http://meetinglibrary.asco.org/record/96376/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries.
Authors: Schmidt N, Ricarte C, Haas G
Affiliations: 1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US.
Authors: Charnock J, Bruce A, Murch L, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK.
Authors: Khanna R, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries.
Authors: Divino V., DeKoven M., Hallinan S., Varol N., Wirta SB., Lee WC., Reaney M.
Affiliations: Lilly. IMS authors: Divino V, DeKoven M
Publications: Diabetes Ther.
Document Types: , Article
Countries: , Belgium, France, Germany, Netherlands, Sweden, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25366334
Condition	Year	Language	Analysis type
, Diabetes	2014	English	, Retrospective database analysis


Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries
Authors: Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5
Affiliations:
Publications: VALUE IN HEALTH 17 ; A684
Document Types: , Abstract
Countries: , Belgium, France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Health economics, Immunology and Vaccination, Oncology	2014	English	, Cost of illness, Retrospective database analysis


Roflumilast in combination with long-acting bronchodilators in the management of patients with severe and very severe COPD.
Authors: Nowak D1, Ehlken B2, Kotchie R3, Wecht S4, Magnussen H5
Affiliations: 1 Institut und Poliklinik fÃ¼r Arbeits-, Sozial- und Umweltmedizin, MÃ¼nchen 2 IMS Health GmbH & Co. OHG, MÃ¼nchen 3 IMS Health, London, UK 4 zum Zeitpunkt der Erstellung Pricing and Health Economics, Nycomed GmbH, Konstanz 5 Pneumologisches Forschungsinstitut am Krankenhaus GroÃŸhansdorf, GroÃŸhansdorf
Publications: Dtsch Med Wochenschr, 2013, 138(4):119-125 Dtsch Med Wochenschr, 2013, Epub Jan 15
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23322425
Condition	Year	Language	Analysis type
, Respiratory disease	2013	German	, Cost effectiveness


The risk of developing depression when suffering from neurological diseases.
Authors: Thielscher C12, Thielscher S3, Kostev K2
Affiliations: 1 FOM University of Applied Sciences, Essen, Germany 2 IMS Health, Frankfurt, Munich, Germany 3 Elisabeth Hospital, Gerolstein, Germany
Publications: GMS German Medical Science, 2013, 11
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Neurological disorders	2013	English	, Survey research


Geringe Korrelation von KrankenhausfÃ¼hrern kann zu verwirrenden Ergebnissen fÃ¼hren [Low Correlation between Hospital Rankings Results in Confusing Recomendations].
Authors: Thielscher C1, Antoni B2, Driedger J23, Jacobi S24, Krol B1
Affiliations: 1 FOM Hochschule fÃ¼r Oekonomie und Management, Essen, Germany 2 IMS Health, Munich, Germany 3 Justus-Liebig-UniversitÃ¤t, GieÃŸen, Germany 4 Ludwig-Maximilians-UniversitÃ¤t, Munich, Germany
Publications: Gesundh Ã¶kon Qual manag, 2014 19(2): 65-69
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Orthopedics	2013	German	, Survey research


Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Authors: Lorenz K1, Wolfram C1, Breitscheidel L2, Shlaen M2, Verboven Y3, Pfeiffer N1
Affiliations: 1 Department of Ophthalmology University Medical Center Johannes Gutenberg-University, Mainz, Germany 2 IMS HEOR, Munich, Germany 3 Alcon Research Ltd., Puurs, Belgium
Publications: Graefes Arch Clin Exp Ophthalmol, 2013, efirst
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2013	English	, Cost analysis, Observational study


Health- and Vision-Related Quality of Life in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma.
Authors: Wofram C1, Lorenz K1, Breitscheidel L2, Verboven Y3, Pfeiffner N1
Affiliations: 1 Department of Ophthalmology University Medical Center, Mainz, Germany 2 IMS Health, Munich, Germany 3 Alcon Research Ltd., Puurs, Belgium
Publications: Ophthalmologica, 2013, eFirst
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2013	English	, Observational study, Quality of life


The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care â€” an observational analysis on non-small-cell lung cancer patients.
Authors: Ihbe-Heffinger A13, Paessens B1, Berger K24, Shlaen M2, Bernard R1, von Schilling C56, Peschel C5
Affiliations: 1 Hospital Pharmacy Department Klinikum rechts der Isar Technische UniversitÃ¤t Munich, Germany 2 IMS Health, Munich, Germany 3 Department of Gynaecology Klinikum rechts der Isar Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Department of Transfusion Medicine and Haemostaseology, Klinikum der UniversitÃ¤t MÃ¼nchen, Munich, Germany 5 Third Medical Department, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 6 Department of Internal Medicine III Klinikum Freising, Freising, Germany
Publications: Support Care Cancer, 2013, 21: 1665â€“1675
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost consequence, Observational study


Budget impact analysis of iso-osmolar iodixanol compared to low osmolar contrast media in an intra-arterial setting in german hospitals
Authors: Greiner RA1, Vandekerckhove S2, Ehlken B1, Driedger J1, Bodnar C3
Affiliations: 1 IMS Health, Munich, Germany 2 IMS Health, Vilvoorde, Belgium 3 GE Healthcare, Buckinghamshire, UK
Publications: European Society of Cardiology (ESC) Cardiovascular Development Meeting, 2013, September 26-29, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Clinical practice	2013	English	, Budget impact


Fixed reference pricing or benefit assessment of established products â€“from the frying pan into the fire?
Authors: Vosgerau S1, Eheberg D1, Lebioda A1, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany
Publications: ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2013	English	, Economic evaluation


Burden of actinic keratosis in germany-results of a literature research
Authors: Pfiffner C1, Macheleidt O2, Batscheider A1, Ehlken B1, Greiner RA1, Schroeder C1, Hutt HJ2
Affiliations: 1 IMS Health, Munich, Germany 2 LEO Pharma GmbH, Neu Isenburg, Germany
Publications: ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology, Oncology	2013	English	, Burden of illness


Cost of influenza in germany
Authors: Anastassopoulou A1, Wahle K1, Hain J1, Schroeder C2, Ehlken B2
Affiliations: 1 Glaxo Smith Kline GmbH & Co. KG, Munich, Germany 2 IMS Health, Munich, Germany
Publications: ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Infectious disease	2013	English	, Cost of illness


Orphan drugs in the German early benefit assessmentâ€“ real world vs. G-BA bureaucracy
Authors: Lebioda A1, M. Huelsebeck M1, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany
Publications: ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Miscellaneous	2013	English	, Review


A comparison of German benefit assessments by G-BA, IQWiG and manufacturers
Authors: Eheberg D1, Lebioda A1, Huelsebeck M1, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany
Publications: ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2013	English	, Review


Relevance of indirect comparisons in the German early benefit assessment (AMNOG)
Authors: Lebioda A1, Gasche D2, Dippel FW 3, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany 2 IMS Health, Barcelona, Spain 3 Universitaet Leipzig, Leipzig, Germany
Publications: ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2013	English	, Review


Methodological challenges in comparing topical therapies in dermatology in the absence of head to head studies
Authors: Greiner RA1, Macheleidt O2, Batscheider A1, Eheberg D1, Ehlken B1, Gohlke A1, Pfiffner C1, Hutt HJ2
Affiliations: 1 IMS Health, Munich, Germany 2 LEO Pharma GmbH, Neu Isenburg, Germany
Publications: ISPOR 16th annual European congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology	2013	English	, Review


Comparison of drug assessments in France, Germany and UK: is European HTA a reality?
Authors: Perrin l1, Troubat A1
Affiliations: 1. IMS Health, La DÃ©fense, France
Publications: ISPOR 16th Annual European Congress - Nov2013
Document Types: , Poster
Countries: , France, Germany, UK
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2013	English	, Pricing & Reimbursement


Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK.
Authors: Kostev K1, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: Prim Care Diabetes., 2013, Jul;7(2):167-71
Document Types: , Article
Countries: , France, Germany, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=influence%20of%20macro%20and%20microvascular%20comorbidity%20on%20time%20to%20insulin%20initiation%20in%20type%202%20diabetes%20patients%20a%20retrospective%20database%20analysis%20in%20germany,%20france,%20and%20uk&cmd=correctspelling
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Retrospective database analysis


Lower incidence of recorded cardiovascular outcomes in patients with Type 2 Diabetes using Insulin Aspart versus those on human regular insulin: Observational evidence from General Practices.
Authors: Rathmann W1, Kostev K2
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 IMS Health, Frankfurt, Germany
Publications: Diabetes Obes Metab., 2013, Apr;15(4):358-63
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23137345
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Observational study


Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
Authors: Kostev K1, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: Prim Care Diabetes., 2013, Oct;7(3):229-33
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23608219
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Retrospective database analysis


Secondary analysis of electronic databases: potentials and limitations. Reply to Asghari S, Mahdavian M [letter].
Authors: Kostev K1, Rathmann W2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: Diabetologia, 2013, Sep;56(9):2098-9
Document Types: , Letter
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Secondary+analysis+of+electronic+databases%3A+potentials+and+limitations.+Reply+to+Asghari+S%2C+Mahdavian+M+%5Bletter%5D.
Condition	Year	Language	Analysis type
, Miscellaneous	2013	English	, Database Study, Utility analysis


Prevalence of female subfertility in German gynecological practices.
Authors: Ziller V1, Hadji P2, Thielscher, C3, Ziller M1, Kostev K4
Affiliations: 1 University hospital of Giessen and Marburg, Marburg, Germany 2 Philipps- University of Marburg, Marburg, Germany 3 FOM University of Applied Sciences, Essen, Germany 4 IMS Health, Frankfurt, Germany
Publications: Gynecol Endocrinol., 2013, Aug;29(8):767-70
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23738676
Condition	Year	Language	Analysis type
, Womens Health	2013	English	, Retrospective database analysis


The prescribing of contraceptives for adolescents in primary care in Germany: a retrospective database analysis
Authors: Ziller M1, Rashed A2, Ziller V1, Kostev K3
Affiliations: 1 University hospital of Giessen and Marburg, Marburg, Germany 2 UCL School of Pharmacy, Faculty of Life Science, London UK 3 IMS Health, Frankfurt, Germany
Publications: J Pediatr Adolesc Gynecol., 2013, Oct;26(5):261-4
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Womens Health	2013	English	, Retrospective database analysis


Different injection frequencies of basal insulins in type 2 diabetes patients under real-life conditions: a retrospective database analysis.
Authors: Rathmann W1, Dippel FW2, Kostev K3
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt, Germany
Publications: J Diabetes Sci Technol., 2013, September, 7(5): 1354â€“1358
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Different+injection+frequencies+of+basal+insulins+in+type+2+diabetes+patients+under+real-life+conditions%3A+A+retrospective+database+analysis
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Retrospective database analysis


Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
Authors: Kostev K1, Dippel FW2, Rathmann W3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany
Publications: Prim Care Diabetes., 2013, Oct 30. pii: S1751-9918(13)00117-4. doi: 10.1016/j.pcd.2013.10.001. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Predictors+of+Hypoglycaemia+in+Insulin-treated+Type+2+Diabetes+Patients+in+Primary+Care%3A+A+Retrospective+Database+Analysis+Primary+Care+Diabetes
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Retrospective database analysis


Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis.
Authors: Rathmann W1, Kostev K2, Gruenberger JB3, Dworak M3, Bader G3, Giani G1
Affiliations: 1 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany 2 IMS Health, Frankfurt, Germany 3 Novartis Pharma, Basel, Switzerland
Publications: Diabetes Obes Metab., 2013, Jan;15(1):55-61
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Treatment+Persistence%2C+Hypoglycemia%2C+and+Clinical+Outcomes+in+Type+2+Diabetes+Patients+with+DPP-4+Inhibitors+and+Sulfonylureas%3A+A+Primary+Care+Database+Analysis
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Retrospective database analysis


Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.
Authors: Hadji P1, Ziller V1, Kyvernitakis J1, Bauer M1, Haas G2, Schmidt N2, Kostev K2
Affiliations: 1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany
Publications: Breast Cancer Res Treat., 2013, Feb;138(1):185-91
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23334803
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Frequency of hospitalizations prior to and after conversion to a rebate pharmaceutical in depression patients in Germany.
Authors: Kostev K1, May U2, Ott C2, Paul M2, Schetschok K2, Tingelhoff M2, Claus C2, Waehlert L2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Hochschule Fresenius, Idstein, Germany
Publications: Int J Clin Pharmacol Ther., 2013, May;51(5):416-22
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=The+frequency+of+hospitalizations+prior+to+and+after+conversion+to+a+rebate+pharmaceutical+in+depression+patients+in+Germany
Condition	Year	Language	Analysis type
, Mental health	2013	English	, Retrospective database analysis


Persistence with bisphosphonates in patients with metastatic breast cancer: A retrospective database analysis.
Authors: Hadji P1, Ziller V1, Kyvernitakis J1, Schmidt N2, Kostev K2
Affiliations: 1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany
Publications: J Cancer Res Clin Oncol., 2013, Jul;139(7):1149-55
Document Types: , Article
Countries: , Germany
Abstract: http://link.springer.com/article/10.1007%2Fs00432-013-1427-z
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Resource consumption and costs of treatment in patients with type 1 diabetes under intensified conventional therapy under German real-life conditions.
Authors: Kostev K1, Dippel FW2, Bierwirth R3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Sanofi Deutschland GmbH, Berlin, Germany 3 Ambulantes Diabeteszentrum am Elisabeth-Krankenhaus, Essen, Germany
Publications: J Diabetes Sci Technol., 2013, May 1;7(3):736-42
Document Types: , Article
Countries: , Germany
Abstract: http://jdst.org/May2013/PDF/Abstracts/VOL-7-3-ORG12-KOSTEV-ABSTRACT.pdf
Condition	Year	Language	Analysis type
, Diabetes	2013	English	, Cost analysis


Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany.
Authors: Kostev K1, May U2, Hog D2, Eisel J2, Kremmers T2, Kosteic M2, Waehlert L2, Hadji P3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Hochschule Fresenius, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany
Publications: Int J Clin Pharmacol Ther., 2013, Dec;51(12):969-75
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Adherence+in+tamoxifen+therapy+after+conversion+to+a+rebate+pharmaceutical+in+breast+cancer+patients+in+Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


(Prevalence and treatment profile of patients with grass and house dust mite allergy) HÃ¤ufigkeit und Versorgungsprofil von Patienten mit GrÃ¤serpollen- und Hausstaubmilbenallergie.
Authors: Worm M1, Lee HH1, Kostev K2
Affiliations: 1 Charite University, Berlin, Germany 2 IMS Health, Frankfurt, Germany
Publications: J Dtsch Dermatol Ges,. 2013, Jul;11(7):653-61
Document Types: , Article
Countries: , Germany
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/ddg.12089_suppl/abstract
Condition	Year	Language	Analysis type
, Dermatology	2013	German	, Retrospective database analysis


(Analysis of the influence of the physician on the compliance of breast cancer patients) Analyse des Einflusses des Arztes auf die Compliance von Brustkrebs-Patientinnen.
Authors: Kostev K1, Oschmann L2, Schneider DM2, GrÃ¶ger S2, Karsten T2, Waehlert L2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany
Publications: Monitor Versorgungsforschung, 2013, Mar. (01): 29-34.
Document Types: , Article
Countries: , Germany
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/Analyse_Einfluss_Arzt_auf_Compliance_Brustkrebs-Patientinnen
Condition	Year	Language	Analysis type
, Oncology	2013	German	, Compliance


(Significantly shortened survival time of patients with prostate cancer in the occurrence of bone metastases) Deutlich verkÃ¼rzte Ãœberlebenszeit von Patienten mit Prostatakarzinom beim Auftreten von Knochenmetastasen.
Authors: Haas G1, Kostev K1
Affiliations: 1 IMS Health, Frankfurt, Germany
Publications: Monitor Versorgungsforschung, 2013, May. (04): 27-31
Document Types: , Article
Countries: , Germany
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/copy_of_Arzneimittelentwicklung-in-der-Onkologie
Condition	Year	Language	Analysis type
, Oncology	2013	German	, Burden of illness, Quality of life


Economic prescribing of corticosteroid nasal sprays in Germany Subtitle: Comparison of mometasone and budesonide nasal sprays on the basis of the DDD, the PDD and reference prices.
Authors: Becker B1, Kruppert S2, Kostev K2
Affiliations: 1 MSD Munich Germany 2 IMS Health, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther., 2013, Jan;51(1):12-8.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Respiratory disease	2013	English	, Cost analysis


(Prescribing pain medications for children and adolescents in primary care and pediatrician practices in Germany) Verschreibung von Schmerzmedikamenten fÃ¼r Kinder und Jugendliche in hausÃ¤rztlichen und pÃ¤diaterischen Praxen in Deutschland
Authors: Trebst D1, Sonntag D1, Kiess W1, Bertsche T1, Kistev K2
Affiliations: University of Leipzig, Leipzig, Germany 2 IMS Health, Frankfurt, Germany
Publications: Dtsch Med Wochenschr., 2013, Jun;138(24):1322-4
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Pediatrics	2013	German	, Retrospective database analysis


(Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis) Verwendung von off-label Medikamenten bei ambulant betreuten Kindern und Jugendlichen in Deutschland.
Authors: Sonntag D1, Trebst D1, Kiess W1, Kapellen T1, Bertsche T1, Kostev K2
Affiliations: 1 University of Leipzig, Leipzig, Germany 2 IMS Health, Frankfurt, Germany
Publications: Dtsch Med Wochenschr., 2013, Oct;138(44):2239-45
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Pediatrics	2013	German	, Utility analysis


ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND UK
Authors: COTTÃ‰ FE1, CARRASCO J1, DUPRATLOMON I1, MARCHANT N2, LETIERCE A3 & HUGUET M3
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: ISPOR Annual European Congress, Dublin. 2013.
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition	Year	Language	Analysis type
, Cardiovascular disease	2013	English	, Retrospective database analysis


Anticoagulation treatment with VKA in France, Italy, Germany, Spain and UK. Results from the REACT-AF study.
Authors: COTTÃ‰ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: ISPOR Annual European Congress, Dublin. 2013
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition	Year	Language	Analysis type
, Cardiovascular disease	2013	English	, Retrospective database analysis


The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations.
Authors: COTTÃ‰ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: 16th Annual European ISPOR Congress Dublin, Ireland
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03127-6/abstract
Condition	Year	Language	Analysis type
, Cardiovascular disease	2013	English	, Retrospective database analysis


Accessibility of Orphan Drugs in France, United Kingdom and Germany: Different Approaches with Regard to HTA and Prices
Authors: N. Grandfils, H. Hounkanlin, A. Troubat
Affiliations: IMS Health, PARIS LA DEFENSE, France
Publications: ISPOR 16th - Dublin 02-03 Novembre 2013
Document Types: , Poster
Countries: , France, Germany, UK
Abstract: http://www.ispor.org/
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2013	English


Current emesis Patterns of chemotherapy and antiemetic treatments in Western Europe.
Authors: Ricarte C, Anger C
Affiliations: 1 IMS Health, France 2 IMSHealth, UK
Publications: ESMO 2013
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
	2013	English	, Retrospective database analysis


Management costs of the first five years after diagosis in Breast Cancer by Stage in France.
Authors: Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F
Affiliations: 1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective cohort analysis


Evaluation of treatment persistence with Tamoxifene or aromatase inhibitors in breast cancer patients in Germany.
Authors: Schmidt N, Haas G, Mergenthaler U, Kostev K, Hadji P
Affiliations: 1 IMS Health, CES Oncology, Frankfurt, Germany, 2 IMS Health, CES Epidemiology, Frankfurt, Germany, 3 Department of Gynecology, Endocrinology and Oncology, Phillips-University of Marburg, Germany
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English


Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition	Year	Language	Analysis type
, Oncology	2013	English


Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology).
Authors: Ricarte C, Bruce A, Anger C
Affiliations: 1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Sharp increase in newly diagnosed patients with dementia in German primary care practices 2013. Better diagnostic process or monetary incentives?
Authors: Bohlken J, Michalowsky B, Kostev K.
Affiliations: Neuro-psychiatrische Praxis, Berlin, Demenz-Referat im Berufsverband Deutscher NervenÃ¤rzte (BVDN). Deutsches Zentrum fÃ¼r Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, AG Translationale Versorgungsforschung. IMS Health, Arbeitsgruppe. Epidemiologie.
Publications: Fortschr Neurol Psychiatr. 2017 Aug;85(8):467-473
Document Types: , Abstract
Countries: , Germany
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28841745
Condition	Year	Language	Analysis type
, Mental health	2013	English	, Retrospective database analysis


Blood component use and associated costs after standard dose chemotherapy-a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany
Authors: Paessens B, Ihbe-Heffinger A, von Schilling C, Shlaen R2, Bernard R, Peschel C, Schramm W, Berger K
Affiliations: Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Support Care Cancer, 2012, 20(5): 1011-1021
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21562801
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Prospective study


Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy â€“ retrospective analysis of changes over 3 yr in a German hospital
Authors: Boehme A1, Atta J1, Mousset S1, Ehlken B2, Shlaen M2, Bug G1, Serve H. 1, Hoelzer D. 1
Affiliations: 1 Department of Medicine, Hematology â„ Oncology, Goethe-University, Frankfurt â„ Main; 2 IMS Health, Munich, Germany
Publications: European Journal of Haematology, 2011, EPub Oct 13 European Journal of Haematology, 2012, 88(1): 68-77
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective cohort analysis


Major surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: J Gastrointest Cancer. 2012 Sep;43(3):456-61
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3
Affiliations: Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3
Publications: Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print]
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany
Authors: Breitscheidel L1, Ehlken B1, Kostev K1, Oberdiek MS2, Sandberg A2, Schmieder RE3
Affiliations: 1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany, 3 University Hospital Erlangen
Publications: Journal of Medical Economics 2011, EPub Nov 8 Journal of Medical Economics 2012, Vol 15(1): 155-165
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2012	English	, Retrospective database analysis


Long-term disease history, clinical symptoms, health status, and healthcare utilization in patients suffering from Lambert Eaton myasthenic syndrome: Results of a patient interview survey in Germany.
Authors: Harms L1, Sieb JP2, Williams AE3, Graham R3, Shlaen R4, Claus V4, Pfiffner C4
Affiliations: 1 CharitÃ©-UniversitÃ¤tsmedizin, Clinic for Neurology, Berlin, Germany, 2 Clinic for Neurology, Geriatric and Palliative Care, Stralsund, Germany, 3 BioMarin Europe Limited, London, UK, 4 IMS Health GmbH & Co, Munich, Germany
Publications: Journal of Medical Economics, 2012, 15(3): 521-530
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22352885
Condition	Year	Language	Analysis type
, Neurological disorders	2012	English	, Survey research


Assessing the budget impact of using ScanBagÂ® in CT in 6 European countries.
Authors: Nivelle E1, Mathou F2, Lamotte M1
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 Guerbet SA, Villepinte, France
Publications: 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Belgium, France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Miscellaneous	2012	English	, Budget impact


The impact of the German pharmaceutical market reorganisation act (AMNOG) on the German reference price market â€“ trends two years after the introduction of the AMNOG.
Authors: Eheberg D1, Batscheider A1, Lebioda A1, Plantoer S1, Fricke FU2
Affiliations: 1 IMS Health, Munich, Germany 2 Georg-Simon-Ohm-Hochschule Nuremberg
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2012	English	, Market impact


How to optimise chances for successful AMNOG assessments â€“ best practice approach for German market access.
Authors: Bonduelle D1, Huelsebeck M1, Plantoer S1
Affiliations: 1 IMS Health, Munich, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2012	English	, Market impact


Fatigue and quality-of-life in Multiple Sclerosis patients with spasticity in Germany - Results of the MOVE 1 study.
Authors: Pfiffner C1, Henze T2, Zettl U3, Essner U4, Flachenecker P5
Affiliations: 1 IMS Health, Munich, Germany 2 Rehabilitation Center Nittenau, Nittenau, Germany 3 University of Rostock, Center of Neurology, Rostock, Germany 4 Almirall Heral, Reinbek, Germany 5 Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany
Publications: ISPOR 15th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2012	English	, Burden of illness, Quality of life


Treatment patterns and resource consumption in patients with multiple sclerosis (MS)-related spasticity in Germany - Results of MOVE 1 study.
Authors: Ehlken B1, Flachenecker P2, Zettl U3, Essner U4, Henze T5
Affiliations: 1 IMS Health, Munich, Germany 2 Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany 3 University of Rostock, Center of Neurology, Rostock, Germany 4 Almirall Hermal, Reinbek, Germany 5 Rehabilitation Center Nittenau, Nittenau, Germany
Publications: ISPOR 15th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2012	English	, Burden of illness


Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis.
Authors: Korolewa V1, Hengst N1, Wolff M1, Berger K2, Ehlken B2, Greiner RA2, Eheberg D2, Pfiffner C2
Affiliations: 1 Abbott GmbH & Co.KG, Wiesbaden, Germany 2 IMS Health, Munich, Germany
Publications: ISPOR 15th Annual European Congress
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2012	English	, Literature Review


Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model update
Authors: Juergensen JS1, Greiner RA2, Hoesel V3, Ikenberg R2, Schiffner-Rohe J4
Affiliations: 1 CharitÃ© - UniversitÃ¤tsmedizin Berlin, Berlin, Germany 2 IMS Health GmbH & Co. OHG, Munich, Germany 3 StatSciConsult, Munich, Germany 4 Pfizer Deutschland GmbH, Berlin, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Urology	2012	English	, Cost effectiveness


HBA1C testing frequency in primary care Diabetes patients in Germany and in the United Kingdom
Authors: Kostev K, Grunow S, Rockel T
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters5.aspx
Condition	Year	Language	Analysis type
, Diabetes	2012	English	, Retrospective database analysis


Chart Audit and Budget impact analysis of Pasireotide versus second-line therapies in the treatment of CushingÂ´s disease in Germany
Authors: Badia X1, Forsythe A2, Stemmer V3, Cummins G4
Affiliations: 1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3Novartis Pharma GmbH, Nuremberg, Germany, 4Quintiles Consulting, Hawthorne, NY, USA
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition	Year	Language	Analysis type
, Endocrinology	2012	English	, Budget impact


Persistence in first line treatment of Metastatic Renal Cell Carcinoma in routine care in Germany
Authors: Mergenthaler U1, Morawski E2, Wendschlag A1
Affiliations: 1IMS Health, Frankfurt, Germany, 2Pfizer GmbH, Berlin, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Burden of illness


Treatment cost of invasive fungal disease (lfd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.
Authors: Rieger CT1, Cornely OA2, Hoppe-Tichy T3, Kiehl M4, Knoth H5, Thalheimer M3, Schuler U, Ullmann AJ6, Ehlken B7, Ostermann H1
Affiliations: 1 Department of Hematology / Oncology, University Hospital of Munich, Munich 2 Germany Department I for Internal Medicine and ZKS KÃ¶ln (BMBF 01KN0706), University of Cologne, Cologne 3 Germany Pharmacy Department, University Hospital of Heidelberg, Heidelberg 4 Germany Clinical Center Frankfurt/Oder 5 Germany University Hospital of Dresden, Dresden 6 Germany Department of Internal Medicine III, Johannes Gutenberg-University, Mainz, Germany 7 IMS Health, Munich, Germany
Publications: Mycoses, 2012, EPub April 3
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22471310
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Safety Assessment of an Anti-Obesity drug (Sibutramine)
Authors: Tyczynski JE1,Oleske DM2, Klingman D3 Ferrufino CP4, Lee WC4
Affiliations: 1 Astellas Pharma, Northbrook, IL,USA 2 Abbott Laboratories, Abbott, IL, USA 3 Gainsville, VA, USA 4 IMS Health, Falls Church, VA, USA
Publications: Drug Safety 2012;35(8):629-644
Document Types: , Article
Countries: , Germany, UK
Condition	Year	Language	Analysis type
, Obesity	2012	English	, Retrospective cohort analysis


Effectiveness of SativexÂ® in multiple sclerosis spasticity. First data from a large observational study in Germany.
Authors: Zettl U1, Henze T2, Pfiffner C3, Vila Silvan C4, Flachenecker P5
Affiliations: 1 University of Rostock, Rostock, Germany 2 Rehabilitation Center Nittenau, Nittenau, Germany 3 IMS Health, Munich, Germany 4 Almirall, Global Medical Affairs, Barcelona, Spain 5 Neurological Rehabilitation Center Quellenhof, Bad Wildbad, Germany
Publications: ECTRIMS 2012, 2012, October 10-13, Lyon, France
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2012	English	, Observational study


Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
Authors: S Ng-Mak D, Ya-Ting C, Who T, Standford B, Roset M.
Affiliations: Global Health Outcomes, Merck Sharp & Dohme Corp., West Point, PA, USA, IMS Health, Barcelona.
Publications: Cephalalgia. 2012 Sep;32(12):875-87.
Document Types: , Article
Countries: , France, Germany, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Results%20of%20a%202-year%20retrospective%20cohort%20study%20of%20newly%20prescribed%20triptan%20users%20in%20European%20nationwide%20practice%20databases.
Condition	Year	Language	Analysis type
, Neurological disorders	2012	English	, Retrospective cohort analysis


Barriers to cardiovascular risk prevention and management in Germany--an analysis of the EURIKA study.
Authors: Schmieder RE1, Goebel M, Bramlage P.
Affiliations: 1Nephrology and Hypertension, University Hospital Erlangen, Germany
Publications: Vasc Health Risk Manag. 2012;8:177-86. doi: 10.2147/VHRM.S29915. Epub 2012 Mar 15
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22536072
Condition	Year	Language	Analysis type
, Cardiovascular disease	2012	English	, Prospective study


Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study.
Authors: Adelman DT1, Burgess A, Davies PR.
Affiliations: 1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Publications: Med Devices (Auckl). 2012;5:103-9. doi: 10.2147/MDER.S37831. Epub 2012 Dec 14.
Document Types: , Article
Countries: , France, Germany, UK, USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23293542
Condition	Year	Language	Analysis type
, Miscellaneous	2012	English	, Survey research


Severe hypertriglyceridaemia in patients treated with lipid-modifying agents.
Authors: DÃ©samÃ©ricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4.
Affiliations: 1UnitÃ© de pharmaco-Ã©pidÃ©miologie, facultÃ© dâ€™odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4UniversitÃ© de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France
Publications: Diabetes & Metabolism Volume 38, nÂ° 3 pages 277-279 (juin 2012)
Document Types: , Article
Countries: , Belgium, France, Germany, Italy, UK
Abstract: http://www.em-consulte.com/en/article/735594
Condition	Year	Language	Analysis type
, Endocrinology, Metabolic Disorders , Vascular disease	2012	English	, Retrospective database analysis


Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey.
Authors: DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria
Affiliations: IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA
Publications: ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570)
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Insulin glargin reduziert das Risiko fÃ¼r ein diabetisches FuÃŸsyndrom und makrovaskulÃ¤re Komplikationen [Insuline glargine reduces the risk of diabetic food syndorme and maro-vascular disease]
Authors: Siegmund T1, Dippel,FW2, Kostev,K3, Lauterbach, S4, Fuchs, S5, Kotowa, W5
Affiliations: 1 StÃ¤dtisches Klinikum MÃ¼nchen GmbH 2 Sanofi-Aventis Deutschland GmbH, Berlin 3 IMS Health GmbH & Co, OHG, Frankfurt/Main 4 Apotheke Rotes-Kreuz-Krankenhaus, Kassel 5 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, NÃ¼rnberg
Publications: Perfusion 2011; 24: 44â€“52
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2011	German	, Retrospective database analysis


Treatment patterns and medication costs in hypertensive patients treated with combinations of angiotensin receptor blockers, amlodipine and hydrochlorothiazide in Germany.
Authors: Breitscheidel L1,Sandberg A2, Kostev K1, Holz B1, Oberdiek A2.
Affiliations: 1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany
Publications: The IHEA 8th World Congress, Toronto, Canada. 2011.
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2011	English	, Retrospective database analysis


"GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates "
Authors: Hadji P1, Claus V2, Steinle T3, Intorcia M4, Kostev K3, Ziller V1
Affiliations: 1 Klinik fÃ¼r GynÃ¤kologie, GynÃ¤kologische Endokrinologie und Onkologie, Philipps-University, Marburg, Germany; 2 IMS Health GmbH & Co. OHG, Munich and Frankfurt, Germany; 3 Health Economics, Amgen GmbH, Munich, Germany; 4 iHE, Amgen (Europe) GmbH, Zug, Switzerland
Publications: Osteoporosis International DOI 10.1007/s00198-011-1535-z
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Musculoskeletal disease	2011	English	, Retrospective cohort analysis


Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen AnÃ¤mie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland [Use of erythropoiesis-stimulating factors in the therapy of renal anemia: Analysis of prescription data of the German routine data]
Authors: SchÃ¶ffski O1, MÃ¼ller H-J2, Kostev K3, Claus V4
Affiliations: 1 Lehrstuhl fÃ¼r Gesundheitsmanagement UniversitÃ¤t Erlangen-NÃ¼rnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany
Publications: Nieren- und Hochdruckkrankheiten 2011; 40(2):84-90
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Hematology, Nephrology	2011	German	, Retrospective cohort analysis


Exenatide (Bid) and Liraglutide (Qd) treatment patterns among type-2 diabetes patients in Germany.
Authors: Miller L, Burudpakdee C, Zagar A, Bhosle M, Reaney M, Schabert V
Affiliations: Eli Lilly and Company, Indianapolis, IN, USA; IMS Health Incorporated, Falls Church, VA, USA;Eli Lilly and Company, Windlesham, Surrey, UK
Publications: ISPOR 16th Annual International Meeting, Baltimore, MD, USA
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2011	English	, Retrospective database analysis


PrÃ¤vention von postoperativen AdhÃ¤sionen - EffektivitÃ¤t und Ã¶konomische Aspekte von hyaluronsÃ¤urehaltigem Gel
Authors: Fuchs S1, Hackethal A2, Ikenberg R1, Pirk O1, Tinneberg HR2
Affiliations: 1 IMS Health GmbH & Co. OHG, NÃ¼rnberg, 2 UniversitÃ¤t GieÃŸen und Marburg, Standort GieÃŸen, Klinik fÃ¼r Frauenheilkunde und Geburtshilfe
Publications: Frauenarzt 2011, 52(4), 2-9
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Womens Health	2011	German


Ermittlung der tatsÃ¤chlichen Tagesdosierung von Liraglutid (PDD) unter realen Versorgungsbedingungen im Hinblick auf die Berechnung von Tagestherapiekosten
Authors: Fuchs S, Kostev K, Seitz L, Wohlleben M
Affiliations:
Publications: 46. Jahrestagung der Deutschen-Diabetes-Gesellschaft (Juni 2011)
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2011	German


Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co, OHG, Frankfurt/Main, Germany 4 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, NÃ¼rnberg, Germany
Publications: Health Outcomes Research in Medicine; 2(1):e39-e50
Document Types: , Article
Countries: , Germany
Abstract: http://www.healthoutcomesresearch.org/article/S1877-1319(11)00002-4/abstract
Condition	Year	Language	Analysis type
, Diabetes	2011	English	, Cost consequence


Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co, OHG, Frankfurt/Main, Germany 4 IMS Health GmbH & Co, OHG, Health Economics & Outcomes Research, NÃ¼rnberg, Germany
Publications: Health Outcomes Research in Medicine Volume 2, Issue 1, Pages e39-e50
Document Types: , Article
Countries: , Germany
Abstract: http://www.healthoutcomesresearch.org/article/S1877-1319(11)00002-4/abstract
Condition	Year	Language	Analysis type
, Diabetes	2011	English


Disease History and Burden of Disease for LEMS Patients in Germany
Authors: Sieb J P1, Harms L2, Williams A E3, GrahamR 3, Shlaen R4, Claus V4, Pfiffner C4
Affiliations: 1HANSE-Klinikum Stralsund GmbH, Stralsund, Germany 2Klinik f. Neurologie, CharitÃ© -UniversitÃ¤tsmedizin, Berlin, Germany, 3BioMarin Europe Ltd., London, UK, 4Health Economicsand Outcomes Research, IMS Health GmbH & Co, Munich, Germany
Publications: Kongresses der Deutschen Gesellschaft fÃ¼r Neurologie (DGN) 2011
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Retrospective cohort analysis


Disease History and Burden of Disease for LEMS Patients in Germany
Authors: Sieb J P1, Harms L2, Williams A E3, Graham R3, Shlaen R4, Claus V4, Pfiffner C4
Affiliations: 1HANSE-Klinikum Stralsund GmbH, Stralsund, Germany 2Klinik f. Neurologie, CharitÃ© -UniversitÃ¤tsmedizin, Berlin, Germany, 3BioMarin Europe Ltd., London, UK, 4Health Economicsand Outcomes Research, IMS Health GmbH & Co, Munich, Germany
Publications: 15th EFNS (European Federation of Neurological Societies) Congress, Budapest, 11 September 2011
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Retrospective cohort analysis


Patient-reported clinical symptoms and health status of LEMS Patients in Germany
Authors: Harms L1, Sieb J P2, Williams A E3, Graham R3, Shlaen R4, Claus V4
Affiliations: 1Klinik f. Neurologie, CharitÃ© - UniversitÃ¤tsmedizin, Berlin, 2HANSE-Klinikum Stralsund GmbH, Stralsund, Germany, 3BioMarin Europe Ltd., London, UK, 4Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: 15th EFNS (European Federation of Neurological Societies) Congress, Budapest, 11 September 2011
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Retrospective cohort analysis


Management of febrile neutropenia - a german prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer
Authors: Ihbe-Heffinger A, Paessens BJ, von Schilling C, Shlaen M2, Gottschalk N, Berger K, Bernard R, Kiechle M, Peschel C, Jacobs VR
Affiliations: 1Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Onkologie 2011;34(5):241-6. Epub 2011 Apr 26
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2011	German	, Prospective study


Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients
Authors: Paessens BJ, von Schilling C, Berger K, Shlaen M2, MÃ¼ller-Thomas C, Bernard R, Peschel C, Ihbe-Heffinger A.
Affiliations: Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Ann Oncol, 2011, 22(10): 2310-2319
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Prospective study


Cost-utility analysis of indacaterol in Germany: A once-daily maintenance bronchodilator for patients with COPD.
Authors: Price D1, Gray A2, Gale R3, Asukai Y4, Mungapen L4, Lloyd A4, Peters L5, Neidhardt K5, Gantner T5.
Affiliations: 1 Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK 2 Health Economics Research Centre, University of Oxford, Oxford, UK 3 Novartis Horsham Research Centre, UK 4 IMS Health, London, UK 5 Novartis Pharma GmbH, NÃ¼rnberg, Germany
Publications: Respir Med. 2011 Jul 15.
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21764277
Condition	Year	Language	Analysis type
, Respiratory disease	2011	English	, Cost utility


Retrospective chart review study of the cost of care of systematic lupus erythematousus (SLE)in 5 European coutries
Authors: Doria A1, Amoura Z 2, Richter J3, Cervera R4, Khamashta M5, Guillemin F6, Garofanno A7, Maurel F7, Roset M8, Perna A9, Schmitt C10, Ager M9, Boucot I11, Gonzalez MC Quire S10, Birch H10.
Affiliations: 1. University of Padova, Padova, Italy, 2. UniversitÃ© Paris VI Pierre et Marie Courie, Paris, France, 3. Heinrich-Heine-University, DÃ¼sseldorf, Germany, 4. Hospital Clinic, Barcelona, Spain, 5. The Rayne Institute, London, United Kingdom, 6. Centre d'Ã©pidÃ©miologie clinique, Vandoeuvre-les-Nancy, France, 7. IMS Health, Paris, France, IMS Health, Barcelona, Spain, 9. GlaxoSmithKline, Brentford, United Kingdom, 10. GlaxoSmithKline, Uxbrige, United Kingdom, 11. GlaxoSmithKline, Marly-le-Roi, France
Publications: Abstract - Presentation PSY17 for the 14th European congress of ISPOR 2011
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2011	English	, Cost analysis, Cost of illness, Epidemiological study, Observational study, Retrospective cohort analysis


Exenatide (BID) and liraglutide (QD) treatment patterns among patients with Type 2 diabetes in Germany.
Authors: Miller LA1, Burudpakdee C2, Zagar A1, Bhosle M3, Reaney M4, Schabert VF3.
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Consulting, Falls Church, VA, USA, 3IMS Health, Falls Church, VA, USA, 4Eli Lilly and Company, Surrey, UK
Publications: 16th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/meetings/baltimore0511/Posters2.aspx
Condition	Year	Language	Analysis type
, Diabetes	2011	English


Economic outcomes of glaucoma treatment with prostaglandin eye drops preserved with polyquadÂ® instead of benzalkonium chloride in Germany.
Authors: Gerlier L1, Lamotte M1, Lorenz K2, Verboven Y3, Berdeaux G4, Pfeiffer N2
Affiliations: 1 IMS Health Consulting, Vilvoorde, Belgium 2 University Medical Center, Mainz, Germany 3 Alcon Research Ltd, Puurs, Belgium 4 Alcon Research Ltd, Rueil Malmaison, France
Publications: 14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2011	English


Market access barriers for Biosimilars in Spain and Germany: Epoetin Alfa Example
Authors: Hurtado P, Vieta A, EspinÃ³s B, Badia X
Affiliations: IMS Health, Barcelona, Spain
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Germany, Spain
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2011	English	, Market impact


Persistence in Hypertension treatment with Olmesartan Medoxomil versus Valsartan - Analysis of real-life prescription data in Germany
Authors: Ehlken B1, Kostev K2, Breitscheidel L1, Sandberg A3, Holz B2, Oberdiek AM3
Affiliations: 1IMS Health, Munich, Germany, 2IMS Health, Frankfurt, Germany, 3Daiichi Sankyo Europe, Munich, Germany
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Spain1111/Posters2.aspx
Condition	Year	Language	Analysis type
, Cardiovascular disease	2011	English	, Cost analysis


Surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


The long term disease history of LEMS patients and current treatment patterns: Results of a patient interview survey in Germany.
Authors: Sieb JP1, Harms L2, Williams AE3, Graham R3, Shlaen R4, Pfiffner C4
Affiliations: 1 HANSE-Klinikum Stralsund GmbH, Clinic for Neurology, Geriatric and Palliative Care, Stralsund, Germany, 2 CharitÃ©-UniversitÃ¤tsmedizin, Clinic for Neurology, Berlin, Germany, 3 BioMarin Europe Ltd., London, UK, 4 IMS Health GmbH & Co, Munich, Germany
Publications: 15th EFNS Congress, 2011, September 10-13, Budapest, Hungary
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Patient-reported clinical symptoms and health status of LEMS Patients in Germany.
Authors: Harms L1, Sieb JP2, Williams AE3, Graham R3, Shlaen R4, Claus V4
Affiliations: 1 CharitÃ©-UniversitÃ¤tsmedizin, Clinic for Neurology, Berlin, Germany, 2 Clinic for Neurology, Geriatric and Palliative Care, Stralsund, Germany, 3 BioMarin Europe Limited, London, UK, 4 IMS Health GmbH & Co, Munich, Germany
Publications: 15th EFNS Congress, 2011, September 10-13, Budapest, Hungary
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Disease History and Burden of Disease for LEMS Patients in Germany.
Authors: Sieb JP1, Harms L2, Williams AE3, Graham R3, Shlaen R4, Claus V4, Pfiffner C4
Affiliations: 1 HANSE-Klinikum Stralsund GmbH, Clinic for Neurology, Geriatric and Palliative Care, Stralsund, Germany, 2 CharitÃ©-UniversitÃ¤tsmedizin, Clinic for Neurology, Berlin, Germany, 3 BioMarin Europe Ltd., London, UK, 4 IMS Health GmbH & Co, Munich, Germany
Publications: 84th DGN Congress, 2011, September-October 28-1, Wiesbaden, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
Authors: JoseÂ´ R. Banegas 1,2*, Esther LoÂ´pez-GarcÄ±Â´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. MassoÂ´-GonzaÂ´lez 10, Francisco J. JimeÂ´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando RodrÄ±Â´guez-Artalejo1,2
Affiliations: 1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad AutoÂ´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca FarmaceÂ´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publiqueâ€“HoË†pitaux de Paris and UniversiteÂ´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium
Publications: Eur Heart J. 2011 Sep;32(17):2143-52
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134
Condition	Year	Language	Analysis type
, Cardiovascular disease	2011	English	, Observational study, Prospective study


Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe.
Authors: Papageorgiou G1, CaÃ±as F, Zink M, Rossi A.
Affiliations: 1Department of Psychiatry, Evangelismos General Hospital
Publications: Eur Psychiatry. 2011 Mar;26(1 Suppl 1):17-28. doi: 10.1016/S0924-9338(11)71710-2.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440220
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.
Authors: Guallar E, Banegas JR, Blasco-Colmenares E, JimÃ©nez FJ, Dallongeville J, Halcox JP, Borghi C, MassÃ³-GonzÃ¡lez EL, Tafalla M, Perk J, De Backer G, Steg PG, RodrÃguez-Artalejo F.
Affiliations:
Publications: BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932
Condition	Year	Language	Analysis type
, Cardiovascular disease	2011	English	, Observational study, Prospective study


Factors associated with hospitalisation of patients with schizophrenia in four European countries.
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: Eur Psychiatry. 2011 May;26(4):224-30. doi: 10.1016/j.eurpsy.2011.02.012. Epub 2011 Mar 23.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21429717
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Patients with schizophrenia : results of a physician-based survey conducted in four European countries (Germany, Greece, Italy and Spain).
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: Eur Psychiatry. 2011 Mar;26(1 Suppl 1):1.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Use of ziprasidone in patients with schizophrenia in four European countries.
Authors: Montes JM1.
Affiliations: 1Hospital del Sureste, Arganda del Rey, Spain
Publications: Eur Psychiatry. 2011 Mar;26(1 Suppl 1):29-37. doi: 10.1016/S0924-9338(11)71711-4.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440221
Condition	Year	Language	Analysis type
, Neurological disorders	2011	English	, Survey research


Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach
Authors: Juergensen JS1, Arns W2, HaÃŸ B3
Affiliations: 1 Department of Nephrology and Medical Intensive Care, ChariteÂ´-Universitaetsmedizin Berlin 2 Kliniken der Stadt KoÂ¨ln GmbH, Cologne, Germany 3 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: European Jpurnal of Health Economics, 11(1): 15-25, 2010
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Transplant	2010	English	, Cost effectiveness


Therapie der Alzheimerdemenz - RÃ¼ckschritt ins letzte Jahrhundert? [Treatment of the Alzheimer's Disease â€“ A step backwards to the last century?]
Authors: Riepe M1, Pirk O2
Affiliations: 1 Psychiatry, University of Ulm, Germany 2 IMS Health GmbH & Co., Nuremberg, Germany
Publications: GesundheitsÃ¶konomie und QualitÃ¤tsmanagement, 15: pp. 7-10
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2010	German	,


Burden of pulmonary arterial hypertension in Germany
Authors: Wilkens H1, Grimminger F2, Hoeper M3, Stahler G4, Ehlken B5, Plesnila-Frank C5, Berger K5, Resch A6, Ghofrani A2
Affiliations: 1 Department of Pneumology, UniversitÃ¤tsklinikum des Saarlandes/Homburg, Homburg, Germany 2 Department of Pneumology, UniversitÃ¤tsklinikum GieÃŸen, GieÃŸen, Germany 3 Department of Pneumology, Medizinische Hochschule Hannover, Hannover, Germany 4 Department of Pneumology, Lungenfachklinik LÃ¶wenstein, LÃ¶wenstein, Germany 5 IMS Health GmbH & Co. OHG, MÃ¼nchen, Germany 6 Pfizer Deutschland Gmbh, Berlin, Germany
Publications: Respiratory Medicine
Document Types: , Online article
Countries: , Germany
Condition	Year	Language	Analysis type
, Respiratory disease	2010	English	, Burden of illness


KosteneffektivitÃ¤t von Pioglitazon bei Patienten mit Typ-2-Diabetes und makrovaskulÃ¤ren Vorerkrankungen in Deutschland [Cost-Effectiveness of Pioglitazone in Patients with Type 2 Diabetes and a History of Macrovascular Disease in Germany]
Authors: Bierwirth R1, Liebl A2, Gschwend MH3
Affiliations: 1 Diabetes-Praxis, Essen 2 Diabetes- und Stoffwechselzentrum, m & i-Fachklinik Bad Heilbrunn 3 IMS Health, Allschwil, Schweiz
Publications: Diabetologie und Stoffwechsel 2010;5(1):32-39
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: https://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1224723
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Cost effectiveness


GRAND: The German retrospective cohort analysis on non-adherence in osteoporosis: Analysis of repsistence with intravenous bisphosphonates in women
Authors: Hadji P1, Claus V2, Kostev K3 Intorcia M4, Steinle T5
Affiliations: 1 Klinik fur Gynakologie, Gynakologisch, Philipps-University, Marburg, Germany 2 Health Economics & Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany 4 Centre of Excellence Patient Data, IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany 5 Health Economics, Amgen GmbH, Munich, Germany
Publications: IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Musculoskeletal disease	2010	English	, Retrospective cohort analysis


Non-adherence in women with osteoporosis treated with oral bisphosphonates: German retrospective cohort analysis on non-adherence (GRAND)
Authors: Hadji P1, Claus V2, Steinle T3, Kostev K4, Intorcia M5
Affiliations: 1 Philipps-University of Marburg, Marburg, Germany, 2 IMS Health GmbH & Co. OHG, Munich, Germany, 3 Amgen GmbH, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany, 5 Amgen Europe GmbH, Zug, Switzerland
Publications: IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Musculoskeletal disease	2010	English	, Retrospective cohort analysis


Non-compliance and associated risk of fracture in osteoporosis is patients treated with oral bisphosphonates: German retrospective cohort analysis on non-adherence (grand)
Authors: Claus V1, Steinle T2, Kostev K3, Intorcia M4
Affiliations: 1 Health Economics & Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany 2 Health Economics, Amgen GmbH, Munich, Germany 3 Centre of Excellence Patient Data, IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany, 4 iHE, Amgen (Europe) GmbH, Zug, Switzerland
Publications: IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance, Musculoskeletal disease	2010	English	, Retrospective cohort analysis


Krebsinzidenz bei insulinpflichtigen Diabetikern in Deutschland â€“ eine Analyse der Publikation von Hemkens et al. anhand der STROBE-QualitÃ¤tskriterien [Cancer incidence for insulin-dependent diabetics in Germany - an analysis of the publication of Hemkens et al. based on the STROBE criteria]
Authors: Fuchs S1, Fricke F-U1,2, Pirk O1
Affiliations: 1 IMS Health GmbH & Co. OHG, Nuremberg, Germany 2 Georg Simon Ohm University, Nuremberg, Germany
Publications: Perfusion 2010; 23: 4-10
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2010	German	, Literature Review


Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months.
Authors: Thaci D1, Chambers C1, Sidhu M1, Dorsch B1, Ehlken B2, Fuchs S3
Affiliations: 1 Department of Dermatology and Venereology, J.W. Goethe University, Frankfurt, Germany 2Astellas Pharma Euope Ltd 3Metronomiea GmbH 2 IMS Health GmbH & Co. OHG, Munich, Germany 3 IMS Health GmbH & Co. OHG, Nuremberg, Germany
Publications: J Eur Acad Dermatol Venereol, Feb 10, 2010
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20158589
Condition	Year	Language	Analysis type
, Dermatology	2010	English	, Cost analysis


[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany]
Authors: Sehouli J1, Goertz A1, Steinle T1, Dubois R1, Plesnila-Frank C2, Lalla A1, von Minckwitz G1
Affiliations: 1 CharitÃ©/Campus Virchow-Klinikum, Klinik fÃ¼r GynÃ¤kologie, UniversitÃ¤tsmedizin Berlin, Berlin, Germany 2 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Deutsche medizinische Wochenschrift 2010 Mar, 135(9): 385-9
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20180162
Condition	Year	Language	Analysis type
, Oncology	2010	German	, Cost effectiveness


Starting an insulin therapy with glargine leads to lower long-term treatment costs compared to detemir in German type-2-diabetics: Results of a model approach
Authors: Pfohl M1, Dippel F-W2, Reichelt A3, Kostev K4, Fuchs S3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 4 IMS HEALTH GmbH & Co. OHG, Frankfurt, Germany
Publications: American Diabetes Association, 70th Scientific Sessions Abstract Book, 2010
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Cost effectiveness


PrÃ¤diktoren fÃ¼r die Initiierung einer basalunterstÃ¼tzten oralen Therapie (BOT) bei Patienten mit Diabetes mellitus Typ 2 unter realen Versorgungsbedingungen [Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions]
Authors: Hammer H1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Facharzt fÃ¼r Innere Medizin und Diabetologie, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: 45th annual conference of the DDG, Stuttgart, Germany, 12. â€“ 15. May, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Retrospective cohort analysis


Insulin Glargin reduziert das Risiko eines diabetischen FuÃŸsyndroms sowie makrovaskulÃ¤rer Komplikationen bei Typ-2-Diabetikern [Insulin glargine reduces the risk of a diabetic foot syndrome and macrovascular complications of type 2 diabetes]
Authors: Martin S1, Dippel FW2, Kostev K3, Lauterbach S4, Fuchs S5, Kotowa W5
Affiliations: 1 Sana Kliniken DÃ¼sseldorf GmbH, DÃ¼sseldorf, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 Apotheke Rotes-Kreuz-Krankenhaus, Kassel, Germany 5 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: 45th annual congress of the DDG, Stuttgart, Germany, 12. -15. May, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Retrospective cohort analysis


Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy
Authors: Mathes J1, Kostev K2, Gabriel A1, Pirk O1, Schmieder RE3
Affiliations: 1 IMS HEALTH GmbH & Co. OHG, Nuremberg 2 IMS HEALTH GmbH & Co. OHG, Frankfurt 3 Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany
Publications: Int J Clin Pharmacol Ther, 2010, Vol. 48, No. 3: S.173-183
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Hematology, Medication compliance	2010	English	, Retrospective cohort analysis


Prozesskostenanalyse in der Thromboembolieprophylaxe nach elektiver HÃ¼ft- und Kniegelenkersatzoperation [Process cost analysis for the prophylaxis of thromboembolism after an elective artificial hip and knee joint replacement surgery]
Authors: Lipp Hâ€P1, Stemmer V2, Kogler C2, Narayanan S3, Eckhard P3
Affiliations: 1 Eberhard Karls University TÃ¼bingen, TÃ¼bingen, Germany 2 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 3 Bayer Vital GmbH, Leverkusen, Germany
Publications: 2nd annual conference of the Deutschen Gesellschaft fÃ¼r GesundheitsÃ¶konomie (dggÃ¶) [German Association for Health Economics], Berlin, Germany, 1.-2.- March, 2010
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Hematology	2010	German	, Cost analysis


LÃ¤ngere Verweildauer auf einer basalunterstÃ¼tzten oralen Therapie mit Insulin glargin (BOT) im Vergleich zu einer Kombinationstherapie aus Insulindetemir und oralen Antidiabetika [Longer length of stay for a basal supporting oral therapy with insulin glargine compared to a combination therapy of insulin detemir and oral antidiabetics]
Authors: Pfohl M1, Dippel F-W2, Kostev KÂ³, Pirk O4, Reichelt A4, Kotowa W4
Affiliations: 1Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, NÃ¼rnberg, Germany
Publications: 2nd annual conference of the Deutschen Gesellschaft fÃ¼r GesundheitsÃ¶konomie (dggÃ¶) [German Association for Health Economics], Berlin, Germany, 1.-2.- March, 2010
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Retrospective database analysis


Aut-idem und RabattvertrÃ¤ge - ein Garant fÃ¼r Kosteneinsparungen? [Me-too prescription and discount contracts - a guarantor for cost savings?
Authors: Elger CE1, FrÃ¶hlich A2, Fuchs S3
Affiliations: 1 Life & Brain GmbH, Bonn, Germany 2 Desitin Arzneimittel GmbH, Hamburg, Germany 3 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: Monitor Versorgungsforschung, 2010, 03: pp. 51-54
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2010	German	, Cost analysis


German real-life data indicate lower costs for basal supported oral therapy (BOT) with insulin glargine compared to combination therapy with exenatide and oral antidiabetic drugs
Authors: Fuchs S1, Dippel FW2, Kostev K3, Kotowa W1
Affiliations: 1 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt/Main, Germany
Publications: 46th EASD Annual Meeting, Stockholm, Sweden, 20.-24. September, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Retrospective cohort analysis


Resource utilization and diabetes-related treatment costs of type-1-diabetics treated with ICT based on insulin glargine, insulindetemir or NPH insulin in Germany
Authors: Bierwirth R1, Dippel FW2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Ambulantes Diabeteszentrum am Elisabth-Krankenhaus, Essen, Germany, 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, Nuremberg, Germany
Publications: 46th EASD Annual Meeting, Stockholm, Sweden, September 20-24, 2010
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Cost analysis


Ressourcenverbrauch und Behandlungskosten unter einer intensivierten konventionellen Therapie (ICT) mit Insulin glargin, Insulindetemir oder NPH-Insulin bei Patienten mit Typ-1-Diabetes [Resource utilization and diabetes-related treatment costs of type-1-diabetics treated with ICT based on insulin glargine, insulin detemir or NPH insulin in Germany]
Authors: Bierwirth R1, Dippel FW2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Ambulantes Diabeteszentrum am Elisabeth-Krankenhaus, Essen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health GmbH & Co. OHG, Nuremberg, Germany
Publications: Perfusion, 2010, 23: pp. 96-103
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Cost analysis


Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany
Authors: Hammer H1, Dippel F-W2, Kostev K3, Fuchs S4, Kotowa W4
Affiliations: 1 Facharzt fÃ¼r Innere Medizin und Diabetologie, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Main, Germany 4 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany
Publications: Perfusion 2010; 23: 132-140
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Retrospective cohort analysis


Systemic lupus erythematosus (SLE) is costly for the Health care system and workplace: a systematic literature review
Authors: Doria A1, Grandfils N2, Maurel F2, Rudge H3
Affiliations: 1 University of Padova, Padova, Italy 2 IMS Health, Paris, France 3 GlaxoSmithKline, Uxbridge, UK
Publications: ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic
Document Types: , Abstract, Poster
Countries: , Canada, Germany, UK, USA
Condition	Year	Language	Analysis type
, Dermatology	2010	English	, Literature Review


Verbrauch und Therapiekosten der Behandlung mit kortikosteroidhaltigen Nasensprays. Vergleich von Mometason- und Budesonid-haltigen Nasensprays auf Basis von Real-life-Verordnungsdaten aus Deutschland
Authors: SchÃ¶ffski O1, Claus V2, Becker B3
Affiliations: 1 Lehrstuhl fÃ¼r Gesundheitsmanagement UniversitÃ¤t Erlangen-NÃ¼rnberg, Deutschland, 2 IMS Health GmbH & Co. OHG, Deutschland, 3 Essex Pharma GmbH, Deutschland
Publications: GesundhÃ¶kon Qualmanag 2010; 15(4): 192-198
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Respiratory disease	2010	German	, Cost analysis


Quality of life in ocular hypertension and primary open angel glucoma
Authors: Wolfram C1, Lorenz K1, Shlaen R2, Verboven Y3, Pfeiffer N1
Affiliations: 1 UniversitÃ¤tsmedizin Mainz,Germany 2 IMS Health GmbH & Co. OHG, Munich, Germany 3 ALCON Couvreur NV, Puurus, Belgium
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Miscellaneous	2010	English	, Quality of life


Change of antifungal tretment patterns and associated costs in patients with acute myelogenous leukemia (AML) after chemotherapy in a german hospital from 2004 to 2006
Authors: Boehme A1, Atta J1, Mousset S1, Steffen B1, Serve H1, Hoelzer D1, Shlaen R2, Ehlken B2, Bug G1
Affiliations: 1 Med Clinic II, J.W. Goethe-University, Frankfurt, Germany, 2 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective cohort analysis


Management of malignant ascites in Germany - treatment patterns, resource consumption and costs
Authors: Ehlken B1, Berger K1, Shalen R1, Gonschior AK2, Lordick F3
Affiliations: 1 IMS Health GmbH & Co. OHG, Munich, Germany, Fresenius Biothech GmbH, Munich, Germany, 3 Medizinische Klinik III, Klinikum Braunschweig, Braunschweig, Germany
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Miscellaneous	2010	English	, Cost analysis, Prospective study, Retrospective cohort analysis


Insulin glargine is associated with a lower incidence of diabetic foot syndrome and macrovascular complications compared to NPH insulin in type 2 diabetics under German real-life conditions
Authors: Siegmund T1, Dippel FW2, Kostev K3, Lauterbach S4, Fuchs S3, Kotowa W3
Affiliations: 1 StÃ¤dt. Klinikum MÃ¼nchen GmbH, Klinikum Bogenhausen, 81925 MÃ¼nchen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG. Frankfurt/Main & NÃ¼rnberg, Germany 4 Apotheke Rotes-Kreuz-Krankenhaus, HansteinstraÃŸe 29, 34121 Kassel, Germany
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Retrospective cohort analysis


Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions
Authors: Hammer H1, Dippel FW2, Kostev K3, Fuchs S3, Kotowa W3
Affiliations: 1 Practice for internal medicine and diabetology, Bremen, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health GmbH & Co. OHG, Frankfurt/Main & NÃ¼rnberg, Germany
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Retrospective cohort analysis


Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen AnÃ¤mie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland
Authors: SchÃ¶ffski O1, MÃ¼ller H-J2, Kostev K3, Claus V4
Affiliations: 1 Lehrstuhl fÃ¼r Gesundheitsmanagement UniversitÃ¤t Erlangen-NÃ¼rnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany
Publications: Nieren- und Hochdruckkrankheiten; XX, 2010 (accepted)
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Hematology, Nephrology	2010	English	, Retrospective cohort analysis


Predictive factors of glaucoma treatment costs in Germany
Authors: Pfeiffer N1, Wolfram C1, Dietlein T2, Claus V3, Verboven Y4, Lorenz K1, on Â behalf of the COGIS study investigators
Affiliations: 1 UniversitÃ¤tsmedizin Mainz,Germany, 2 UniversitÃ¤tsklinim KÃ¶ln, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 ALCON Couvreur NV, Puurus, Belgium
Publications: 9th Congress of European Glaucoma Society, 12-17 September, 2010 Madrid,
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2010	English	, Cost analysis


Predictive factors of glaucoma treatment costs in Germany
Authors: Pfeiffer N1, Wolfram C1, Dietlein T2, Claus V3, Plesnila-Frank C3, Verboven Y4, Lorenz K1, on Â behalf of the COGIS study investigators
Affiliations: 1 UniversitÃ¤tsmedizin Mainz,Germany, 2 UniversitÃ¤tsklinim KÃ¶ln, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 ALCON Couvreur NV, Puurus, Belgium
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2010	English	, Cost analysis


Insulin glargin und Exenatide bei Typ-2-Diabetes: Ein Kostenvergleich in Kombination mit oralen Antidiabetika [Cost comparison between insulin glargine and exenatide in type-2-diabetes both in combination with oral antidiabetics]
Authors: Fuchs S1, Kostev K2, W. Kotowa W1, Dippel F-W3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt/Main, Germany 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany
Publications: Monitor Versorgungsforschung 2010: 3. Jahrgang 11.10.2010
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Retrospective cohort analysis


Different persistence on initial basal supported oral therapy in type-2-diabetics results in unequal distributions of insulin treatment regimens under real-life conditions in Germany
Authors: Pfohl M1, Dippel F-W2, Kostev K3, Fuchs S3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt/Nuremberg, Germany
Publications: International Journal of Clinical Pharmacology and Therapeutics, Vol. 48 â€“ No. 11/2010 (761-766)
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	English	, Retrospective cohort analysis


Modellierung der Langzeit-Behandlungskosten insulinpflichtiger Typ-2-Diabetiker in AbhÃ¤ngigkeit von der Art des Insulineinstiegs: Vergleich zwischen Insulin glargin und NPH-Insulin [Modelling of long-term treatment costs of type-2-diabetes patients depending on the initial insulin therapy: A comparison of insulin glargine vs. NPH-insulin.]
Authors: Pfohl M1, Dippel FW2, Kostev K3, Kotowa W3
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt/NÃ¼rnberg, Germany
Publications: Gesundh Ã¶kon Qual manag 2010; 15: 1â€“7
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2010	German	, Retrospective cohort analysis


Quality of life in ocular hypertension and primary open-angle glaucoma
Authors: Wolfram C1, Lorenz K1, Waltrich H2, Shlaen R3, Verboven Y4, Pfeiffer N1, on Â behalf of the COGIS study investigators
Affiliations: 1 UniversitÃ¤tsmedizin Mainz,Germany, 2 Private Practice Prof. Neuhann and colleagues Munich Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 ALCON Couvreur NV, Puurus, Belgium
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2010	English	, Quality of life


Quality of life in ocular hypertension and primary open-angle glaucoma
Authors: Wolfram C1, Lorenz K1, Waltrich H2, Shlaen R3, Verboven Y4, Pfeiffer N1, on Â behalf of the COGIS study investigators
Affiliations: 1 UniversitÃ¤tsmedizin Mainz,Germany, 2 Private Practice Prof. Neuhann and colleagues Munich Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 ALCON Couvreur NV, Puurus, Belgium
Publications: 9th Congress of European Glaucoma Society, 12-17 September, 2010 Madrid,
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Ophthalmology	2010	English	, Quality of life


Comparison of Prescribing Patterns for Asthma in Five European Countries
Authors: Laforest L, Schwalm MS, Dufour M, Broquet M, Bourke A & Van Ganse E
Affiliations: Cegedim
Publications: ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13
Condition	Year	Language	Analysis type
, Respiratory disease	2010	English	, Retrospective database analysis


The Economic Impact of Overactive Bladder Syndrome in Six Western Countries.
Authors: Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5
Affiliations: 1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guyâ€™s and St Thomasâ€™ NHS Foundation Trust, London, UK
Publications: British Journal of Urology International (BJU International), 103(2):202-209
Document Types: , Article
Countries: , Canada, Germany, Italy, Spain, Sweden, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19278532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
Condition	Year	Language	Analysis type
, Overactive bladder	2009	English	, Budget impact


A Review Of Treatment Patterns Of Patients With Pulmonary Arterial Hypertension In Three European Countries
Authors: Angalakuditi M1, Wright D2, Gaskin M2, Fakhoury W2
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Health, London, UK
Publications: ISPOR 14th Annual International Meeting, Orlando, Florida, USA 16 - 20 May 2009
Document Types: , Poster
Countries: , France, Germany, UK
Condition	Year	Language	Analysis type
, Cardiovascular disease	2009	English	, Review


The cost-effectiveness of 13-valent pneumococcal conjugate vaccine (pcv13) compared to 7-valent pneumococcal conjugate vaccine (pcv7) for childhood vaccination in Germany.
Authors: Patel, R1, Kuchenbecker, U2, Bowrin, K1, Lloyd, A1
Affiliations: 1 IMS Health, London, UK 2 Wyeth Pharmaceuticals, Muenster, Germany
Publications: 27th Annual Meeting of the European Society for Paediatric Infectious Diseases Brussels, Belgium, June 9-13, 2009
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2009	English	, Cost effectiveness


Kosten fÃ¼r antihyperglykÃ¤mische Arznei- und Verbrauchsmittel und Therapiezufriedenheit bei Typ-2-Diabetes: Ergebnisse der Versorgungsforschungsstudie LIVE-DE [Costs of antihyperglycemic treatment and consumables and treatment satisfaction in patients with type 2 diabetes: results of a cross-sectional cost-evaluation study of long-acting insulin glargine compared with NPH insulin in Germany (LIVE-DE)]
Authors: Hauner H1, Kohlmann T2, Landgraf W3, Holle R4, Pirk O5, Scholten T6
Affiliations: 1 ElseKrÃ¶ner-Fresenius-Zentrum fÃ¼r ErnÃ¤hrungswissenschaft, TU MÃ¼nchen, Germany 2 Institut fÃ¼r Cummunity Medicine, UniversitÃ¤t Greifswald, Germany 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Institut fÃ¼r GesundheitsÃ¶konomie und Management, Helmholtz-Zentrum MÃ¼nchen, Germany 5 IMS HEOR NÃ¼rnberg, Germany 6 Lehrstuhl fÃ¼r Innere Medizin, UniversitÃ¤t Witten/Herdecke, Germany
Publications: Dsch Med Wochenschr., 2009, 134: pp.1207-1213
Document Types: , Article
Countries: , Germany
Abstract: http://www.find-health-articles.com/rec_pub_19472091-costs-antihyperglycemic-drugs-consumables-treatment-satisfaction.htm
Condition	Year	Language	Analysis type
, Diabetes	2009	German	, Cost analysis


LÃ¤ngere Verweildauer unter einer basalunterstÃ¼tzten oralen Thearpie mit Insulin Glargin (BOT) im Vergleich zu einer Kombinationstherapie aus NPH-Insulin und oralen Antidiabetika [Higher Persistence with basal supported oral therapy (BOT) with insulin glargine compared to NPH insulin therapy combined with oral antidiabetics]
Authors: Pfohl M1, Dippel FW2, Kostev K3, Maltz A4, Kotowa W4
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin 3 IMS Health GmbH&Co. OHG, Frankfurt, Germany 4 IMS GmbH&Co. OHG, NÃ¼rnberg, Germany
Publications: Diabetologie, 2009; 4: pp.1-6
Document Types: , Article
Countries: , Germany
Abstract: http://www.thieme-connect.com/ejournals/abstract/ds/doi/10.1055/s-0028-1098896
Condition	Year	Language	Analysis type
, Diabetes	2009	German	, Retrospective cohort analysis


Worin unterscheiden sich Patienten mit und ohne komplexe postoperative Akutschmerztherapie? - Eine Analyse medizinischer und Ã¶konomischer Charakteristika [What is the difference between patients with and without complex postoperative acute pain therapy? - An analysis of medical and economic characteristics]
Authors: Fricke F-U1, Hertel N1, Kubitz N2, Assenmacher D3, Schrede H2
Affiliations: 1 Health Economics & Outcomes Research, IMS Health GmbH&Co. OHG, NÃ¼rnberg, Germany 2 Janssen-Cilag GmbH, Neuss, Germany 3 3M Health Information Systems, Neuss, Germany
Publications: Schmerz, 2009, 23(4): pp. 385-391
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Surgery	2009	German	, Cost analysis


Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries.
Authors: Gschwend MH1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk Inc., New Jersey, United States
Publications: Journal of Medical Economics, 2009; 12(2): 114â€“123
Document Types: , Manuscript in preparation
Countries: , Belgium, France, Germany, Italy, Spain
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990903080344
Condition	Year	Language	Analysis type
, Diabetes	2009	English	, Cost effectiveness


Evaluation of exenatide versus insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.
Authors: Mittendorf T1, Happich M2, Smith-Palmer J3, Timlin L4, Goodall G3
Affiliations: 1Gottfried Wilhelm Leibniz University, Hannover, Germany, 2Lilly Deutschland GmbH, Bad Homburg, Germany, 3IMS Health, Basel, Switzerland, 4Lilly UK, Surrey, United Kingdom
Publications: Diabetes, Obesity and Metabolism (In press)
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19732121
Condition	Year	Language	Analysis type
, Diabetes	2009	English	, Cost effectiveness


Estimating the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in Germany: a cost-effectiveness analysis based on the results of a recent meta-analysis
Authors: Pratoomsoot C1, Smith HT2, Arellano J2, Goodall G1
Affiliations: 1IMS Health, Basel, Switzerland, 2Eli Lilly, Surrey, UK
Publications: Deutsche Diabetes-Gesellschaft, 20-23 Mai 2009, Leipzig, Germany
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2009	German	, Cost effectiveness


Dementia care initiative in primary practice â€“ study protocol of a cluster randomized trial on dementia management in a general practice setting
Authors: Holle R1,2, GrÃ¤ÃŸel E3, RuckdÃ¤schel S4, Wunder S5, Mehlig H6, Marx P7, Pirk O8, Butzlaff M9, Kunz S1,2, Lauterberg J10
Affiliations: 1Institute of Health Economics and Health Care Management, Helmholtz Zentrum, MÃ¼nchen, Germany, 2German Research Center for Environmental Health, Neuherberg, Germany, 3Department of Psychiatry and Psychotherapy, Medical Psychology and Medical Sociology, University Hospital Erlangen, Erlangen, Germany, 4HealthEcon AG, Basel, Switzerland, 5AOK Bavaria, NÃ¼rnberg, Germany, 6Eisai GmbH, Frankfurt, Germany, 7Pfizer Germany GmbH, Berlin, Germany, 8Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, NÃ¼rnberg, Germany, 9Competence Center for General Practice and Outpatients' Health Care, Witten/Herdecke University, Witten, Germany and 10Federal Association of the AOK, Berlin, Germany, and Institute for Patient Safety, University of Bonn, Bonn, Germany
Publications: BMC Health Services Research, 2009, 9(91)
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702286/?tool=pubmed
Condition	Year	Language	Analysis type
, Mental health	2009	English	, Economic evaluation


Insulin glargin mit oralen Antidiabetika: Vorteilhafter Einstieg in die Insulintherapie [Insulin glargine with oral antidiabetic agents: Advantageous access to the insulin therapy]
Authors: Kress S1, Dippel FW2, Kostev K3, Pirk O3, Reichelt A3, Kotowa W3
Affiliations: 1 Vinzentius-Krankenhaus, Landau, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS Health, Frankfurt/NÃ¼rnberg, Germany
Publications: Diabetes Stoffw Herz 2009; 18: pp.377-385
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2009	German	, Retrospective database analysis


Clinical and economic characteristics of patients with painful neuropathic disorders in Germany.
Authors: Berger A, Toelle T, Sadosky A, Dukes E, Edelsberg J, Oster G
Affiliations:
Publications: Pain Pract., 2009, 9(1): 8-17
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19019057
Condition	Year	Language	Analysis type
, Neurological disorders	2009	English	, Retrospective database analysis


Daily costs of Prostaglandin analogues as monotherapy or in fixed combinations with Timolol, in Denmark, Finland, Germany and Sweden
Authors: Bergstrom A1, Maurel F2, Le Pen C3, Lamure E2, Kent M4, Bardoulat I2,Berdeaux GH5,6
Affiliations: 1 Lund Hospital, Lund, Sweden 2 IMS France, Puteaux, France 3 UniversitÃ© Paris-Dauphine, Paris, France 4 Alcon Inc, Fort Worth, Texas, USA 5 Alcon France SA, Rueil-Malmaison, France 6Conservatoire National des Arts et MÃ©tiers, Paris, France
Publications: Clin Ophthalmol. 2009;3:471-81
Document Types: , Article
Countries: , Denmark, Finland, Germany, Nordic, Sweden
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732058/?tool=pubmed
Condition	Year	Language	Analysis type
, Ophthalmology	2009	English	, Economic evaluation


Cost-Effectiveness of immunosuppresive regimens in renal transplant recipients in Germany
Authors: Kotowa W1, Reichelt A1, Theidel U3, Juergensen JS4
Affiliations: 1IMS HEALTH GmbH & Co. OHG, Health Economic & Outcomes Research, Nuremberg, Germany, 3Wyeth Pharma, Muenster, Germany, 4CharitÃ©-Universitaetsmedizin, Berlin, Germany
Publications: 18th Annual meeting German Society of transplantation (poster presentation), Berlin, Germany, October 29-31, 2009
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Transplant	2009	German


Interstitial fibrosis and tubular atrophy (IFTA) is associated with a significant economic burden in Germany
Authors: Machnicki G1, Kotowa W2, Reichelt A2, Pirk O2, Naujoks C3
Affiliations: 1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US 2 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 3 Novartis Pharma AG, Basel, Switzerland.
Publications: J Am Soc Nephrol 20: SA-PO308, 2009
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Nephrology	2009	English


Does pharmaceutical consumption improve healthcare status?
Authors: Grandfils N1, Hauser S1, Amalric F1, Le Pen C2
Affiliations: 1IMS Health, Puteaux, France, 2Paris Dauphine University, Paris, France
Publications: ISPOR 12th Annual European Congress, Paris, France, 24â€“27th October 2009
Document Types: , Abstract, Poster
Countries: , Denmark, France, Germany, Italy, Spain, Sweden, UK
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx
Condition	Year	Language	Analysis type
, Health policy	2009	English	, Economic evaluation


Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen AnÃ¤mie - eine â€žreal lifeâ€œ- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation]
Authors: SchÃ¶ffski O1, MÃ¼ller H-J2, Kostev K3, Claus V4
Affiliations: 1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany
Publications: Congress for nephrology, GÃ¶ttingen, Germany, 26-29 September 2009
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Hematology, Nephrology	2009	German	, Retrospective database analysis


Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Authors: Werner A Scherbaum1, Gordon Goodall2, Katrina M Erny-Albrecht2, Massimo Massi-Benedetti3, Erland Erdmann4, William J Valentine2
Affiliations: 1UniversitÃ¤t DÃ¼sseldorf, Klinik fÃ¼r Endokrinologie, Diabetologie und Rheumatologie, 2IMS Health, Basel, Switzerland, 3University of Perugia, Medicine and Metabolic Diseases, Perugia, Italy and 4Medizinische Klinik III der UniversitÃ¤t zu KÃ¶ln, KÃ¶ln, Germany
Publications: Cost Effectiveness and Resource Allocation
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.resource-allocation.com/content/pdf/1478-7547-7-9.pdf
Condition	Year	Language	Analysis type
, Diabetes	2009	English	, Cost effectiveness


Im langzeitvergleich sind sartane die bessere Alternative [In a long-run comparison sartanes are the better alternative]
Authors: Sonntag F1, Kotowa W2
Affiliations: 1 Niedergelassener Kardiologe, Henstedt-Ulzburg, Germany 2 IMS Health Economics & Outcomes Research, Nuremberg, Germany
Publications: Cardio News, 2009, 12(4): p.47
Document Types: , Newspaper article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2009	German	, Economic evaluation


KosteneffektivitÃ¤t von Sartanen im Vergleich zu anderen Antihypertensiva bei Hypertonikern [Cost-efficacy of sartans in comparison to other Antihypertensives in patients with hypertension]
Authors: Sonntag F1, BrÃ¼ggenjÃ¼rgen B2, Kotowa W3, Mathes J3, HaÃŸ B3
Affiliations: 1 Niedergelassener Kardiologe, Henstedt-Ulzburg 2 Institut fÃ¼r Sozialmedizin, Epidemiologie und GesundheitsÃ¶konomie, UniversitÃ¤tsmedizin CharitÃ©, Berlin 3 IMS Health Economics & Outcomes Research, NÃ¼rnberg"
Publications: Medreview Nr. 7, 10. Jahrgang, Mai 2009 (75. Jahrestagung der Deutschen Gesellschaft fÃ¼r Kardiologie â€“ Herz- und Kreislaufforschung e.V. 16. bis 18. April 2009 in Mannheim)
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2009	German	, Cost effectiveness


Can the relationship between age and cholesterol levels indicate effectiveness of lipid lowering therapy in primary care? France, Germany, Italy and UK
Authors: Blak BT, Hards M, Maguire A & Schwalm MS
Affiliations: Cegedim
Publications: ISPOR Orlando, USA Value in Health 12(3):A142-A143
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, UK
Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-ef0c58f0-1c99-3554-8596-1bce21118531
Condition	Year	Language	Analysis type
, Endocrinology, Metabolic Disorders	2009	English	, Retrospective database analysis


Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies.
Authors: Becher H1, Kostev K2, SchrÃ¶der-Bernhardi D.
Affiliations: 1Ruprecht-Karls-University, Heidelberg, Germany; 2, IMS Health Germany
Publications: Int J Clin Pharmacol Ther. 2009 Oct;47(10):617-26.
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Database Validity and methodology	2009	English	, Retrospective database analysis


The impact of insulin detemir compared to Neutral Protamine Hagedorn insulin on long-term diabetes-related complications: a modeling analysis in type 1 diabetes patients in Belgium, France, Germany, Italy and Spain
Authors: Gschwend M1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk A/S, BagsvÃ¦rd, Denmark
Publications: ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Economic evaluation


Long-term cost-effectiveness of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a basalâ€“bolus regimen in Belgium, France, Germany, Italy and Spain.
Authors: Gschwend M, Aagren M, Valentine WJ
Affiliations:
Publications: ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Cost effectiveness


Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes.
Authors: Valentine WJ1, Goodall G1, Aagren M2, Nielsen S2, Palmer AJ1, Erny-Albrecht K1
Affiliations: 1 IMS Health, Allschwil, Switzerland, 2 Novo Nordisk A/S, BagsvÃ¦rd, Denmark
Publications: Adv Ther. 2008 Jun;25(6):567-84.
Document Types: , Manuscript in preparation
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Cost effectiveness


Adding Insulin Glargine to oral Therapy in patients with type 2 diabetes results in longer persistence with treatment compared to NPH insulin
Authors: Pfohl M4, Dippel FW3, Kostev K2, Kotowa W1
Affiliations: 1 Evangelisches Bethesda-Johanniter-Klinikum Duisburg GmbH, Duisburg, Germany 2 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 3 IMS HEALTH GmbH & Co. OHG, Frankfurt, Germany 4 IMS Health HEOR, Nuremberg, Germany
Publications: ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Retrospective database analysis


Insulin glargine- and NPH insulin-based regimens reveal comparable total direct treatment costs in patients with type 2 diabetes. Results of the long-acting insulin glargine vs. NPH insulin cost evaluation study in Germany (LIVE-DE)
Authors: Scholten T1, Holle R2, Dippel FW3, Spiesecke A4, Hauner H5
Affiliations: 1 University of Witten-Herdecke, Hagen, Germany 2 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 3 sanofi-aventis, Berlin, Germany 4 IMS Health HEOR, Nuremberg, Germany 5 Else KrÃ¶ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany
Publications: ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Cost effectiveness


Insulin Glargine and NPH Insulin based regimens reveal comparable total direct treatment costs in type 2 diabetes patients. The long-acting insulin Glargine vs. NPH insulin cost evaluaton study in germany (LIVE-DE)
Authors: Scholten T1, Holle R2, Dippel FW3, Spiesecke A4, Hauner H5
Affiliations: 1 University of Witten-Herdecke, Hagen, Germany 2 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 3 sanofi-aventis, Berlin, Germany 4 IMS Health HEOR, Nuremberg, Germany 5 Else KrÃ¶ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany
Publications: ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Cost effectiveness, Retrospective database analysis


Basal insulins (e. g. glargine) combined with oral antidiabetics are most commonly used to initiate insulin therapy in type-2-diabetes patients in Germany
Authors: Kress S4, Dippel FW3, Kostev K2, Kogler C1, Kotowa W1
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health GmbH, Frankfurt, Germany 3 Sanofi-Aventis, Berlin, Germany 4 Vinzentius-Krankenhaus Landau
Publications: 15. Annual Meeting GAA e.V., 20-21. November 2008, Bonn, Germany
Document Types: , Abstract
Countries: , Germany
Abstract: http://www.egms.de/en/meetings/gaa2008/08gaa22.shtml
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Retrospective database analysis


Impact of brain metastases on health care costs associated with the management of patients with metastatic breast cancer in France and Germany.
Authors: S Cottrell1, M Walker2, H Scheijbeler1, L Christova1, N Hertel3, B Hass3, M Behrens4, E Roux5, M Amonkar6, Aristides M1
Affiliations: 1 IMS HEOR, London, UK 2 GlaxoSmithKline, Greenford, UK 3 IMS HEOR, Nuremberg, Germany 4 GlaxoSmithKline, Munich, Germany 5 GlaxoSmithKline, Paris, France 6 GlaxoSmithKline, Philadelphia, USA
Publications: 6th European Breast Cancer Conference (EBCC-6), 15-19 April 2008, Berlin, Germany
Document Types: , Oral presentation
Countries: , France, Germany
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Budget impact


Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany
Authors: Hass B1, Arns W2, Kuchenbecker U3, Juergensen JS4
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Kliniken der Stadt Koeln, Cologne, Germany 3 Wyeth Pharma, Muenster, Germany 4CharitÃ©- Universitaetsmedizin, Berlin, Germany
Publications: ISPOR 13th Annual International Congress, May 3-7, 2008 ,Toronto, Canada Value in Health, 11(3): A302, 2008
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Nephrology	2008	English	, Cost effectiveness


Cost-effectiveness of transdermal opioids regarding opioid-related fractures in Germany - a model approach
Authors: Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3
Affiliations: 1 IMS Health, Nuremberg, Germany, 2 EAH Consulting, Juelich, Northrhine Westf, Germany 3 GrÃ¼nenthal GmbH, Aachen, Germany
Publications: ISPOR 13th Annual International Congress, May 3-7, 2008 ,Toronto, Canada
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2008	English	, Cost effectiveness


Freie Arzneimittelpreise in Deutschland â€“ eine Fiktion? Auswirkungen der Methode des Instituts fÃ¼r QualitÃ¤t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) zur Kosten-Nutzen-Bewertung auf die Preisbildung von Arzneimitteln [Free pricing for pharmaceuticals in Germany - a fiction? Effects of the method of the institute for quality and economic efficiency in health care for cost-utility-evaluation regarding the pricing of pharmaceuticals]
Authors: Pirk O1, Fricke F-U1
Affiliations: 1 IMS Health, Nuremberg, Germany
Publications: Pharm. Ind. 70(4): 452â€“456
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Pricing and reimbursement	2008	German	, Pricing & Reimbursement


Treatment of patients hospitalised with community-acquired pneumonia using moxifloxacin versus levofloxacin and ceftriaxone: comparing costs from the hospital and social insurance perspectives.
Authors: Lloyd A1, Holman A1, Evers T.
Affiliations: 1 Fourth Hurdle Consulting, London, UK 2 Wyeth Pharmaceuticals
Publications: European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, 2008.
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Respiratory disease	2008	English	, Cost of illness


Cost advantages and improved patient treatment satisfaction with insulin glargine in type 2 diabetes patients. The long-acting insulin glergine vs NPH insulin cost evaluation study in germany (LIVE-DE)
Authors: Scholten T1, Kohlmann T2, Moock J2, Holle R3, Landgraf W4, Pirk O5, Hauner H6
Affiliations: 1 Internal Medicine, Univ. of Witten/Herdecke, Germany; 2 Institute of Community Medicine, Univ. of Greifswald, Germany; 3 Institute of Health Economics & Health Care Management, Helmholtz Centre Munich, Germany; 4 sanofi-aventis, Berlin, Germany; 5 IMS Health HEOR, Nuremberg, Germany; 6 Else KrÃ¶ner-Fresenius-Centre for Nutritional Medicine, TU Munich, Germany
Publications: EASD 44th Annual Meeting, 7-11. September 2008, Rome, Italy
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	English	, Cost effectiveness


Myelodysplastic Syndromes: Aspects of current medical care and economic considerations in Germany
Authors: Gattermann N 1, Hofmann WK 2, MeeÃŸen A 3, Schmitz S 4, Tsamaloukas A 5, Vollmer T 6, Wedding U 7, Plesnila-Frank C 8, Schramm W 9, Berger K 8
Affiliations: 1 UniversitÃ¤tsklinukum DÃ¼sseldorf,Germany 2 CharitÃ© Campus Benjamin Franklin, Berlin, Germany 3 Verband der Angestellten-Krankenkassen e.V. / Arbeiter-Ersatzkassen-Verband e.V., Siegburg, Germany 4 HÃ¤matologe/Onkologe, Cologne, Germany 5 Internist/Onkologe, Hilden, Germany 6 Psycho-Onkologin, Rotterdam, Netherlands 7 UniversitÃ¤tsklinikum Jena, Germany 8 IMS Health, Munich, Germany 9 Klinikum der UniversitÃ¤t MÃ¼nchen, Munich, Germany
Publications: Onkologie 2008; 31: 477-84.
Document Types: , Article
Countries: , Germany
Abstract: http://content.karger.com/produktedb/produkte.asp?doi=142900
Condition	Year	Language	Analysis type
, Hematology	2008	English	, Workshop


A Cost-Minimization analysis comparing Moxifloxacin versus Levofloxacin and Ceftriaxone for the treatment of patients hospitalized with community-acquired Pneumonia in Germany: Results from the MOTIV Trial.
Authors: Lloyd A1, Holman AJ1, Evers T2
Affiliations: 1 IMS Health, London, UK 2 Bayer Healthcare AG, Wuppertal, Germany
Publications: Current Medical Research and Opinion 2008 May;24(5):1279-84
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Infectious disease	2008	English	, Cost minimization


Cross-cultural comparisons of the overweight/obese population in the US and Europe
Authors: Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D
Affiliations:
Publications: ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK, USA
Condition	Year	Language	Analysis type
, Obesity	2008	English	, Retrospective database analysis


Risk and cost of the first hypertension-associated event, compliance and persistence in naive hypertension patients after initiating monotherapy
Authors: Mathes J1, Kostev K2, Gabriel A1, Pirk O1, Schmieder RE3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt, Germany, 3 Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany
Publications: ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2008	English	, Retrospective database analysis


Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany.
Authors: Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G
Affiliations:
Publications: Curr Med Res Opinion, 2008, 24(9): 2489-2499
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Musculoskeletal disease	2008	English	, Retrospective database analysis


Basalinsuline in Kombination mit oralen Antidiabetika stellen den hÃ¤ufigsten Einstieg in die Insulintherapie bei Patienten mit Typ-2-Diabetes dar [Basal insulins (e. g. glargine) combined with oral antidiabetics are most commonly used to initiate insulin therapy in type-2-diabetes patients in Germany].
Authors: Kress S1, Dippel FW2, Kostev K3, Kogler C4, Kotowa W4
Affiliations: 1 Vinzentius-Krankenhaus Landau, Germany 2 Sanofi-Aventis Deutschland GmbH, Germany 3 IMS Health GmbH, Frankfurt, Germany 4 IMS Health, Nuremberg, Germany
Publications: 15. Jahrestagung der Gesellschaft fÃ¼r Arzneimittelanwendungsforschung und Arzneimittelepidemiologie 20.11. - 21.11.2008, Bonn
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2008	German	, Retrospective database analysis


Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
Authors: Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH-Consulting, Juelich, Germany 3 Gruenenthal GmbH, Aachen, Germany
Publications: The European journal of health economics, 21. Dezember 2008
Document Types: , Online article
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Musculoskeletal disease	2008	English	, Cost effectiveness


Erlotinib bei nichtkleinzelligem Lungenkarzinom in Deutschland - eine kostensparende Option [Erlotinib in Non-Smal Cell Lung Cancer (NSCLC) - A cost-saving second-line treatment option]
Authors: Gatzemeier U1,Kotowa W2, Pirk O2, Gabriel A2, Heigener D1
Affiliations: 1 Zentrum fÃ¼r Pneumologie und Thoraxchirurgie Krankenhaus GroÃŸhansdorf, GroÃŸhansdorf, Germany 2 IMS Health, Nuremberg, Germany
Publications: Tumordiagn u Ther 2008; 29:Â 211-217
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2008	German	, Cost minimization


Proactive use of tacrolimus 0.03% ointment in children with moderate or severe atopic dermatitis - outcomes and cost
Authors: ThaÃ§i D 1, Sidhu M 2, Dorsch B 3, KÃ¶hne-Volland R 3, Ehlken B 4, Berger K 4
Affiliations: 1 Dept. of Dermatology, JW Goethe University, Frankfurt, Germany 2 Astellas Pharma Europe Ltd., Middlesex, UK 3 Metronomia GmbH, Munich, Germany 4 IMS Health, Munich, Germany
Publications: ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Pediatrics	2008	English	, Cost of illness


Lungenkarzinom in Deutschland - eine kostensparende Option
Authors: SchÃ¶ffski O1, Fricke FU2, Gabriel SC
Affiliations: 1 University Erlangen-Nuremberg, Germany 2 IMS Health, Nuremberg, Germany
Publications: SchÃ¶ffski O, Fricke F-U, Guminski W (ed.). Pharmabetriebslehre, Berlin-Heidelberg, Springer, 2008, 507-524
Document Types: , Book chapter
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2008	German


Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain.
Authors: Benedict A, Black L, Stokes M, Dorval
Affiliations: 1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada
Publications: ISPOR 11th Annual European Congress
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost effectiveness


Working with IQWiG (Institute for Quality and Economic Efficiency in Health Care)
Authors: Fricke FU
Affiliations: IMS Health, Nuremberg, Germany
Publications: Pharmaceutical Executive Magazine Europe, 2007, Nov/Dec: pp. 24-26
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Regulatory	2007	English	, Pricing & Reimbursement


Second-line treatment of non-small lung cancer (NSCLC) with erlotinib is potentially cost-saving for the German healthcare system
Authors: Gatzemeier U1, Pirk O2, Kotowa W2, Erhardt W3, Gabriel A2
Affiliations: 1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland
Publications: 12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost minimization


A comparison of the estimated cost of erlotinib, docetaxel and pemetrexed for the second-lne treatment of non-small cell lung cancer from the German healthcare perspective
Authors: Kotowa W1 , Gatzemeier U2, Pirk O1, Gabriel A1 , Heigener D2
Affiliations: 1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland
Publications: 12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul Journal of Medical Economics; 10:255-271
Document Types: , Article, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost minimization


Estimated costs associated with different fracture risks related to opioid treatment in Germany
Authors: Kotowa W1, VÃ¶lkl M1, Hass B1, Poulsen Nautrup B2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 EAH Consulting, Juelich, Northrhine Westf
Publications: ISPOR 12th Annual International Meeting 2007, May 19-23, Arlington, VA, USA
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics	2007	English	, Cost effectiveness


Cost-effectineness analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for post-herpetic neuralgia in Germany
Authors: Liedgens H1, Hertel N2, Gabriel A2, Nuijten MJC3, Dakin HA4, SpÃ¶hrer U5, Poulsen Nautrup B1
Affiliations: 1 GrÃ¼nenthal GmbH, Aachen, Germany 2 IMS Health, Nuremberg, Germany 3 Erasmus University, Rotterdam, The Netherlands 4 Abacus International, Bicester, Oxfordshire, UK 5 University Hospital of Munich, Munich, Germany
Publications: Value in Health 10 (6): A 383-384
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2007	English	, Cost effectiveness


Cost-utility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for post-herpetic neuralgia in Germany
Authors: Liedgens H1, Hertel N2, Gabriel A2, Nuijten MJC3, Dakin HA4, Spoehrer U5, Poulsen Nautrup B1
Affiliations: 1 Gruenenthal GmbH, Aachen, Germany 2 IMS Health, Nuernberg, Germany 3 Erasmus University, Rotterdam, Netherlands 4 Abacus International, Bicester, Oxfordshire, UK 5 University Hospital of Munich, Munich, Germany
Publications: ISPOR 10th Annual European Congress, 20-23 October 2007, Dublin, Ireland
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2007	English	, Cost utility


Bleibt die Therapietreue auf der Strecke? [Will compliance get lost?]
Authors: Pirk O
Affiliations: IMS Health, Nuremberg, Germany
Publications: GesundheitsÃ¶konomie & QualitÃ¤tsmanagement 2007, 12(2): 73-74
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Medication compliance	2007	German


Long-term cost-effectiveness of rimonabant in Germany
Authors: Pirk O1, Hessel F2, Kotowa W1, Hertel N1
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Sanofi Aventis Deutschland, Berlin, Germany
Publications: ISPOR 10th Annual European Congress, 20-23 October 2007, Dublin, Irel Value in Health 10 (6): A 414
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Obesity	2007	English	, Cost effectiveness


Depressionsbehandlung in Deutschland: Eine Analyse zur Wirtschaftlichkeit durch Remission [Treatment of depression in Germany: An analysis on cost-effectiveness through remission]
Authors: Voelkl M1, Fritze J2, Hoeffler J3, Roth G4, Ruether E5, Schreiber W6, Schwarzer W7
Affiliations: 1 IMS Health, Nuremberg, Germany 2 Verband der Privaten Krankenversicherung, Koeln, Germany 3 Privatklinik, Bad Gleisweiler, Germany 4 Nervenaerztliche Praxis, Ostfildern, Germany 5 Klinik und Poliklinik fuer Psychiatrie, Georg-August-UniversitÃ¤t, Goettingen, Germany 6 Bezirksklinikum Mainkofen, Deggendorf, Germany 7 Katholische Fachhochschule fr Sozialarbeit, KÃ§ln
Publications: GesundheitsÃ¶konomie & QualitÃ¤tsmanagement 2007, 12(1): 35-43
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health	2007	German	, Cost effectiveness


Cost-effectiveness of insulin detemir versus NPH for type 1 diabetes patients in a German setting. A modeling evaluation based upon results from a meta-analysis.
Authors: Kotchie RW1, Scheijbeler HW1, Aagren M2, Nielsen S3, Valentine WJ3 , Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, BagsvÃ¦rd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Oral presentation, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2007	English	, Cost effectiveness


Long-term cost-effectiveness analysis of a modern insulin in patients with poorly controlled type 2 diabetes in the German setting; data from the PREDICTIVE study
Authors: Palmer JL1, Goodall G1, Aagren M2, Nielsen S2, Kotchie RW3, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk A/S, BagsvÃ¦rd, Denmark; 3 IMS Health, London, UK.
Publications: ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2007	English	, Cost effectiveness


Long-term cost-utility analysis of insulin aspart (NovorapidÂ®) versus human soluble insulin in type 2 diabetes patients in the German setting
Authors: Erny-Albrecht K1, Valentine WJ1, Townsend C2, Kotchie RW3, Nielsen S2, Goodall G1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 NovoNordisk, BagsvÃ¦rd, Denmark; 3 IMS Health, London, UK.
Publications: ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Oral presentation, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2007	English	, Cost effectiveness, Cost utility


Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
Authors: Lloyd A1, Patel N1, Scott DA1, Runge C2, Claes C3, Rose M4.
Affiliations: 1 IMS Health incorporating Fourth Hurdle Consulting, London, UK 2 Wyeth Pharmaceuticals, MÃ¼nster, Germany 3 UniversitÃ¤t Hannover, Hannover, Germany 4 Childrensâ€™ Hospital, Goethe University, Frankfurt, Germany
Publications: Eur J Health Econ 2008 Feb;9(1):7-15. Epub 2007 Mar 2
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.springerlink.com/content/0445788730g5102l/
Condition	Year	Language	Analysis type
, Immunology and Vaccination	2007	English	, Cost effectiveness


Evaluating the long-term clinical and economic implications of converting type 2 diabetes patients to insulin detemir (Â± oral hypoglycemic agents) from insulin glargine based regimens in Germany; data from the PREDICTIVE study
Authors: Valentine WJ1, Goodall G1, Aagren M2, Nielsen S2, Kotchie RW3
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk A/S, BagsvÃ¦rd, Denmark; 3 IMS Health, London, UK.
Publications: ISPOR 2007 10th Annual European Congress ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2007	English	, Cost effectiveness


A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (q3w_da) compared to weekly epoetin alfa (qw_ea) or epoetin beta (qw_eb) in patients with chemotherapy-induced anemia (cia): the German case.
Authors: Van Bellinghen LA, Esposito G, Lamotte M, Bracco A, Goertz A, Annemans L
Affiliations:
Publications: ISPOR 10th Annual European Congress Value in Health 10(6):A328 ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost consequence


Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany.
Authors: Berger K 1, Hessel F 2,3, Kreuzer J 4, Smala A 5, Diener HC 6.
Affiliations: 1 University Hospital Munich, Dept. of Hemostaseology and Transfusion Medicine, Economic Working Group, Munich, Germany 2 HEOR Sanofi-Aventis, Berlin, Germany 3 Institute for Health Care Management, University of Duisburg-Essen, Campus Essen, Essen, Germany 4 St. Vincent- Hospital Limburg, Dept. of Cardiology, Limburg, Germany 5 IMS Health, Munich, Germany 6 University Hospital Essen, Neurological Clinic and Policlinic, Essen, Germany
Publications: Curr Med Res Opin. 2008 Jan; 24(1): 267-74.
Document Types: , Article
Countries: , Germany
Abstract: http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=22008000363
Condition	Year	Language	Analysis type
, Cardiovascular disease	2007	English	, Cost effectiveness


Economic burden of disease of pulmonary arterial hypertension in Germany: an interim analysis of resource utilisation
Authors: Ehlken B, Plesnila Frank C, Ghofrani A, Grimminger F, Hoeper M, StÃ¤hler G, Wilkens H, Berger K, Resch A.
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2007	English	, Burden of illness


Insulin Glargine and NPH Insulin based regimens reveal comparable total direct treatment costs in type 2 diabetes patients. The lon-acting insulin Glargine vs. NPH insulin cost evaluaton study in germany (LIVE-DE)
Authors: Scholten T2, Holle R3, Landgraf W5, Spiesecke A1, Hauner H4
Affiliations: 1 IMS Health, Nuremberg, Germany 2 University of Witten-Herdecke, Hagen, Germany 3 Institute of Health Economics & Health Care Management, Helmholtz Center Munich, Germany 4 Else KrÃ¶ner-Fresenius-Center for Nutritional Medicine, Technical University Munich, Munich, Germany 5 sanofi-aventis, Berlin, Germany
Publications: ISPOR 11th Annual European Congress, 8-11. November 2008, Athen, Greece
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2007	English	, Cost effectiveness


Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
Authors: Plesnila Frank C, Rottenkolber D, Berger K
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics	2007	English


Kosten-Nutzen-Bewertungen von Arzneimitteln werden entscheidungsrelevant [Cost-benefit-assessments become relevant for decision-making].
Authors: Fricke FU1, SchrÃ¶der-Bernhardi D2
Affiliations: 1 IMS Health, Nuremberg, Germany 2 IMS Health, Frankfurt, Germany
Publications: Pharm. Ind., 69(2):160-164
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Health policy	2007	German	, Cost benefit


Anxiety and depression prevalence rates in age-related macular degeneration.
Authors: Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G.
Affiliations:
Publications: Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1498-503.
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy
Abstract: http://www.iovs.org/cgi/content/full/48/4/1498
Condition	Year	Language	Analysis type
, Mental health	2007	English


Treatment outcomes and medical care of patients with neurogenic detrusor overactivity (NDO) receiving botulinum toxin a (BotoxÂ®) therapy
Authors: Ehlken B , Bremer J , BurgdÃ¶rfer H , Domurath B , Hampel C , Kutzenberger J , Seif C , Sievert KD , Wefer B , BÃ¤r K , Berger K , Pannek J
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2007	English


Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Authors: Lordick F, Ehlken B, Ihbe-Heffinger A, Berger K, Krobot KJ, Pellissier J, Davies G, Deuson R.
Affiliations:
Publications: Eur J Cancer 2007; 43(2): 299-307
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.druglib.com/abstract/lo/lordick-f_eur-j-cancer_20070100.html
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Treatment patterns and costs at the point of initiation of oncology patients with moderate to severe pain, not urgent transdermal Opioidanalgetika [Neueinstellung onkologischer Patienten auf transdermale Opioid-Analgetika - Behandlungsmuster und Kosten]
Authors: Paessens B 1, Lippert B 2, Ehlken B 2, Berger K 2, Amann S 1, Bernard R 1, Ihbe-Heffinger A 1.
Affiliations: 1 Klinikum rechts der Isar der Technischen UniversitÃ¤t MÃ¼nchen, Apotheke, Munich, Germany 2 IMS Health, Munich, Germany
Publications: Krankenhauspharmazie 2007; 28 (2): 47-53.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	German	, Prospective study


Treatment patterns for patients with glioblastoma multiforme (GBM) in Germany
Authors: Jenkins A, Aristides M, Liepa AM, Relf C, Feilding B.
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English


Association Between Visual Acuity and Costs, Medical and Non-Medical, in Patients with Wet Age-Related Macular Degeneration in France, Germany and Italy.
Authors: Bandello F, Augustin A, Sahel JA, Benhaddi H, Maurel F, Negrini C, Hieke K, Berdeaux G.
Affiliations:
Publications: Drugs & Aging, 2007.
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy
Abstract: http://cat.inist.fr/?aModele=afficheN&cpsidt=20238855
Condition	Year	Language	Analysis type
, Ophthalmology	2007	English


Estimated cost-savings associated with the use of a new taste-masked oral clarithromycin preparation for the treatment of respiratory tract infections in children in Germany
Authors: Fricke FU1, Gabriel A1, Lungershausen J1, Poulsen Nautrup B2
Affiliations: 1 IMS Health,Nuremberg, Germany 2 Gruenenthal GmbH, Aachen, Germany
Publications: Value in Health 2007, 10(3): A179-A180. Value in Health 2007, 10(3):A 179-A180
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Respiratory disease	2007	English	, Cost analysis, Cost minimization


The effect of cancer drug vintage on cancer survival and mortality.
Authors:
Affiliations: IMS Health
Publications: 2007 European Society of Medical Oncology
Document Types: , Article
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer
Condition	Year	Language	Analysis type
, Oncology	2007	English


Auswirkungen der GesundheitsÃ¶konomie in Industrie und Politik [Effects of Health Economy in Industry and Politics]
Authors: Fricke F-U
Affiliations: IMS Health, Nuremberg, Germany
Publications: Daumann F. et al.: Wettbewerb und Gesundheitswesen: Konzeption und Felder ordnungsÃ¶konomischen Denkens, Budapest, 2006, 335-344
Document Types: , Book chapter
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics	2006	German


Erlotinib in non-small cell lung cancer (NSCLC) in Germany - A cost-saving second-line treatment option?
Authors: Gabriel A1, Pirk O1, Kotowa W1
Affiliations: 1 IMS Health, Nuremberg, Germany
Publications: Value in Health 2006, 9(6): A278
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost minimization


Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany
Authors: Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4
Affiliations: 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands
Publications: ECCEO 6, 2006, March 15-18, Vienna, Austria
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Obesity	2006	English	, Cost effectiveness


Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach?
Authors: Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4
Affiliations: 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands
Publications: ISPOR 9th Annual International Congress, 29-31 October 2006, Copenhagen, Denmark
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Obesity	2006	English	, Cost effectiveness


Zoledronic acid in the long-term management of Paget's disease of the bone in Germany - a cost savings approach?
Authors: Kurth AA1, Kotowa W2, Fricke F-U2, Quednau K3, Maiwenn JA4
Affiliations: 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands
Publications: Value in Health 2006, 9(6)
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Obesity	2006	English	, Cost effectiveness


Long-term cost-effectiveness of zoledronic acid versus risedronate in patients with Paget's disease of the bone in Germany
Authors: Kurth AA1 , Kotowa W2, Goel D3, Maiwenn JA4
Affiliations: 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands
Publications: ECCEO 6, 2006, March 15-18, Vienna, Austria
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Obesity	2006	English	, Cost effectiveness


Zoledronic acid in the long-term management of Pagets disease of the bone in Germany - a cost savings approach?
Authors: Kurth AA1, Kotowa W2, Fricke FU2, Quednau K3, Maiwenn JA4
Affiliations: 1 Orthopaedische Universitaetsklinik Stiftung Friedrichsheim, Frankfurt am Main, Germany 2 IMS Health, Nuremberg, Germany 3 Novartis Pharma GmbH, Nuremberg, Germany 4 Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, Netherlands
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2006	English


Kosten-EffektivitÃ¤t der Acarbosetherapie bei Patienten mit gestÃ¶rter Glukosetoleranz [Cost-effectiveness for acarbose therapy of patients with impaired glucose intolerance]
Authors: Liebl A, Lueddeke HJ, Kotowa W et al
Affiliations: IMS Health, Nuremberg, Germany
Publications: Gesundh Ã¶kon Qual manag 2006; 11:105-111
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2006	German	, Cost effectiveness


Candesartan bei Herzinsuffizienzpatienten - eine kosteneffektive Therapieoption? [Candesartan as a treatment for patients with heart insufficiency - a cost-effectiveness therapy option?]
Authors: Sonntag F1, Schoeffski O2, Voelkl M3
Affiliations: 1 Bundesverband niedergelassener Kardiologen Deutschland, Henstedt-Ulzburg, Germany 2 Lehrstuhl fuer Gesundheitsmanagement, Wirtschafts- und Sozialwissenschaftliche Fakultaet, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Germany 3 IMS Health, Nuremberg, Germany
Publications: MÃ¼nchener Medizinische Wochenschrift (MMW), Fortschritte der Medizin Originalien, I/2006 (148. Jg.): 41-49, 2006.
Document Types: , Manuscript in preparation
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2006	German	, Cost effectiveness


Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany.
Authors: BrÃ¼ggenjÃ¼rgen B, Lindgren P, Ehlken B, Rupprecht HJ, Willich SN.
Affiliations:
Publications: Eur J Health Econ. 2007; 8: 51-7.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Cardiovascular disease	2006	English	, Cost effectiveness


Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a German government payer setting
Authors: Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL
Affiliations:
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes	2006	English	, Cost utility


The Current and Future Burden and Cost of Overactive Bladder in Five European Countries.
Authors: Reeves P1, Irwin D2, Kelleher C3, Milsom I4, Kopp Z5, Calvert N1, Lloyd A1.
Affiliations: 1 Fourth Hurdle Consulting, London, UK 2 Dept of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC,US 3 Dept of Obstetrics and Gynaecology, Guy's and St Thomas' NHS Trust, London, UK 4 Dept of Obstetrics and Gynecology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden 5 Pfizer Inc., New York, US
Publications: European Urology 2006; 50(5): 1050-1057
Document Types: , Manuscript in preparation
Countries: , Germany, Italy, Spain, Sweden, UK
Condition	Year	Language	Analysis type
, Gastrointestinal disorders	2006	English	, Cost of illness


Health care-associated rotavirus illness in pediatric inpatients in Germany, Austria, and Switzerland.
Authors: Foppa I, Karmaus W, Ehlken B, Fruhwirth M, Heiniger U, Plenge-Bonig A, Forster J.
Affiliations:
Publications: Infect Control Hosp Epidemiol. 2006; 27(6): 633-5.
Document Types: , Article
Countries: , Austria, Germany, Switzerland
Condition	Year	Language	Analysis type
, Infectious disease	2006	English	, Epidemiological study


Assessing health-related quality of life in patients with Parkinsonâ€™s disease in a prospective longitudinal study. Parkinsonism Relat Disort.
Authors: Reuther M 1, Spottke EA 1, Klotsche J 1, Riedel O 1, Peter H 1, Berger K 3, Athen O 2, KÃ¶hne-Volland R 2, Dodel RC 1.
Affiliations: 1 University of Marburg, Marburg, Germany 2 Metronomia MÃ¼nchen, Munich, Germany 3 IMS Health, Munich, Germany
Publications: Parkinsonism Relat Disort. 2007 Mar; 13(2): 108-14.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2006	English	, Quality of life


Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Authors: Lordick F 1, Ehlken B 2, Ihbe-Heffinger A 3, Berger K 2, Krobot KJ 4, Pellissier J 5, Davies G 5, Deuson R 6.
Affiliations: 1 Third Medical Department, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 2 IMS Health, Munich, Germany 3 Dept. of Pharmacy, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Outcomes Research, MSD Sharp & Dohme GmbH, Haar, Germany 5 Health Economic Statistics, Merck & Co. Inc., 10 Sentry Pkwy, Blue Bell, USA 6 Outcomes Research, Merck & Co. Inc., One Merck Drive, Whitehouse Station, NJ, USA
Publications: Eur J Cancer 2007; 43(2): 299-307
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Cost of scheduled and unscheduled asthma management in seven EU countries.
Authors: Williams AE1, Lloyd AC2, Watson L1, Rabe KF3.
Affiliations: 1 GlaxoSmithKline R&D, Greenford, 2 Fourth Hurdle Consulting Ltd, London, UK. 3 Leiden University Medical Centre, Leiden, The Netherlands
Publications: European Respiratory Review 2006; 15:(98): 4â€“9
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy, Netherlands, Spain, Sweden, UK
Condition	Year	Language	Analysis type
, Respiratory disease	2006	English	, Burden of illness


Costs and quality of life of multiple sclerosis in Germany
Authors: Kobelt G1, Berg J2, Lindgren P2, Berger K3, Elias WG4, Flachenecker P5, Freidel M6, KÃ¶nig N7, Limmroth V8, Straube E9
Affiliations: 1 Lund University, Lund, Sweden, and European Health Economics, SpÃ©racÃ¨des, France 2 Stockholm Health Economics, Stockholm, Sweden 3 Medical Economics Research Group, Munich, Germany 4 Praxis Hamburg, Hamburg, Germany 5 Neurologisches-Reha.-Zentrum Bad Wildbad, Bad Wildbad, Germany 6 Praxis Kaltenkirchen, Kaltenkirchen, Germany 7 Marianne-Strauss-Klinik Berg, Berg, Germany 8 StÃ¤dtisches Krankenhaus KÃ¶ln-Merheim, KÃ¶ln-Merheim, Germany 9 SIDAplus Hannover, Hannover, Germany
Publications: Eur J Health Econ 2006 Â· 7:S34â€“S44
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Neurological disorders	2006	English	, Quality of life

Selection from HEOR Bibliography